Long-term alterations in the corticotropin-releasing hormone system : effects on emotional function and attention by Van Gaalen, Marcel Maria
Open Research Online
The Open University’s repository of research publications
and other research outputs
Long-term alterations in the corticotropin-releasing
hormone system : effects on emotional function and
attention
Thesis
How to cite:
Van Gaalen, Marcel Maria (2002). Long-term alterations in the corticotropin-releasing hormone system : effects on
emotional function and attention. PhD thesis. The Open University.
For guidance on citations see FAQs.
c© 2002 Marcel Maria van Gaalen
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
Long-term alterations in the 
corticotropin-releasing hormone 
system: effects on emotional function 
and attention
Marcel Maria van Gaalen, MSc 
Submitted for PhD 
Discipline: Life Sciences 
Date of resubmission: 10-07-2002
Sponsor establishment: Max Planck Institute of Psychiatry, Munich, Germany
OP ; 13 -z_ooz.
ProQuest Number: 27532769
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 27532769
Published by ProQuest LLO (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
Director of Studies: Dr T. Steckler
Second Supervisors: Dr A Sahgal
Prof. Dr. Dr. F Holsboer
For Carla & Kim
Table of contents
Abstract........................................................................................................................°
Chapter 1 .................................................................................................................... H
Introduction............................................................................................................. H
Discovery of CRH................................................................................................................................. 11
CRH projection.............................................................................   13
Urocortin................................................................................................................................................14
CRH Receptors...................................................................................................................................... 16
CRH and Behaviour..............................................................................................................................17
CRH in depression, clinical findings...................................................................................................20
Interactions of CRH and the serotonergic system............................................................................. 22
Interactions of CRH and the cholinergic system............................................................................... 25
Anxiety in depression........................................................................................................................... 27
Anxiety-related behaviour in animals..................................................................................................28
Experimental approaches to study anxiety-related behaviour.......................................................... 31
5-HTlA stimulation............................................................................................................................. 34
Attentional processes and depression..................................................................................................34
Attentional processes in animals......................................................................................................... 35
Outline and scope of this thesis........................................................................................................... 36
Chapter 2 ....................................................................................................................39
Material and methods.............................................................................................. 39
Animals.................................................................................................................................................. 39
Examination of spontaneous behaviour...............................................................................................39
Elevated plus maze................................................................................................................................42
Light dark exploration.......................................................................................................................... 42
Open field...............................................................................................................................................43
Novel object exploration.................................................................................................................... •43
Vogel conflict task....................................................................................   44
Hole board exploration......................................................................................................................... 44
Conditioned fear.................................................................................................................................... 45
Hot plate.................................................................................................................................................47
Rotarod................................................................................................................................................... 47
Inescapable swim stress........................................................................................................................ 48
8-OH DP AT induced hypothermia......................................................................................... 48
5-choice serial reaction time task (5-CSRTT)....................................................................................48
5-CSRTT: Apparatus.............................................................................................................................48
5-CSRTT: Habituation............................................       49
5-CSRTT : Autoshaping....................................................................................................................49
5-CSRTT: Simple visual discrimination learning..........................................................................50
5-CSRTT: Baseline performance....................................................................  51
5-CSRTT: Measures..........................................................................................................................51
Plasma corticosterone and ACTH....................................................................................................... 52
Statistics................................................................................................................................................. 52
Chapter 3 .................................................................................................................... 53
Behavioural analysis of four mouse strains in an anxiety test battery.......................53
Introduction............................................................................................................................................53
Material and Methods............................................................................................................................54
Animals..............................................................................................................................................54
Behavioural analysis..........................................................................................................................55
Results.................................................................................................................................................... 55
Examination of spontaneous behaviour...........................................................................................55
Elevated plus maze............................................................................................................................56
Light dark exploration...................................................................................................................... 57
Open field.......................................................................................................................................... 60
Novel object exploration..................................................................................................................61
Vogel conflict task............................................................................................................................ 64
Hole board exploration.....................................................................................................................64
Conditioned fear................................................................................................................................66
Hot plate.............................................................................................................................................68
Inescapable Swim stress...................................................................................................................70
Inescapable Swim stress...................................................................................................................70
Discussion..............................................................................................................................................70
Chapter 4 ....................................................................................................................74
Task-dependent effects of chronic citalopram on treatment on murine anxiety- 
related behaviour.....................................................................................................74
Introduction........................................................................................................................................... 74
Material and Methods........................................................................................................................... 75
Animals..............................................................................................................................................75
Treatment........................................................................................................................................... 75
Behavioural analysis......................................................................................................................... 76
Results....................................................................................................................................................76
Elevated plus maze........................................................................................................................... 76
Light dark exploration...................................................................................................................... 77
Novel Object Exploration..................................  77
Hole board exploration.....................................................................................................................79
Vogel Conflict Task......................................................................................................................... 79
Conditioned fear................................................................................................................................81
Hot plate.............................................................................................................................................81
Body weight.................................................................................................................................. ...81
Discussion.........................................   84
Chapter 5 ....................................................................................................................89
Effects of life-long overproduction of CRH on anxiety-related behaviour in mice 89
Introduction............................................................................................................................................89
Material and Methods........................................................................................................................... 91
Animals....................................................................................................   91
Experiment 1 ..................................................................................................................................... 91
Experiment 2 ..................................................................................................................................... 92
Conditioned fear................................................................................................................................93
Results.................................................................................................................................................... 93
Examination of spontaneous behaviour.......................................................................................... 93
Light dark exploration...................................................................................................................... 95
Novel open field.......................................................................   95
Familiar open field: effects of diazepam........................................................................................ 95
Hole board exploration..................................................................................................................... 98
Lick suppression................................................................................................................................99
Conditioned fear..............................   100
Hot plate...........................................................................................................................................101
Water intake.................................................................................................................................... 103
Sensorimotor skills..........................................................................................................................105
Inescapable swim stress.................................................................................................................. 106
Discussion............................................................................................................................................107
Chapter 6 .................................................................................................................. 113
Transgenic Mice Overexpressing Corticotrophin-Releasing Hormone show reduced 
responsiveness in plasma corticosterone after a 5-HTlA receptor challenge.......... 113
Introduction................................................ 113
Material and Methods............... .........................................................................................................114
Results.................................................................................................................................................. 115
Experiment 1 ................................................................................................................................... 115
Experiment 2 ................................................................................................................................... 116
Discussion......................................................................  117
Chapter 7 ..................................................................................................................121
Effects of chronic treatment with citalopram on anxiety-related behaviour depends 
on emotionality state of test subject........................................................................ 121
Introduction......................................................................................................................................... 121
Material and methods......................................................................................................................... 122
Animals............................................................................................................................................122
Treatment......................................................................................................................................... 122
Behavioural analysis....................................................................................................................... 122
8-OH DPAT induced hyperthermia and HPA-axis activation....................................................123
Body weight.................................................................................................................................... 123
Statistics...........................................................................................................................................123
Results.................................................................................................................................................. 123
Light dark exploration....................................................................................................................123
Open field........................................................................................................................................ 124
Hole board exploration...................................................................................................................126
Conditioned fear..............................................................................................................................126
8-OH DPAT induced hypothermia................................................................................................128
8-OH DPAT induced HPA-axis activation................................................................................... 130
Body weight.................................................................................................................................... 131
Discussion............................................................................................................................................131
Chapter 8 .................................................................................................................. 137
Effects of overproducing CRH on attention in mice................................................137
Introduction..........................................................................................................................................137
Material and methods......................................................................................................................... 139
Animals............................................................................................................................................139
Behavioural procedure.................................................................................................................... 140
Cued detection.................................................................................................................................140
Manipulations of basic task parameters........................................................................................ 140
Drug treatment................................................................................................................................. 141
Results.................................................................................................................................................. 141
Autoshaping procedure................................................................................................................... 141
Acquisition of a simple visual discrimination..............................................................................142
Reduction of stimulus duration...................................................................................................... 144
Extended testing with short stimulus durations............................................................................147
Cued detection.................................................................................................................................150
Effects of mild stress............................................................................................... 151
Effects of acute diazepam treatment..............................................................................................152
Effects of acute R121919 treatment..............................................................................................154
Effects of acute scopolamine treatment.........................................................................................156
Effects of acute physostigmine treatment..................................................................................... 158
Discussion............................................................................................................................................161
Chapter 9 .................................................................................................................. 165
Effects of lack of CRH on................................................................................... ....165
5-choice serial reaction time task performance....................................................... 165
Introduction..........................................................................................................................................165
Material and methods..........................................................................................................................166
Animals............................................................................................................................................166
Behavioural procedure.................................................................................................................... 166
5-CSRRT..........................................................................................................................................166
Manipulations of basic task parameters.........................................................................................166
Effects of social defeat on 5-CSRTT performance.......................................................................167
Effects of inescapable swim stress on 5-CSRRT performance.................................................. 167
Effects of acute scopolamine treatment..................  167
Results.................................................................................................................................................. 167
Autoshaping procedure................................................................................................................... 168
Simple visual discrimination learning...........................................................................................168
Reduction of stimulus duration...................................................................................................... 170
Baseline performance..................................................................................................................... 172
White noise distractor..................................................................................................................... 174
Alterations of ITI duration.............................................................   175
Effects of social defeat................................................................................................................... 177
Effect of Forced swimming on 5-CSRRT.................................................................................... 179
Effect of acute scopolamine treatment..........................................................................................180
Discussion............................................................................................................................................182
Chapter 10................................................................................................................ 187
Effects of reduced CRHRl activity on five-choice serial reaction time performance in 
mice........................................................................................................................ 187
Introduction..........................................................................................................................................187
Material and methods..........................................................................................................................189
Animals............................................................................................................................................189
5-CSRRT..........................................................................................................................................189
Effects of R121919 on baseline schedule..................................................................................... 190
Effects of R121919 in the presence of white noise..............................................  190
Effects of scopolamine on baseline performance........................................................................ 190
Interaction between R121919 and scopolamine...........................................................................191
Effects of CRHRl knockout on task acquisition......................................................................... 191
Effects of CRHRl knockout under conditions of altered stimulus predictability..................... 191
Results.................................................................................................................................................. 191
Effects of acute administration of R121919................................................................................. 191
Effects of acute administration of R121919 in the presence of white noise..............................192
Effects of acute treatment with scopolamine................................................................................ 192
Interaction between R121919 and scopolamine...........................................................................193
Autoshaping in CRHRl knockout mice........................................................................................198
Simple visual discrimination learning in CRHRl knockout mice..............................................198
Effects of reduced stimulus duration on performance of CRHRl knockout mice................... 200
Baseline responding of CRHRl knockout mice.......................................................................... 204
Effects of decreasing the ITI duration.......................................................................................... 206
Effects of increasing the ITI duration........................................................................................... 207
Discussion............................................................................................................................................209
Chapter 11................................................................................................................213
The role of CRHR2 on five-choice serial reaction time performance in mice.... 213
Introduction......................................................................................................................................... 213
Animals........................................................................................................................................... 214
5-CSRRT......................................................................................................................................... 214
Manipulations of basic task parameters........................................................................................ 215
Cued detection.................................................................................................................................215
Effects o f pharmacological treatment on baseline performance.................................................215
Results..................................................................................................................................................216
Autoshaping procedure...................................................................................................................216
Simple visual discrimination learning.......................................................................................... 216
Reduction of stimulus duration...................................................................................................... 218
Baseline performance..................................................................................................................... 222
Effects of acute scopolamine treatment........................................................................................ 231
Effects of acute R121919 treatment..............................................................................................232
Discussion............................................................................................................................................233
Chapter 12................................................................................................................240
Discussion............................................................................................................... 240
The role of CRH on different aspects of Anxiety.............................................................................241
Secondairy effects of overproduction of CRH.................................................................................243
Measuring attention in mice...............................................................................................................247
Overproduction of CRH disturbs sustained and divided attentional processes............................ 248
Sustained and divided attention remains intact without CRH........................................................252
The role of CRHRl and CRHR2 in sustained and divided attention............................................. 252
Acute blockade of CRHRl does not affect sustained and divided attention................................ 254
Effects o f cholinergic durgs are altered in mice with mutations in the CRH system.................. 254
Conclusions......................................................................................................................................... 257
Acknowledgements................................................................................................ 259
List of abbreviations.............................................................................................. 260
List of figures and tables........................................................................................261
List of publications.................................................................................................265
List of publications.................................................................................................265
Abstract
Depression is one of the most common medical conditions worldwide. The most 
frequently observed neuroendocrine symptom among depressives is an enhanced 
secretion of the stress hormone cortisol. It has been hypothesised that corticotropin- 
releasing hormone (CRH) hypersecretion is, at least in part, responsible for these 
elevated cortisol levels. In addition, increased CRH levels in the CSF indicate that 
the hyperactivity of the CRH system is not limited to an augmented release of CRH 
into the portal vein, which indirectly enhances cortisol release, but possibly also in 
the brain. Therefore, it is possible that some of the symptoms, such as increased 
anxiety, altered endocrinological responses to 5-HTia receptor challenge and reduced 
attentional performance observed in depression are due to a hyperactive central CRH 
system. In this work, the role of CRH on these phenomena was investigated in mice.
In order to assess anxiety-related behaviour, a range of anxiety tests, based on 
different principles, were employed. Investigation of differences between four mouse 
strains and effects of long-term treatment with the selective serotonin reuptake 
inhibitor citalopram on anxiety-related behaviour revealed that the outcome of one 
test does not necessarily predict the outcome of another test based on different 
principles, suggesting that different aspects of anxiety can be taxed. Along similar 
lines, life-long overproduction of CRH increases anxiety-related behaviour in some 
paradigms, but not in all. Therefore, one might speculate that chronic CRH excess 
may increase some, but not all, aspects of anxiety. Treatment of CRH overexpressors 
revealed that chronic treatment with citalopram increased anxiety-related behaviour 
in wildtype mice, but induced opposite effects in CRH overexpressing mice, i.e., the
effects of antidepressants depended on baseline performance. Citalopram has 
beneficial effects in both patients suffering from anxiety disorders as well as 
depressive patients. These findings open the possibility that the beneficial effects of 
citalopram in depressed patients may at least in part depend on the activity of the 
CRH system seen in these patients, and that the elevation of CRH activity may be the 
cause of the occurrence of increased anxiety in this illness.
Furthermore, the results obtained with citalopram suggest important interactions 
between CRH and serotonin (5-HT). Related to this, a lack of increased HPA-axis 
activation after a 5-HTia receptor challenge was demonstrated, a phenomenon also 
reported in depressed patients. This contrasts an unaltered hypothermic response 
after such pharmacological challenge in CRH transgenic mice, which has also been 
reported in depressed patients.
Finally, the role of CRH in attentional processes, which are also impaired in 
depressed patients, were investigated. Lack of CRH did not affect visuospatial 
attention. In addition, lack of CRH receptor 2 or acute blockade of CRH receptor 1 
did not affect attentional processes. Life-long loss of CRH receptor 1 resulted in a 
mild impairment. However, closer examination of performance of these animals 
suggest that this may not be a pure attentional deficit and opens the possibility that 
other factors contributed to these effects. In contrast, overproduction of CRH induced 
a more clear-cut impairment in visuospatial attention. Moreover, altered 
responsiveness to cholinergic drugs on visuospatial attentional performance observed 
in these mice point towards an interaction of the CRH system and the cholinergic 
neurotransmitter system in the modulation of these processes.
Taken together, overproduction of CRH increases some aspects of anxiety-related 
behaviour, blocks 5-HTia receptor mediated HPA-axis activation, and disrupts 
visuospatial attention, all symptoms that occur in depression. Therefore, inhibiting 
CRH activity may be a potential target for treatment of depression.
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Chapter 1
Introduction
Discovery of CRH
Regulation of the pituitary-adrenocortical axis by the hypothalamus was first 
proposed by Sir Geoffrey Harris in 1948. This was followed by the discovery in 1955 
that the presence of a factor in hypothalamic extracts could stimulate the release of 
adrenocorticotropic hormone (ACTH; see p. 257 for a list of abbreviations used 
throughout the text) from pituitary cells in vivo (Guillemin and Rosenberg, 1955; 
Saffran and Schally, 1955). This factor was called corticotropin-releasing factor, later 
also known as corticotropin-releasing hormone (CRH). It was not until 1981 that 
CRH was purified and its chemical structure was discovered (Vale et al., 1981). Vale 
and colleagues showed that this 41-residue peptide is highly active in stimulating the 
secretion of ACTH and p-endorphin in vitro as well as in vivo. Stimulation of ACTH 
release in vivo occurs through release of CRH from neurons located in the 
hypothalamic paraventricular nucleus (PVN) into the portal vein. However, not only 
CRH can stimulate ACTH release, but also other molecules, such as arginine 
vasopressin (AVP), catecholamines and angiotensin II have these properties, albeit 
with weaker potency compared to CRH (De Wied et al., 1969; Vale et al., 1981). 
These molecules show synergistic effects with CRH on ACTH secretion
11
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Figure 1.1 Overview of the HPA-axis.
Thus, CRH seems to be the main activator of the hypothalamus-pituitary- 
adrenocortical (HPA) axis (Figure 1.1). ACTH in turn stimulates the adrenal cortex 
to release glucocorticoid hormones (cortisol in humans, and corticosterone in 
animals). The release of glucocorticoids shows circadian rhythmicity, which is under 
influence of the suprachiasmatic nuclei (Moore and Eichler, 1972; Watanabe and 
Hiroshige, 1981). Glucocorticoids are released in the peripheral circulation, where 
most of the glucocorticoids bind to corticosteroid-binding globulin. Only the “free” 
glucocorticoids are biologically active. Glucocorticoids bind to intracellular 
receptors. Two subtypes have been identified, mineralocorticoid receptors (MR) and 
glucocorticoid receptors (GR), which have been shown to differ in topography and 
occupation in the rat brain (Reul and de Kloet, 1985). These authors have 
demonstrated that MR are predominantly expressed in the hippocampus but also, for 
example, in the lateral septum, whereas the distribution of GR is more widespread in 
the brain. The highest density of GR is found in the lateral septum, dentate gyrus, the 
nucleus tractus solitarii and central amygdala, while moderate GR density can be
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observed in the PVN and locus coeruleus. Lowest GR densities were found in the 
raphe nuclei, subiculum and hippocampal CAi field. MR have high affinity for 
corticosterone, which contrasts the affinity of the GR for corticosterone, which is 
about 6 to 10-fold lower. Therefore, the MR is extensively occupied with 
endogenous corticosterone under most circumstances. The GR becomes occupied 
after increasing plasma corticosterone levels, such as at the diurnal peak or after 
stress (Reul and de Kloet, 1985). From that, Reul and De Kloet suggested that the 
MR may be involved in tonic influence of brain fiinction, whereas the GR may be 
involved in feedback action on stress-activated brain mechanisms.
Glucocorticoids inhibit the HPA-axis at several levels. One mechanism acts directly 
at the level of the parvocellular PVN and anterior pituitary (Swanson and Simmons,
1989), whereas indirect inhibition of HPA-axis activity occurs at the level of the 
ventral hippocampus, which projects to the bed nucleus of the stria terminalis 
(BNST). The latter inhibits HPA-axis activity via projections to the PVN (Cullinan et 
al., 1993). Furthermore, it has been shown that lesioning the medial prefi^ontal cortex 
results in an augmented ACTH and corticosterone release after restrained stress, but 
not after exposure to ether. This suggests that the medial preffontal cortex plays a 
role in negative feedback effects on HPA-axis activation under some stressftil 
conditions (Diorio et al., 1993).
CRH projection
CRH is not only a potent activator of the HPA-axis, but CRH is also known to play a 
role in the central nervous system as a neuromodulator. CRH-containing neurons 
have been identified throughout the neocortex, with high densities in the preffontal
13
and cingulate cortices (Swanson et al., 1983). Furthermore, high densities of CRH- 
immunoreactivity have been observed in the central nucleus of the amygdala, the 
BNST, the hippocampus, the nucleus accumbens, the posteromedial thalamic nuclei, 
such as the mediodorsal nuclei, the substantia nigra, the locus coeruleus, the dorsal 
and medial raphe nuclei, the periaqueductal grey, the olfactory bulbs, the 
parabrachial nuclei, the nucleus of the solitary tract and the cerebellum 
(Merchenthaler, 1984; Morin et al., 1999; Sakanaka et al., 1986; Swanson et al., 
1983; Van Bockstaele et al., 1996; Takahashi et al., 1998). Furthermore, CRH has 
been localised in the adrenal medulla, lymphocytes, testis, pancreas, stomach and 
small intestine. High levels of CRH have been measured in the plasma of pregnant 
women, whereas CRH is not detectable under non-pregnant circumstances. The 
source of CRH in pregnancy appears to be the placenta (Owens and Nemeroff, 
1991).
Urocortin
Two non-mammalian homologues of CRH, urotensin and sauvagine, have been 
described (Lederis et al., 1982; Montecucchi et al., 1980). More recently, a new 
member of the CRH peptide family was discovered. This mammalian peptide, called 
urocortin (UCN), was found to bind to CRH receptors with higher affinity than CRH 
itself (Vaughan et al., 1995; Donaldson et al., 1996). High levels of mRNA of this 
endogenous neuropeptide have been found in various midbrain areas and the 
Edinger-Westphal nucleus in the rat brain. Moderate levels have been observed in the 
hippocampus, the basal ganglia, the medial septum, the medial and cortical 
amygdaloid nuclei, the PVN, the ventromedial nucleus of the hypothalamus, the 
superior colliculus, the red nucleus, the substantia nigra pars compacta and the
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cerebellar cortex (Wong et al., 1996). Furthermore, UCN containing cell bodies have 
been identified in the cholinergic laterodorsal tegmental nuclei, the serotonergic 
dorsal raphe nucleus, the periaqueductal grey and, although only few, in the 
hypothalamus (Kozicz et al., 1998; Morin et al., 1999). In addition, a dense 
immunoreactive fiber network but no UCN-immunoreactive neurons were observed 
in the lateral septum (Kozicz et al., 1998; Morin et al., 1999). Although there seems 
to be a regional specificity for UCN expression in rat brain, in human brain it has 
been reported to show a much more uniform distribution (Takahashi et al., 1998). 
Veiy recently, urocortin II (UCNII, also known as stresscopin-related peptide) 
(Reyes et al, 2001; Hsu et al, 2001) and urocortin III (UCNIII, also known as 
stresscopin) (Hsu et al, 2001; Lewis et al, 2001), two new members of the CRH 
neuropeptide family, have been described. This peptide binds to CRHR2 only, and is 
expressed in discrete regions of the rodent brain, including stress related cell groups 
in the hypothalamus (PVN and arcuate nuclei) and brainstem (locus coeruleus), and 
partly overlaps with the expression of CRH and Urocortin. The localisation of 
UCNIII, on the other hand, is distinct from that of CRF, UCN and UCNII. UCNIII is 
found in the median pre-optic area, the rostral perifomical area, the posterior part of 
the BNST and the medial nucleus of the amygdala (Lewis et al, 2001).
Urocortin is more potent in stimulating HPA-axis activity compared to CRH in rat. 
However, there is evidence that CRH, and not urocortin, is the major endogenous 
regulator of pituitary ACTH secretion under basal conditions or during acute 
footshock stress (Turnbull et al, 1999; Masuzawa et al, 1999)
15
CRH Receptors
So far, two CRH receptors, CRHRl and CRHR2, have been identified (Chang et al., 
1993; Chen et al., 1993; Vita et al., 1993; Lovenberg et al., 1995b). Two splice 
variants are known from CRHR2, CRHR2a and CRHR2P (Lovenberg et al., 1995a). 
CRHR2p have been observed to be expressed in the brain and in the periphery, with 
the greatest abundance in the heart and skeletal muscle. CRHR2a, in contrast, is 
found almost exclusively in the brain. Likewise, CRHRl is primarily localised in the 
brain. CRHRl and CRHR2a receptor distribution patterns, however, are partly 
distinct. Thus, CRHRl have been almost exclusively observed in frontal cortical 
areas, the cholinergic basal forebrain (medial septum and diagonal band of Broca), 
the brainstem cholinergic nuclei (laterodorsal tegmental nucleus and 
pedunculopontine tegmental nucleus), the superior colliculus, the basolateral nucleus 
of the amygdala, the cerebellum, the red nucleus, the trigeminal nuclei, and anterior 
pituitary. CRHR2a receptors, however, are more strongly expressed in the PVN, the 
ventromedial nucleus of the hypothalamus, the lateral septum, the cortical and medial 
nuclei of the amygdala and the serotonergic nuclei, whereas other areas such as the 
olfactory bulb, the hippocampus, the entorhinal cortex, the BNST and periaqueductal 
grey show a more mixed expression of CRHRl and CRHR2a (Chalmers et al., 1995; 
Lacroix and Rivest, 1996; Lovenberg et al., 1995b; Sauvage and Steckler, 2001). 
Furthermore, others have reported additional CRHRl expression in the central 
nucleus of the amygdala and substantia nigra (Ambrosio et al., 1997; Lacroix and 
Rivest, 1996) and in the locus coeruleus, (Sauvage and Steckler, 2001; Sanchez et 
al., 1999). There is, however, evidence that expression patterns differ between 
species and even strains (for review see: Steckler, Holsboer, 1999).
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On the basis of expression patterns, it has been suggested that UCN might be the 
endogenous ligand of CRHR2 (Vaughan et al., 1995). However, the recently 
discovered ligands which have stronger affinity for the CRHR2, UCNII and UCN III, 
also known as stresscopin in human, may be more likely candidates (Reyers et al., 
2001, Hsu and Hsueh, 2001, Lewis et al., 2001).
CRH and Behaviour
Effects of CRH administration on behaviour have been extensively reviewed (Dunn 
and Berridge, 1990; Owens and Nemeroff, 1991; Heinrichs et al., 1997; Steckler and 
Holsboer, 1999). Intracereboventricular (i.c.v.) CRH administration increases 
anxiety-related behaviour in a variety of anxiety tests (Dunn and Berridge, 1990). 
Similar effects have been found after i.c.v. administration of urocortin (Moreau et al., 
1997). These effects seem to be centrally mediated, as peripheral CRH 
administration does not result in altered anxiety-related behaviour, and anxiogenic 
effects are still present after CRH administration following pre-treatment with doses 
of dexamethasone that adequately block HPA-axis activation (Dunn and Berridge, 
1990). However, i.c.v. administration results in non-specific stimulation of both 
CRHRl and CRHR2. Several techniques have been applied to reveal which receptor 
subtype mediates the effects on anxiety-related behaviour. Investigations using 
oligodeoxynucleotides (ODNs) indicated that ODNs against CRHRl reduced 
anxiety-related behaviour (Liebsch et al., 1999; Skutella et al., 1998; Heinrichs et al., 
1997a), whereas ODNs against CRHR2a mRNA did not affect anxiety-related 
behaviour (Liebsch et al., 1999; Heinrichs et al., 1997a).
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In addition, two studies, investigating two independently generated CRHRl 
knockout mice, show that loss of CRHRl leads to reduction in anxiety-related 
behaviour (Timpl et al., 1998; Smith et al., 1998). Subsequently, anxiety-related 
behaviour in three independently generated CRHR2 knockout mice was investigated. 
Two groups reported increased anxiety-related behaviour in these knockout animals 
in some, but not all anxiety tasks (Kishimoto et al., 2000; Bale et al., 2000), whereas 
Coste and colleagues (2000) did not find a significant genotype dependent effect on 
anxiety-related behaviour. Further support for a role for CRHRl subtype in anxiety- 
related behaviour comes from reports of anxiolytic effects induced by several 
CRHRl antagonists (Griebel et al., 1998; Steckler and Holsboer, 1999). However, 
others reported that the anxiolytic actions of these antagonists only became apparent 
after CRH administration (Schulz et al., 1996), or after increment of stress in the test 
paradigm (anxiolytic effects of CRHRl antagonist treatment in the fear potentiated 
startle paradigm, but not in acoustic startle paradigm for example). This is in line 
with a study fi*om Okuyama and colleagues (1999), in which they showed reversal of 
CRH induced anxiety-related behaviour and anxiolytic effects after stress, but not 
under basal conditions. These stress-dependent effects of CRHRl antagonists have 
also been suggested as a possible explanation for the equivocal results in rats tested 
on the plus maze (Griebel et al., 1998). Recently, Takahashi and colleques (2001) 
showed that acute blockade of CRHR2 using antisauvagine-30 also reduces anxiety- 
related behaviour in three models of anxiety, which is in contrast to the effects of 
life-long loss of CRHR2 (see above). In addition, results from recent data suggest 
that i.c.v. administration of UCNII and UCNIII reduce anxiety related behaviour on 
the elevated plus maze, but only hours after administration (Reul and Holsboer, 
2002). Taken together, this suggests that stimulation of CRHRl increases anxiety-
18
related behaviour, whereas the role of CRHR2 in anxiety-related behaviour is less 
clear.
Increasing anxiety, in general, is accompanied by a change in arousal. This is 
coupled with a heightened focus of attention towards stimuli perceived as 
threatening. CRH, however, might modulate arousal and attentional processes 
independent of the positive and negative value of stimuli.
Animals may be underaroused, optimally aroused or overaroused, and performance 
is related to arousal in a negative-U-related manner (Yerkes and Dodson, 1908). 
CRHRl are found in brain areas such as the cholinergic basal forebrain nuclei, the 
brainstem cholinergic nuclei, the superior colliculi, frontal cortical areas, locus 
coeruleus, ventral tegmental area and substantia nigra (Sauvage and Steckler, 2001). 
These brain areas play an important role in the mediation of attentional and executive 
functions (Gallagher and Holland, 1994; Garcia-Rill, 1991; Muir et al., 1992, 1994, 
1996; Steckler et al., 1994), and have reciprocal connections with the central 
amygdala, an area which has also been implicated in attentional processes (Gallagher 
and Holland, 1994; Loughlin and Fallon, 1983). It is of course tempting to speculate 
that the central amygdala is one of the important sources of CRH input to, at least 
some, of these areas (Steckler and Holsboer, 1999). This, together with the 
interactions between CRH and the cholinergic system (see above), a system that is 
crucial in attentional processes, suggest that CRH might play a role in attention.
Furthermore, CRH is known to have effects on several other aspects of behaviour. 
Locomotor activity, for example, is affected by CRH administration, although this 
effect seems to depend on the testing environment. Thus, increased locomotor
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activity occurs in familiar environments after CRH treatment, whereas CRH 
administration reduces locomotor activity under novel conditions (Dunn, Berridge,
1990). In addition, numerous studies show that CRH plays a role in learning and 
memory, feeding and reproductive behaviour (Dunn, Berridge, 1990).
CRH in depression, clinical findings
When Harvey Cushing described the Cushing syndrome in the early 20th century, he 
already mentioned a high occurrence of depression in these patients (Cushing, 1913; 
1932). Later studies showed that patients diagnosed with Cushing syndrome show a 
higher occurrence of depression than patients with other pituitary tumours (Kelly et 
al., 1980). Furthermore, reduction of Hamilton rating scale score, an index for the 
severity of depression, was found to be accompanied by normalisation of the cortisol 
plasma levels in these patients (Kelly et al., 1983). This suggests that increased HPA- 
axis activity and depression may correlate.
ACTH and cortisol plasma levels of patients suffering from depression are often 
elevated. Moreover, a flattening of circadian cortisol plasma levels was observed 
(Schmider et al., 1995; Deuschle et al., 1997). Furthermore, the circadian disturbance 
in ACTH and cortisol plasma levels in depressives normalises during clinical 
remission (Mendlewicz and Linkowski, 1987). In addition, increased adrenal 
volumes have been reported in depressed patients (Nemeroff et al., 1992; Amsterdam 
et al., 1987; Rubin et al., 1995). Likewise, the size of the pituitary has been shown to 
be increased in depressed patients (Krishnan et al., 1991). Although it has been 
suggested that adrenal gland enlargement might be a measure of cumulative life time 
depression (Nemeroff et al., 1992), there is also evidence that increased adrenal
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gland size is state dependent, as it has been shown that it reverts to the normal size 
range during treatment induced remission (Rubin et al., 1995).
It has been hypothesised that CRH hypersecretion is, at least in part, responsible for 
the hyperactivity of the HPA-axis seen in depression. Results from several studies 
indicate that CRH levels in the cerebrospinal fluid (CSF) are increased in depressed 
patients (Risch et al., 1992; Nemeroff et al., 1991, 1984; Banki et al., 1987). 
Moreover, there is evidence that CRH neurons in the PVN are hyperactive in 
depressed patients (Raadsheer et al., 1994, 1995). However, others indicated that 
increased CSF CRH levels could only be demonstrated in depressed patients who 
were nonsuppressors in the dexamethasone suppression test (DST, see below: Roy et 
al., 1987). One possibility could be that the level of CRH overactivity is related to 
the severity of depression, and both, factors have indeed been shown to correlate 
(Risch et al., 1992).
Administration of dexamethasone, a glucocorticoid agonist, can suppress HPA-axis 
activity in controls, whereas it is less effective in depressed patients, which was first 
described by Caroll and co-workers (Caroll et al., 1968). This effect became known 
as the dexamethasone suppression test (DST). Furthermore, in healthy controls, 
dexamethasone is sufficiently potent to inhibit CRH-induced ACTH and cortisol 
stimulation (von Bardeleben et al., 1985), whereas ACTH and cortisol are released 
after CRH administration despite dexamethasone pre-treatment in depressed patients 
(Holsboer et al., 1987; Holsboer-Trachsler et al., 1991). Successful treatment has 
been reported to result in cortisol levels indistinguishable from that of controls, 
whereas ACTH levels were still enhanced (Holsboer-Trachsler et al., 1991). CRH
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administration in depressives results in a blunted ACTH response, but not in cortisol 
response, compared to healthy controls (Holsboer et al., 1986). However, others 
reported that only DST nonsuppressors exhibit a blunted ACTH response to CRH, 
whereas DST suppressors exhibit a normal ACTH response to CRH (Krishnan et al., 
1993). Krishnan and co-workers suggested that these two abnormalities in HPA-axis 
function are functionally related related, and therfore may be due to similar 
pathophysiological mechanisms. Furthermore, elevations of CSF CRH levels in 
depressed patients were normalised after ECT, suggesting that the increase in CSF 
CRH concentrations in depressed patients is state dependent (Nemeroff et al., 1991).
Taken together, disregulated HPA-axis functioning in depression is, at least in part, 
likely to be due to increased CRH secretion. Furthermore, increased CRH levels in 
the CSF indicate that the hyperactivity of the CRH system is not limited to an 
augmented release of CRH into the portal vein, but possibly also in the brain. 
Therefore, it is possible that some of the symptoms, such as increased anxiety and 
reduced attentional performance, observed in depression, are due to a hyperactive 
central CRH system. This could be due to direct effects of CRH, or via alteration of 
other neurotransmitter systems.
Interactions of CRH and the serotonergic system
Occurrence of depression is not only associated with alteration in the CRH system. 
In particular, the serotonergic (5-hydroxytryptamine, 5-HT) system has been 
implicated in the modulation of anxiety and depression, especially the 5-HTia 
receptor (Deakin, 1998; Heinrichs et al., 1997b; Holsboer and Barden, 1996). There 
are nine clusters of serotonin containing cells in the brain (Bl—>B9). Serotonergic
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neurons projecting to the forebrain are primarily located within the pons structures, 
the dorsal (B6 and B7) and median (8) raphe nuclei and B9. The other clusters 
(B1-^B5) project to the brainstem and spinal cord. 5-HTia receptors are expressed 
presynaptically, where they function as inhibitory autoreceptors, and 
postsynaptically. Systemic administration of 5-HTia agonists can inhibit the firing 
rate of serotonergic neurons in the dorsal raphe nucleus (Sprouse and Aghajanian, 
1987) and has been reported to inhibit central 5-HT release (Hjorth and Sharp, 1991).
Interactions between the serotonergic system and CRH can be found at various 
levels. It has been shown that CRH can affect serotonergic function via actions at the 
level of the cell body region of the dorsal raphe serotonergic system (Kirby et al., 
2000; Price et al., 1998) and serotonergic responsivity is altered after long-term i.c.v. 
infusion of CRH (Linthorst et al., 1997). Furthermore, CRH can affect the 
serotonergic system indirectly via HPA-axis activation. For example, glucocorticoid 
hypersecretion may downregulate the sensitivity of postsynaptic 5-HTia signal 
transduction or downregulate the expression of 5-HTia receptors (Chaouloff, 1993; 
Deakin et al., 1990). Furthermore, serotonergic hyperresponsivity following 
exposure to a psychological stressor has been reported in mice with impaired GR 
(Linthorst et al., 2000). Conversely 5-HT is known to influence HPA-axis activity 
via induction of CRH release. Serotonergic neurons have been shown to synapse at 
CRH-containing fibers in the PVN (Sawchenko et al., 1983; Liposits et al., 1987). 
More specifically, 5-HTia receptors seem to play a role in regulating CRH release. 
Systemic administration of 8-hydroxy-2-(di-n-propylamino)tertalin (8-OH DPAT), a 
5-HTiA receptor agonist, activates the HPA-axis (Calogero et al., 1990). 
Furthermore, local application of 8-OH DPAT into the hypothalamus, or more
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specifically, into the PVN also increases HPA-axis activity (Korte et al., 1991; Pan 
and Gilbert, 1992). The 8-OH DPAT-induced increase of ACTH is inversely 
correlated with a reduction of hypothalamic CRH. Moreover, 8-OH DPAT induced 
ACTH release can be diminished by CRH antiserum (Calogero et al., 1990), 
suggesting that activation of the HPA-axis by 8-OH DPAT occurs, at least in part, 
via CRH release triggered off by stimulation of 5-HTia receptors at hypothalamic 
level. In addition, ipsapirone (another 5-HTia agonist) also induces corticosterone 
release, and this effect is abolished after lesion of the PVN (Bagdy, 1996).
5-HT also plays a role in sleep, appetite-regulation, cognitive function, impulsivity, 
sexual behaviour, motor function and modulation of limbic/affective responsiveness. 
Furthermore, 5-HT is involved in neuronal homeostasis, and in regulation of the 
HPA-axis (Ressler and Nemeroff, 2000). In depression, most pharmacological 
evidence supports the hypothesis that the serotonergic system is hypoactive (Maes 
and Meltzer, 1995). In addition, dysfunction of the serotonergic system has been 
reported to occur in patients suffering ftrom anxiety disorders. It has been suggested 
that this dysfunction mediates the symptoms of both disorders, although it is less 
likely that the underlying causes of these disorders could be found in the 5-HT 
system per se (Ressler and Nemeroff, 2000): antidepressants are effective in both 
treatment of major depression and some anxiety disorders. However, it requires 
several weeks of treatment before clinical improvement can be observed (Blier et al., 
1990; Chamey et al., 1990). Data from preclinical studies show that long-term, but 
not acute, treatment with SSRI’s enhances 5-HT neurotransmission (Chaput et al., 
1986). Furthermore, increased density and sensitivity of the postsynaptic 5-HTia 
receptor has been shown after repeated antidepressant treatment or electroconvulsive
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shock therapy (ECT) (de Montigny and Aghajanian, 1978; Dijcks et al., 1991). This 
opens the possibility for an important role of the 5-HTia receptor in the treatment 
response, although it is not clear at this moment whether main effects are mediated at 
pre- and/or postsynaptic level. Thus, data from studies investigating presynaptic 5- 
HTia function indicate that long-term antidepressant treatment desensitises 5-HTia 
autoreceptors function (Chaput et al., 1986; Hervas et al., 2001; Invemizzi et al., 
1994; Le Poul et al., 1995), and it has been suggested that effects of chronic 
antidepressant treatment on pre- or post-synaptical binding sites might be dependent 
on the class of antidepressant used (Weiner et al., 1989).
This evidence has led to the hypothesis that anti-anxiety or antidepressant effects of 
antidepressants might exert their clinical action via enhancement of serotonergic 
neurotransmission caused by desensitisation of 5-HTia autoreceptors (Albert et al., 
1996), possibly in concert with the increased postsynaptic sensitivity of 5-HTia 
receptors (Weiner et al., 1989). However, interactions with other 5-HT receptor 
subtypes, or other neurotransmitter / neuromodulator systems, such as CRH, are 
likely to contribute as well.
Interactions of CRH and the cholinergic system
Another candidate neurotransmitter system via which CRH may effect behaviour is 
the cholinergic system. One of the properties of CRH is to potentiate arousal (Koob 
et al., 1990). Arousal can be defined as a state which optimises the processing of 
sensory stimuli in the cerebral cortex (Hebb, 1955) and is therefore related to 
attentional function (Robbins and Everitt, 1994). This in turn suggests that CRH 
plays a more general role than just to mediate responses to aversive events, but
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maintains attention towards events or cues of biological significance, regardless of 
the nature of the reinforcer (Merali et al., 1998). It could be speculated that activation 
of the CRH system is beneficial for optimising attentional processes, whereas a 
hyperactive CRH system might be disruptive. Effects of CRH on attentional 
processes might be via interactions with the cholinergic system.
There are several findings to support this hypothesis. For example, CRHRl is highly 
abundant in brain areas which have been suggested to play a role in attention, such as 
fi*ontal cortical areas, the superior colliculi, the cholinergic basal forebrain and 
brainstem nuclei (Bittencourt and Sawchenko, 2000; Chalmers et al., 1995). 
Furthermore, a high degree of co-localisation of choline-acetyltransferase and CRH 
receptor-like immunoreactivity has been observed in both the murine basal forebrain 
and brainstem, with the exception of the substantia innominata (Sauvage and 
Steckler, 2001). The prefi*ontal cortex (Muir et al., 1996), the superior colliculi and 
the cholinergic basal forebrain (Muir et al., 1992; 1994; Robbins et al., 1989) have 
been strongly implicated in the mediation of different types of attention, and the 
cholinergic brainstem nuclei have been also demonstrated to control arousal and 
attentional fimctions (Garcia-Rill, 1991; Steckler et al., 1994). Moreover, in rats, 
i.c.v. CRH administration produces moderate to strong stimulation of Fos expression 
within the basal forebrain and brainstem nuclei, i.e., within the medial septum and 
diagonal band of Broca, the laterodorsal and the pedunculopontine tegmental nuclei, 
while only relatively weak Fos expression is induced within the substantia 
innominata (Bittencourt and Sawchenko, 2000). Furthermore, i.c.v. but not 
peripheral injections of CRH increases hippocampal acetylcholine release (Day et al., 
1998a).
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However, CRH might affect attentional processes via other neurotransmitter system 
such as the noradrenergic system. It has been demonstrated that the locus coeruleus 
is also involved in modulation of arousal and attention (Carli et al., 1983; Cole and 
Robbins, 1992; Foote et al., 1983; Usher et al., 1999). Electrophysiological activation 
of the noradrenergic locus coeruleus by CRH has been reported (Butler et al., 1990; 
Valentino et al., 1993), opening the possibility that this may be an additional site 
through which CRH exerts influence on attentional abilities. Interestingly, there is 
evidence for strong CRHRl immunoreactivity co-localised with tyrosine 
hydroxylase at the level of the locus coeruleus (Sauvage and Steckler, 2001). Taken 
together, these observations support the idea that CRH might play a prominent role 
in the modulation of attentional processes, possibly through activation of CRHRl. 
However, behavioural evidence is lacking.
Anxiety in depression
From clinical investigations, we know that the CRH system is disturbed in depressed 
patients. It is less clear whether these disturbances are the cause or the result of 
depressive illness.
Even if CRH is causally involved, disruption of the CRH system may only lead to a 
limited set of depressive symptoms. Therefore, investigation of the role of the CRH 
system in different behavioural processes linked to depression is desirable. However, 
depression is hard to model in animals. Although a number of tests have been 
described in which effects of antidepressants can be measured in animals, they do not 
necessarily reflect good models of depression with high validity. Employing a range
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of paradigms might therefore be advisable for investigation of several phenomena 
that are disturbed in depression.
One of the frequently occurring symptoms in depression is increased anxiety. 
Depression and anxiety disorders are generally classified as separate types of 
syndromes, however, many of the symptoms are overlapping in these diseases 
including fatigue, impaired concentration, irritability, sleep disturbance, worry and 
restlessness (Ninan, 1999). In addition, these syndromes share a common 
pathophysiology (Weiss et al., 1994). Furthermore, there is a high occurrence of 
anxiety disorders in depressive patients and vice versa (Ressler and Nemeroff, 2000).
Anxiety-related behaviour in animals
Exposure to a foot shock avoidance procedure or just to an elevated plus maze 
induced Fos-like immunoreactivity in the medial prefrontal, cingulate and 
ventrolateral orbital cortices, taenia tecta, nucleus accumbens, PVN, medial nucleus 
of the amygdala and lateral septum (Duncan et al., 1996). Exposure to airpuff stimuli 
that produced ultrasonic vocalisations induced Fos-like immunoreactivity to a more 
limited extent compared to shock avoidance and exposure to an elevated plus maze, 
with only the medial prefrontal cortex, medial nucleus of the amygdala and lateral 
septum being affected. Common forebrain regions affected after all three procedural 
manipulations were the medial prefrontal cortex, the medial amygdala and the lateral 
septum. Therefore, it has been suggested that these three regions are components of a 
common circuit related to anxiety or distress (Duncan et al., 1996). However, it is 
also evident from these results that there are task-specific alterations in brain activity. 
For example, expression of Fos-like immunoreactivity in the PVN and locus
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coeruleus is increased after foot shock avoidance procedure, but not after elevated 
plus maze or air puff procedures, although others did find an increased after plus 
maze behaviour in the PVN (Silveira et al., 1993). Lack of Fos-like 
immunoreactivity in the PVN was also reported after conditioned fear, whereas 
conditioned fear did increase Fos-like immunoreactivity in, among other areas, 
medial prefrontal cortex, various amygdalar nuclei and the lateral septal nucleus 
(Beck and Fibiger, 1995).
This is in line with findings showing that different brain structures are involved in 
different types of anxiety-related behaviour. For example, a dissociation between 
trait and state anxiety has been suggested (Griebel et al., 1993; Beuzen and Belzung, 
1995). Anxiolytics of the GAB A/benzodiazepine and serotonergic class have been 
reported to reduce anxiety-related behaviour in a light-dark choice test, a model that 
has been suggested to allow investigation of state anxiety. Conversely, anxiolytics of 
the GAB A/benzodiazepine class, but not of the serotonergic class, reduce anxiety- 
related behaviour in a free exploration paradigm, a model for trait anxiety (Kopp et 
al., 1999). Likewise, it has been demonstrated that selective cholecystokinin type B 
receptor agonists reduces state, but not trait anxiety, measured in these paradigms 
(Belzung et al., 1994b). The anxiolytic effects of 5-HTia agonists have also been 
demonstrated to be test specific (Griebel et al., 2000). In addition, it has been 
claimed that drugs with proven clinical efficacy in panic disorder have reliably 
stronger effects on flight responses than on other components of the defensive 
repertoire (Rodgers, 1997). This indicates that various neurotransmitter systems play 
different roles in the modulation of anxiety depending on the type of anxiety-related 
behaviour being assessed.
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To complicate matters, anxiolytic effects of benzodiazepines in different anxiety 
tasks seem to be dependent on brain area. Local administration of midazolam, an 
anxiolytic of the benzodiazepine class, into the septum increased open arm 
exploration on the elevated plus maze and decreased burying behaviour in the shock- 
probe test, both indicative for anxiolytic action. When midazolam was administered 
in the amygdala, it did not affect these parameters. However, injection of midazolam 
into the amygdala impaired shock-probe avoidance, an effect that did not occur after 
septal infusions (Pesold and Treit, 1994). A follow-up experiment of the same group 
showed that these impairment in shock-probe avoidance can be induced by infusion 
of midazolam in the central, but not in the basolateral nucleus of the amygdala 
(Pesold, Treit, 1995), which indicates that the shock-probe avoidance effects of 
midazolam are likely to be mediated by the central nucleus of the amygdala. 
Strikingly, basolateral infusion increased open arm activity on the elevated plus 
maze, but left shock-probe burying behaviour unaffected. This is in line with 
amygdaloid nuclei-dependent effects of benzodiazepines on plus maze behaviour by 
Green and Vale (Green and Val, 1992). Further support for a specialised role of 
distinct nuclei of the amygdala comes from a fear conditioning study. Here, it was 
shown that lesioning the central nucleus of the amygdala or basolateral amygdala 
prevented distinct lesion-specific behavioural responses elicited by a conditioned 
stimulus (Killcross et al., 1997).
Taken together, there is evidence that different aspects of anxiety-related behaviour 
can be assessed in rodents. These aspects may be mediated via different brain 
structures / pathways. However, there is also evidence that some areas mediate
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symptoms across different anxiety disorders. Rauch and colleagues (1997), for 
example, showed in a positron emission tomography study that elements of the 
paralimbic belt (i.e., posterior medial orbitofrontal, anterior cingulate, insular, 
parahippocampal and anterior temporal cortex), and right inferior frontal cortex 
mediate symptoms across different anxiety disorders in man.
Experimental approaches to study anxiety-related behaviour
In this work, a range of tests was used in order to assess anxiety-related behaviour. 
Conceptually, the paradigms used in this work can be grouped into different 
categories, such as tasks primarily based on free exploration of novel environments 
(elevated plus maze, light dark exploration, hole board), free exploration of novelty, 
but based within a familiar surrounding (novel object exploration), conflict 
paradigms (Vogel conflict) and tasks involving a strong mnemonic component (fear 
conditioning).
The elevated plus maze has been suggested to be based on the natural aversion of 
rodents for heights and open spaces (Montgomery, 1955), and can be considered a 
standard paradigm for testing anxiogenic- and anxiolytic-like responses in rats and 
mice (Lister, 1987). The main anxiogenic factor suggested to underlie explorative 
behaviour in the light dark exploration is the aversive nature of an open, brightly 
illuminated area (Costall et al., 1989; Crawley and Goodwin, 1980; Crawley, 1981). 
Explorative anxiety paradigms like these have been suggested to measure state 
anxiety (Belzung and Le Pape, 1994a; Belzung et al., 1994b; Kopp et al., 1999). In 
contrast, in the novel object exploration task, mice are first habituated to an 
environment and subsequently exposed to novelty (Misslin and Ropartz, 1981).
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Exploration of novelty from an area known to be safe has been suggested to 
fundamentally differ from exploration of a totally new environment and has been 
claimed to reflect trait rather than state anxiety (Griebel et al., 1993).
The hole board, on the other hand, has been suggested to allow investigation of 
exploratory behaviour in rats (Escorihuela et al., 1999) and mice (Rogers et al., 
1999). In mice, it has been shown that the number of hole visits decreases following 
restraint stress, which is prevented by treatment with benzodiazepine and non­
benzodiazepine anxiolytics, independent of locomotor activity (Takeda et al., 1998).
In addition, analysis of different aspects of spontaneous behaviour has been 
suggested to be indicative of anxiety-related behaviour. For example grooming 
behaviour, which has been shown to increase after stress exposure in a range of 
paradigms, has been considered as displacement behaviour (Dunn et al., 1981; van 
Erp et al., 1994; Spruijt et al., 1992). In addition, it has been demonstrated to increase 
after i.c.v. CRH administration (Britton et al., 1986; Diamant, de Wied, 1993; 
Sherman, Kalin, 1986), independently of HPA-axis activation (Morley and Levine, 
1982).
Conflict behaviour can be assessed by several procedures, and is also believed to 
reflect anxiety-related behaviour. In the present set of studies, the Vogel conflict test 
was chosen. In this paradigm, water deprived animals receive a mild electric shock 
during drinking. The test has been shown to be sensitive to various anxiolytics, but 
not to a number of other psychoactive drugs, such as d-amphetamine, and 
scopolamine (Vogel et al., 1971). The advantage of this test, compared to other
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conflict tests, is that it allows one-trial measurements, whereas others require 
training. It has been shown that, as in conditioned fear (see below), the amygdala 
plays an important role in conflict behaviour (Moller et al., 1994).
Conditioned fear was employed as a test in which remembrance of a stressful 
situation plays a role. The key brain area involved in conditioned fear is the 
amygdala. Damage to this area greatly changes the way animals and people act in the 
face of danger. It has been proposed that this fear system of the brain is involved in 
at least some anxiety disorders (LeDoux, 1998; Ohman, 2001). Several brain areas, 
which appeared to be involved in conditioned fear, have been suggested to play a 
role in some anxiety disorders, which occur in man. For example, damage to the 
hippocampus interferes with conditioning to contextual cues (Phillips and LeDoux, 
1992; Kim and Fanselow, 1992; Selden et al., 1991; Blanchard et al., 1970). It has 
been suggested that generalisation to fear, as is seen in some anxiety disorders, might 
be due to weakening of contextual constrains on fear (LeDoux, 1998). This is 
consistent with the fact that stress impairs the anatomy and physiology of the 
hippocampus and behavioural aspects in which the hippocampus is believed to play a 
role (Sapolsky, 1996; McEwen and Sapolsky, 1995). In addition, damage to the 
medial prefrontal cortex results in a prolongation of extinction of the conditioned 
response (Morgan et al., 1993; Morgan, LeDoux, 1995). Thus, fear that is established 
is difficult to get rid off, again a similar to what is seen in some anxiety disorders. 
Furthermore, prefrontal cortex functioning is also known to be affected by stress 
(Diorio et al., 1993).
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5-HTlA stimulation
A simple model for assessing 5-HTia autoreceptor function has been described by 
Bill and colleagues (1991). Administration of a range 5-HTia receptor agonists 
induces hypothermia in rodents. In mice it is believed to be due to stimulation of 
presynaptic autoreceptors whereas in rats it appears to be due to postsynaptic 
receptor stimulation (Bill et al., 1991; Martin et al., 1992). 8-OH DP AT induced 
hypothermia in mice is attenuated after long-term treatment with antidepressants of 
various classes, as well as by repeated ECT (Bill et al., 1991; Goodwin, 1989), 
indicating desensitisation of 5-HTia autoreceptor function. This is in agreement with 
studies using other techniques such as microdialysis or single cell recording (Chaput 
et al., 1986; Hervas et al., 2001; Invemizzi et al., 1994; Le Poul et al., 1999). 
However, the attenuation of the hypothermic response is not entirely specific for 
antidepressant treatment. Furthermore, 8-OH DP AT induced hypothermia can also 
be antagonised by D2 antagonists, suggesting a role for dopamine D2 receptors in 
this phenomenon (Martin et al., 1992).
Atteutioual processes aud depression
Patients suffering from major depression also display attentional deficits (Mialet et 
al., 1996; Rief and Hermanutz, 1996; Lemelin et al., 1997; Williams et al., 2000). 
These attentional deficits have been reported to be particularly marked in patients 
with psychomotor retardation, whereas non-retarded depressed patients have fewer 
attentional disturbances. Different attentional deficit patterns in clinical depression 
are reported, such as distractor inhibition disturbance and deficiency in processing 
resources, which occurs in different depressive subgroups. (Lemelin and Baruch, 
1998). In fact, the emotional and the cognitive aspects of the disorder are not
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independent, and it may be suggested that the increased anxiety often observed in 
depression is in part related to attentional dysfunction: given that CRH increases 
arousal, patients may have problems filtering relevant from irrelevant environmental 
stimuli, and therefore have difficulties in monitoring and amending their behaviour 
to the demands of the environment. This in turn may lead to a bias in the perception 
of stimuli as being potentially threatening, with consequently increased anxiety.
Attentional processes in animals
Many behavioural procedures have been proposed for modelling attention in animals. 
Recently, Bushnell categorised these tasks in orienting, expectance, stimulus 
differentiation, sustained attention and parallel processing (Bushnell, 1998). In this 
work, attentional processes are assessed with the 5-choice serial reaction time task 
(5-CSRTT), one of the most well characterised stimulus selection models for animals 
(Bushnell, 1998). This task has analogies with a range of human attentional 
paradigms (Mirsky and Rosvod, 1960; Sahakian et al., 1993; Wilkinson, 1963), and 
provides measures of sustained and divided attention in temporal and spatial domains 
(Bushnell, 1998; Muir et al., 1996; Robbins et al., 1993): the animal has to 
continually monitor an array of five possible stimulus locations for the occurrence of 
a brief visual stimulus (sustained attention), has to distribute its responding across 
this array (spatially divided attention) and to respond to repeatedly presented light 
stimuli.
The paradigm was originally developed by the group of Robbins (Carli et al., 1983) 
for testing rats. Recently, it has been demonstrated that attentional processes could be 
assessed in mice in an adapted 5-CSRTT set-up (Humby et al., 1999), and that 
attentional performance can be manipulated by the same mechanisms as described
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for manipulating performance in rats (Muir et al, 1994; Bushnell et al., 1997), 
monkeys (Voytko et al., 1994) and humans (Wesnes and Revell, 1984a; Wesnes and 
Warburton, 1984b).
The use of mouse mutants to study behavioural effects of chronic alterations in 
the CRH system
The use of genetically engineered mice has several advantages. Firstly, receptors can 
be specifically inactivated which, for several receptors, cannot be done with the use 
of antagonists. Secondly, these techniques enable the possibility to study the effects 
of overproduction of a peptide, without exposing animals to surgery. Thirdly, effects 
of long-term loss or overproduction of peptides can be assessed. However, there are 
also some disadvantages of the use of mutant animals. Altering gene products in a 
mutant mouse may lead to a cascade of effects, which may make it difficult to 
predict direct effects of alteration of gene expression and phenotype (for example. 
Holmes, 2001). Therefore, the use of mutant animals should be considered as an 
addition to pharmacological methods, and not as a replacement.
Outline and scope of this thesis
The aim of the experiments presented in this thesis is to investigate the role of CRH 
in several behavioural and neuroendocrinological phenomena that are known to be 
disturbed in patients suffering from depression and can be assessed in rodents. In 
order to exploit the advantage of molecular engineered selective inactivation or 
overproduction of genes, the mouse was chosen as study object.
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First, it was investigated whether test results from one anxiety paradigm would be 
predictive for the outcome of another, based on different psychological principles, 
and whether these effects would be strain specific. These data could then be used for 
choosing an appropriate mouse strain in studies in which these tasks were applied. 
Next, it was investigated whether long-term treatment with citalopram, a compound 
that has been shown to be effective in the treatment of depression as well as anxiety 
disorders, would affect anxiety-related behaviour in mice.
On basis of these results, it was hypothesised that, in order to investigate the 
pathophysiology of anxiety, subjects with increased emotionality are needed. 
Therefore, mice overexpressing CRH were chosen. In Chapter 5, the anxiety-related 
behaviour of these animals in a range of anxiety paradigms is presented.
Furthermore, it was investigated whether the neuroendocrinological profile of these 
animals would show analogies with that of patients suffering from depressive or 
anxiety disorders. Therefore, HPA-axis activity was studied, both under basal 
conditions and after pharmacological challenges, which is presented in Chapter 6.
Next, it was investigated whether the effects of citalopram would be different in 
CRH overexpressing mice compared to wildtype littermates (Chapter 7).
These results indicated that overproduction of CRH leads to an increase in some 
aspects of anxiety and to a disturbed neuroendocrinological profile. Next, it was 
investigated whether CRH overproduction would affect sustained and divided
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attention. In Chapter 8, the results of excessive CRH production on these attentional 
processes are presented.
Subsequently, the effects lack of CRH on 5-CSRTT performance was studied. 
However, lack of CRH does not implicate that CRHR cannot be activated, as several 
other endogenous peptides are capable of activating CRH receptors (see above). 
Therefore, in Chapters 10 and 11, data are presented from experiments studying the 
impaired function of CRHRl or CRHR2 on visuospatial attentional processes.
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Chapter 2
Material and methods
Animals
In all experiments, animals were singly housed in type II cages (207 x 140 x 265 
mm) and kept under 12:12 h light-dark cycle (lights on 6.00h), with food and water 
at libitum unless mentioned differently in the specific paradigm descriptions. All 
testing took place during the light phase of the light-dark cycle, except for the 
elevated plus maze test, which was performed during the early dark phase. The 
experiments were performed in compliance with the guidelines of the European 
Communities Council Directive of 24 November 1986 (86/609/EEC). The following 
paradigms were used in the different studies:
Examination of spontaneous behaviour
Spontaneous behaviour was analysed in the home cage. Shortly before testing, the 
animal was aroused by placing it in a confinement for 1 min in order to ensure a 
certain level of behavioural activation. During this time, the bedding in the home 
cage was shuffled around and evenly redistributed. A clear plastic lid was placed on 
top of the cage that prevented escape of the animal but allowed video recording, 
which started as soon as the mouse was returned to its home cage and lasted for ten 
minutes. For measurements of locomotor activity, distance travelled was analysed by 
a video tracking system (VideoMot2, TSE, Bad Homburg, Germany). When
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videotracking was not possible due to insufficient difference in contrast between the 
animals and background, measuring the number of line crossing was used to assess 
locomotor activity. This was measured by dividing the bottom of the cage virtually in 
3 x 2  equally sized fields, after which the number of line crossings was scored. The 
times spent rearing, grooming and digging in the bedding material were scored and 
were calculated as a percentage of the total session time. Digging behaviour was 
included because pilot studies in which male C57B1/6 N mice were tested in a marble 
burying paradigm, indicated that these mice dig in the bedding material, independent 
of whether marbles were present in the cage or not. Video analysis indicated that 
when marbles got buried, it happened accidentally by general digging in the bedding 
material. Data fi*om an additional pilot test, without the presence of marbles, but 
performed as described above, indicated that acute treatment with diazepam, 20 min 
before testing, tended to reduce digging behaviour, in male C57BL/6 N mice (n = 
10). Repeated social defeat increased digging behaviour, which could be 
significantly prevented by diazepam treatment (Figure 2.1). No effect of diazepam 
was found in terms of rearing. Takeda and colleagues (1998) showed that rearing 
decreases in concert with the distance travelled when diazepam is administered in the 
high dosage. This suggests that the reduced digging in the social defeated groups is 
not due to sedative effects. Taken together, analysis of digging behaviour might 
provide additional information on anxiety-like behaviour, although more 
experimental data is necessary to interpret this parameter.
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Figure 2.1 Effect of acute diazepam treatment and repeated social defeat in the spontaneous 
behaviour paradigm. Data is presented as means, with errors bars denoting S.E.M. * * p < 0.010 
compared to all other groups.
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Elevated plus maze
The maze was made of dark grey plastic and was elevated 72 cm above the floor. 
Four maze arms (28 x 5 cm) originated from a central platform (5 cm square), 
effectively forming a cross. Two of these arms (closed arms), located opposite to 
each other, were enclosed by clear Perspex walls (15 cm high), while the other two 
arms (open arms) were equipped with a small threshold (0.5 cm high) only, which 
was fixed at the edges of the arms. Testing took place during the early dark phase. 
Indirect dim illumination (< 1 lux) was provided by a red light. A test session started 
by placing the animal on the central platform, facing the enclosed arm. Over a period 
of 5 min, exploration was video recorded. Between sessions, the maze was 
thoroughly cleaned with water and dried with paper towel. Subsequently, the number 
of open and closed arm entries (an arm entry was counted when four paws on an 
arm), and the time spent in the different compartments of the maze (central platform, 
open and closed arms) were scored.
Light dark exploration
Testing took place in four chambers (Coulboum Instruments, Allentown, USA), 
which allowed testing four animals in parallel. Each chamber was divided into two 
equally sized compartments (26 x 13 x 38 cm high each). One compartment was 
made of clear plastic walls and was illuminated by bright light (500 lux), while the 
other compartment was made of black plastic, not illuminated and covered by a black 
roof. An opening, 7.5 x 7.5 cm wide, connected the two parts of the box. Two infra­
red sensor rings (sensor spacings 1.52 cm) allowed measurement of vertical and 
horizontal activity (sampling frequency 4 Hz), and were connected to a computer 
equipped with the True Scan Software Vers 1.1 A (Coulboum Instmments). Each
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box, including its sensor rings, was surrounded by an additional box (47 x 47 x 38 
cm, white plastic), which prevented the animals from seeing each other.
A session lasted 5 min. From the raw data, the distance travelled and the number of 
rears made over the 5-min period was calculated. Furthermore, moving time, entries, 
and relative distance travelled and the relative number of rears in the illuminated 
compartment was calculated.
Open field
Animals were tested in a square open field (26 x 26 x 38 cm high, 500 lux 
illumination), made of a white floor and clear plastic walls, and equipped with 
infrared photocell sensors. The field was surrounded by an additional box (47 x 47 x 
38 cm high, white plastic). Horizontal and vertical activation was measured using 
infrared sensor rings and Truscan software version 1.1 A (Coulboum Instmments). 
Furthermore, exploration of the centre of the open field (18.4 x 18.4 cm) was 
assessesd.
Novel object exploration
The response to the introduction of a novel object placed in a familiar environment 
was investigated. First, mice were habituated to an open field for thirty min (26 x 26 
X 38 cm high, 500 lux illumination). Subsequently, animals were briefly retumed to 
their home cage and an object (a bolt, M 12 x 60 mm high) was placed into the 
centre of one of the quadrants of the field, after which the mouse was retumed for an 
additional 15 min. During the habituation stage, the distance travelled was measured 
in 3-min time bins. Furthermore, the number of entries and the time spent in the
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quadrant which would contain the object was measured during the last 15 min of the 
habituation stage and taken as baseline. The same measures were taken once the 
object had been introduced, and the number of entries and time spent in the object 
quadrant relative to baseline were calculated. This procedure corrects for preference 
for a particular quadrant in the testing box. In addition, the total time spent in the 
object quadrant was measured during this stage.
Vogel conflict task
Testing took place in a grey plastic chamber (20.5 x 20.5 x 30 cm, < 1 lux 
illumination) equipped with a metal grid and a waterspout, which was located in the 
centre of one of the walls, 1 cm above the grid. The spout and the grid were 
connected to a drinkometer and a shock generator (Coulboum Instmments), which 
allowed to deliver a 0.15 mA shock over 10 ms. Prior to testing, animals were water 
deprived for 24 hours. A session started after the animal made 20 licks on the spout 
to ensure knowledge about the position of the spout prior to start, and terminated 
after 20 min. Every twentieth lick, the mouse received a shock. Animals failing to 
make at least 20 responses necessary to start the session within 20 min were 
excluded. The latency to start the session and number of responses made during the 
session were registered by a computer.
Hole board exploration
Mice were tested in the same square boxes used for novel object exploration (500 lux 
illumination), except now a metal floor was inserted, containing sixteen holes (2.2 
cm diameter) evenly distributed over the floor ( 4 x 4  holes). Animals were placed in 
a comer of the field and allowed to freely explore for 30 min. Distance travelled.
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rearing and holes visited were monitored by three infra-red sensor rings connected to 
a computer equipped with the True Scan Software Vers 1.1 A (Coulboum 
Instmments).
Conditioned fear
Two chambers were used. One chamber (the conditioning chamber) was identical to 
the box used for the assessment of the novel object and hole board exploration, 
except that now a shock grid was placed on the floor, and that the chamber was 
dimly illuminated (1 lux). The shock grid was connected to a shock generator 
(Coulboum Instmments), which allowed delivery of a 0.35 mA shock over 2s time 
period. The other chamber (the test chamber) was similar, except that instead of a 
shock floor, the box was equipped with a white plastic floor plate. The shock grid 
was cleaned with 70% ethanol while the white plastic floor was cleaned with a 
lemon-flavoured detergent after each animal in order to change the olfactory 
properties of the two chambers. A light source, placed on top of the chambers, 
allowed to present a flashing light (26 lux at floor level, flash rate 5 Hz).
A mouse was placed into the centre of the conditioning chamber. After five min of 
free exploration, a series of three light-shock pairings was delivered, once every 100 
sec, with the unconditioned stimulus (US, shock) always presented during the last 
two seconds of conditioned stimulus (CS, light) presentation (15 sec). Twenty-four 
hours later, the mice were re-exposed to the test box. After five min of exploration, 
the CS was presented for a period of five min, but no shock was delivered. The first 
five minutes of exploration on day 2 were analysed in order to assess when animals 
reached stable baseline in terms of distance travelled and the time not moving, the
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latter being defined as the cumulative time during which an animal did not change its 
position within a sample time of 250 ms. Therefore, the mean distance travelled and 
the mean time not moving over this period were taken as baselines. Conditioned 
suppression of activity, i.e., the distance travelled and the time not moving relative to 
baseline were taken as indicators for fear conditioning. Automated measurement of 
the conditioned suppression of ongoing spontaneous behaviour has been shown to be 
a reliable measure of fear conditioning (Crestani et al., 1999; Killcross et al., 1997), 
and previous studies have shown a high correlation between freezing scored
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Figure 2.2 Effect of re-exposure to the CS, 24 h after training with or without US. Data is presented 
as means, with error bars denoting S.E.M.
46
manually and automated measurement of locomotor activity in mice (Radulovic et 
al., 1998; Steckler et al., unpublished results) and rats (Bouton and Holies, 1980). 
Therefore, time not moving was used.
In order to examine whether the US is not inhibiting activity by it self, a pilot study 
was performed. Male C57BL/6 N mice (n = 10) were tested according to the above 
described protocol (shocked group), whereas another group was tested following the 
same protocol, without presentation of the US (non shocked group). In the shocked 
group, re-exposure to the CS resulted in suppression of activity, whereas this was 
absent in the non shocked group (Figure 2.2).
Hot plate
Pain threshold was investigated in the hot plate test. Here, an animal was placed on a 
square plate (27.5 x 22.5 cm), heated to 55° C. Latency to feet licking or jumping, 
whatever occurred first, was scored by visual observation.
Rotarod
A rotarod (diameter of rod 3 cm), mounted horizontally 25 cm above a platform, was 
used in order to examine sensorimotor skills. Plastic dividers (perpendicular to the 
rod and spaced 10 cm apart) prevented mice from escaping. A trial started by placing 
an animal on the stationary rod. Each mouse was then required to balance on the 
rotating rod (3 rpm). A trial terminated either if the mouse fell off the rod or after 5 
min. Each animal had three sessions, each spaced with 2 hours.
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Inescapable swim stress
A clear plastic cylinder (11 cm in diameter, 25 cm high) was filled to a depth of 7.5 
cm with water (25° C). Animals were placed in the water for 6 min. Behaviour was 
video recorded and immobility time during the last three min of testing was scored 
by visual observation after testing.
8-OH DPAT induced hypothermia
Animals were weighed and rectal temperature was recorded over 4 seconds ( probe 
length = 2 cm, Thermo-electra, Pijnacker, The Netherlands). Immediately afterwards, 
animals received a subcutaneous (s.c.) injection of either 8-OH DPAT (0.5 mg/kg) or 
saline and were retumed to their homecage for 20 min, followed by another 
measurement of rectal temperature.
5-choice serial reaction time task (5-CSRTT) 
5-CSRTT: Apparatus
Five operant chambers (20 x 15 cm) with curved rear walls (jointly developed with 
TSE, Bad Homburg, Germany) were used (Steckler et al., 2000). Set in the curved 
wall of each box was an array of five circular holes, 2 cm in diameter, 3 cm deep and 
1.5 cm above floor level. Each hole was equipped with an infra-red photocell beam 
crossing the entrance vertically, a yellow LED at the rear end of the hole, providing 5 
lux illumination at the hole’s entrance, and a food pellet dispenser which allowed 
delivery of a 20 mg dustless food pellet (Noyes, Lancaster, UK) directly into the hole 
where a correct response had been made. Presentation of the light stimulus, the
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operandum and the food reward all in the same location was chosen to enhance 
stimulus-response-reward contiguity. In addition, a white house light (30 lux) 
mounted in the centre of the roof could illuminate the chamber. The boxes were 
housed in dark, sound-attenuating compartments. On-line control of the apparatus 
and data collection was performed using a computer system with software written by 
TSE (CBS, Version 1.56).
5-CSRTT: Habituation
Mice were first exposed to the boxes for 20 min per session, with the house light 
switched off and each hole containing two food pellets. Once all animals reliably ate 
all food pellets within a session, training proceeded to the next stage.
5-CSRTT: Autoshaping
Autoshaping was carried out as described by Steckler et al. (2000). During 
autoshaping, all lights were switched off at the beginning of a session. A session 
terminated after a maximum of 20 completed trials or after 30 min, whichever came 
first. A trial started with the illumination of one of the five holes (in pseudorandom 
order), the house light being switched off. If an animal did not respond by nose 
poking into the illuminated hole within a limited hold of 5 s, a pellet was delivered 
into that hole. The stimulus light remained illuminated until a response into that hole 
(arbitrarily designated ‘correct’) had been made to collect the pellet, after which the 
stimulus light was switched off. If an animal responded into the illuminated (correct) 
hole within the limited hold of 5 s, a pellet was delivered immediately and the 
stimulus light was extinguished prior to the end of the limited hold. A response into 
the correct hole initiated an inter-trial interval (ITI) of 5 s, during which only the
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house light was illuminated. This was followed by the next trial. Responses into the 
other holes were counted but had no further consequences.
5-CSRTT: Simple visual discrimination learning
The following sessions always started after a 2 min habituation period, during which 
all lights were switched off, and terminated after 60 trials or after 30 min, whichever 
came first. At the end of the 2 min habituation, the first trial commenced. Each trial 
started with the illumination of one of the holes (in pseudorandom order) for a 
maximum of 8 s or until a response was made. Animals had to respond within a 
limited hold of 10 s, i.e., a nose poke made within the 2 s after the 8 s-light stimulus 
had been switched off was still considered a response. Nose poking into the hole 
where the stimulus was presented was considered to be correct. This was followed by 
the delivery of a food pellet into that hole and the stimulus light was extinguished 
immediately if the response occurred within the first 8 s, followed by an inter trial 
interval (ITI) of at least 5 s, during which all lights were turned off. A response into 
another hole was recorded as an incorrect response, the stimulus light in the correct 
hole was extinguished, if still necessary, but no food pellet was given. If an animal 
did not respond within the limited hold of 10 s, this was counted as an omission. 
Incorrect responses or failures to respond (omission) resulted in a time out period of 
5 s, during which only the house light was illuminated. After termination of the time 
out period, an ITI of at least 5 s duration commenced, followed by the next trial. In 
order to ensure that stimulus presentation was not overlapping with a hole poke, 
which could potentially prevent an animal from stimulus detection, the next trial only 
commenced if no holes were visited for at least 1 s prior to the end of the ITI, i.e., the 
ITI could continue over and above the 5 s limit. This was followed by gradual
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reduction of the stimulus duration (i.e., 8 s, 4 s, 2 s, 1 s), with 5 sessions per stimulus 
duration.
5-CSRTT: Baseline performance
Subsequently, animals were tested for extended number of sessions with a stimulus 
duration of 0.5 s.
5-CSRTT: Measures
During autoshaping, the number of nose-pokes made until the illuminated hole was 
visited, the average latency to complete a trial, and the relative number of trials 
completed within the limited hold of 5 s, i.e., prior to pellet delivery [= number of 
trials completed within the limited hold / total number of trials completed per session 
X 100], were studied.
The number of correct responses determined the absolute number of reinforcers 
earned. Accuracy was measured in terms of percentage correct responses [= correct 
responses / (correct + incorrect responses) x 100]. Errors of omission equalled the 
number of trials during which no response was made within the limited hold of 10 s. 
Furthermore, the number of nose-pokes made during the ITI was counted and 
expressed per ITI, normalised to 5 s as ITI s could be longer, given that one second 
had to lapse between the last response made during the ITI and the beginning of the 
next trial. Moreover, correct and incorrect response latencies were measured, defined 
as the time between stimulus onset and the response. Finally, bias was evaluated by 
calculating the absolute number of correct responses made into the two left-hand 
holes minus the number of correct responses made into the two right-hand holes,
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divided by the total number of correct responses made into these four holes. This 
measure has close resemblance to the bias measure Index Y, which has been 
suggested to reflect ‘cognitive bias’ (Sahgal, 1987). Unbiased responding would 
result in Index Y = 0. This index increases if an animal stays for a prolonged time at 
a particular position, responding in a go/no-go-like manner, and reflects regression 
towards a simpler problem solving strategy.
Plasma corticosterone and ACTH
Animals were anaesthetised with isofluran and decapitated within 15 seconds. Trunk 
blood was collected in ice-chilled EDTA-coated tubes containing 140 pg aprotinin 
(Trasylol; Bayer, Cologne, Germany). Plasma was separated and stored at -80°C 
until corticosterone or ACTH measurement. Plasma ACTH and corticosterone 
concentrations were measured using commercially available radioimmunoassay kits 
(ICN Biomedicals, Costa Mesa, USA). The inter- and intraassay coefficients of 
variability for ACTH were 7 and 5 % with a detection limit of 2 pg/ml. For 
corticosterone, the inter- and intraassay coefficients were 7 and 4 %, respectively, 
with a detection limit of 1.5 ng/ml.
Statistics
Data were analysed by multiple analyses of variance (MANOVA), followed by post 
hoc Tukey test if appropriate.
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Chapter 3
Behavioural analysis of four mouse strains in an
anxiety test battery
Introduction
Recent advances in molecular biology have led to the generation of an increasing 
number of genetically engineered mice with specific mutations in single genes. 
However, such mutations can have veiy different phenotypes, for example with 
respect to anxiety-related behaviour, depending on genetic background (Banbury 
Conference on Genetic Background in mice, 1997; Frankel, 1998). Indeed, strain 
differences in murine anxiety paradigms are well established (Crawley et al., 1997; 
Gerlai, 1996; Homanics et al., 1999; Rogers et al., 1999; Trullas and Skolnick, 1993) 
-  differences which do not only affect the outcome of experiments with mouse 
mutants, but which are of course of equal relevance for pharmacological (Conti et al., 
1994; Crawley and Davis, 1982,1997; Lepicard et al., 2000) or lesion studies.
Here, three inbred mouse strains were compared in these tests: the A/J strain, which 
has been suggested to show a high degree of anxiety-related behaviour (Crawley et 
all, 1997; Crawley and Davis, 1982), the C57BL/6J strain, which has been suggested
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to display intermediate levels of anxiety (Crawley and Davis, 1982) and which is 
commonly used for the generation of mouse mutants, and the C57BL/6ChR strain. 
The C57BL/6ChR subline originated from the C57BL/6J line, but both sublines have 
been bred independently for several generations since 1974 and are provided by 
different suppliers. Previous studies have shown genetic divergence in a number of 
inbred strains, and certain C57BL/6 sublines show marked differences in behaviour, 
for example in exploratory activity (Crusio et al., 1991). Finally, the Swiss Webster 
outbred strain was tested. This strain was chosen as a literature search revealed the 
Swiss Webster mouse to be a popular mouse strain for pharmacological tests of 
anxiety-related behaviour.
Anxiety-related behaviour was assessed using a battery of tasks, taxing different 
aspects of anxiety-related behaviour (see introduction), such as free exploration of 
novel environments, free exploration of a novel object, but based within a familiar 
surrounding, conflict behaviour and conditioned fear.
Material and Methods
Animals
Male A/J mice (n = 11), C57BL/6 J mice (B6J; n = 10) and Swiss Webster mice 
(SW/J; n = 11) were supplied by Harlan Winkelman (Borchen, Germany), while 
C57Bl/6CrlBR mice (B6/ChR; n = 10) were supplied by Charles River (Sulzfeld, 
Germany). Animals were singly housed in type II cages and kept under 12:12 h light- 
dark cycle as of two weeks before testing, with food and water at libitum. All testing 
took place during the light phase of the light-dark cycle, except for the elevated plus
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maze test, which was performed during the early dark phase. Animals were aged 8 -  
9 weeks at the beginning of testing.
Behavioural analysis
After placing the animal in a confinement for 1 min, spontaneous behaviour was 
analysed in the home cage for ten minutes. Counting the number of line crossings 
was used as a measure to assess locomotor activity. Next, animals were tested on the 
elevated plus maze. Then, animals were tested in the light-dark exploration 
paradigm. Locomotor activity was further assessed in a 30 minutes open field 
session, after which the response to the introduction of a novel object in a familiar 
environment was investigated in the novel object exploration paradigm. Conflict 
behaviour was investigated in the Vogel conflict task. Further, exploratory behaviour 
was analysed in the hole board paradigm, after which conditioned fear was studied. 
Furthermore, pain threshold was assessed using the hot plate test, and 24-hour water 
intake was measured. Finally, animals were exposed to inescapable swim stress, of 
which the immobility time during the last three min of testing was scored. At least 5 
days lapsed between tests.
Results 
Examination of spontaneous behaviour
Locomotor activity in the home cage, as measured by the number of line crossings, 
was significantly different between strains (Fi,3s = 67.05, p < 0.001; Figure 3.1 A). 
Post hoc analysis showed the following rank order: SW/J > B6/J = B6/ChR > A/J. 
Furthermore, locomotor activity decreased over time in all strains (Fi,3s = 334.65, p <
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0.001). Analysis of rearing activity also revealed an effect of strain (F338 = 8 6 .6 6 , p < 
0.001), with the SW/J mice spending more time rearing than the other three groups, 
and the B6 /ChR mice rearing more than mice of the A/J strain (Figure 3. IB). Strains 
also differed in the time spent grooming (F3,3g = 14.80, p < 0.001), whereby A/J mice 
groomed significantly more than animals from the other strains (Figure 3.1C). 
Finally, there was an effect of strain on the time spent digging in the sawdust (F3,3g = 
22.01, p < 0.001), with the following rank order: B6 /J > B6 /ChR > SW/J = A/J 
(Figure 3. ID).
Elevated plus maze
The time spent on the central platform was significantly different between strains 
(F3,36= 11.62, p < 0.001), with the A/J strain spending more time on the central 
platform compared to all other groups (Figure 3.2A). A strain difference was also 
seen in terms of total arm entries (F3,36= 45.07, p < 0.001), and post hoc comparison 
indicated that the SW/J mice were more active than all the other strains (Figure 
3.2B). Latency to enter the open arm also differed between strains (F3,36= 3.46, p = 
0.026). Post hoc analysis showed that A/J mice had longer latencies than B6/J 
animals (Figure 3.2C). Moreover, strains differed in the total time spent on the open 
arms (F3,36= 8.74, p < 0.001), with B6/J mice spending significantly more time there 
than the SW/J or the A/J strains (Figure 3.2D). When the relative number of entries 
into the open arms was analysed, MANOVA revealed a further effect of strain (F3,35= 
3.49, p = 0.026), but post hoc testing failed to show significant group differences 
(Figure 3.2E).
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Figure 3.1 Strain dependent differences in spontaneous behavioural in the home cage. Line crossings 
(A) were quantified over two successive 5-min time bins (means with different symbols indicate p< 
0.05). The times spent rearing (B; # p < 0.05 compared to all other groups; $ p < 0.05 compared to 
B6/ChR), grooming (C; f  p < 0.05 compared to all groups) and digging (D; means with different 
symbols indicate p< 0.05) were analysed over 10 min. Data are presented as means, with error bars 
denoting SEMs.
Light dark exploration
There was a strain effect in terms of the total distance travelled (Fg^ sg = 22.81, p < 
0.001). A/J animals were less active than all the other strains (Figure 3.3A). The total 
number of rearings was also significantly different between strains (Fs,3g = 4.61, p = 
0.008), and A/J mice reared less frequently than the two B6 strains (Figure 3.3B). 
Furthermore, strains differed in the number of entries into the light (F3,3g = 2.89, p = 
0.048), which were increased in the B6/J animals compared to B6/ChR mice, in
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Figure 3.2 Strain dependent differences in elevated plus maze exploration: the time spent on the 
central platform (A), total arm entries (B), the latency to enter an open arm (C), the time spent on the 
open arms (D) and the relative number of open arm entries (E) are shown. Data are presented as 
means, with error bars denoting SEMs; *,p < 0.050; **,p < 0,010; ***,p < 0.001, significant differences 
between strains.
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Figure 3.3 Strain dependent differences in light dark box exploration: the total distance travelled over 
5 min (A), the total number of rearings (B), the number of entries into the illuminated part of the box 
(C), the time the animal spent moving in the illuminated part (D), the relative distance travelled in the 
light (E) and the relative number of rearings made in the illuminated area (F) are shown. Data are 
presented as means, with error bars denoting SEMs; *,p < 0.050; ***p < 0.001, significant differences 
between strains.
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terms of moving time in the light (Fg^ sg = 3.83, p = 0.017), in the relative distance 
travelled (Fg^ gg = 5.44, p = 0.003), and in the relative number of rearings made in the 
illuminated part of the box (Fs^ gg = 6.35, p < 0.001) (Figures 3.3C-F). Post hoc 
analyses revealed that A/J animals made relatively more rearings and travelled a 
relatively greater distance in the illuminated half of the box than both B6/ChR and 
SW/J mice, and spent more time moving in the illuminated part than B6/ChR 
animals.
Open field
A significant effect of time bin was found on the distance travelled measure during 
the 30 min habituation stage (F9,g42 = 4.22, p < 0.001; Figure 3.4). Furthermore, an 
overall significant strain difference (Fg,3g= 26.85, p < 0.001), but no strain x bin 
interaction (F2?,342 = 1.29, p >0.050) was seen for this measure. Post hoc analysis 
indicated that the A/J mice were hypoactive compared to all other strains, and that 
SW/J animals showed significant higher locomotor activity than B6/ChR mice did. 
No preference for a particular quadrant of the field was observed during the 
habituation stage according to time spent in the different quadrants (F3J 52 = 2.60, P 
>0.050).
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Figure 3.4 Strain dependent differences in habituation to the open field prior to presentation of a 
novel object in terms of the distance travelled. Data are presented as means, with error bars denoting 
SEMs.
Novel object exploration
After introduction of the novel object in the open field, strains differed in the total 
time spent in the object quadrant (F338 = 6.48, p = 0.001), and a significant genotype 
X bin interaction was observed (Fi2,i52= 2.56, p = 0.010). This interaction was due to 
the fact that SW/J mice spent more time in the object quadrant compared to all other 
groups during the first three minutes of exposure to the object (Figure 3.5A), and 
continued to differ significantly during the second 3-min bin from both the B6/J and
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A/J strains (data not shown). A strain effect was also seen if the time spent in the 
object quadrant relative to baseline was calculated (Fs^ sg = 3.21, p = 0.034), and a 
significant strain x bin interaction was found for this measure (Fi2,i52= 2.25, p = 
0.012). As for the quadrant preference measure, SW/J mice spent more time in the 
object quadrant than all other groups if the relative change from baseline was 
considered (Figure 3.5B). In addition, analysis of the change from baseline also 
revealed that B6/ChR animals spent more time in the object quadrant than A/J mice 
during the first 3 min of object exposure did. Strains did not differ during subsequent 
bins on this measure.
Visual inspection of the data indicated that the strains reacted very differently to the 
introduction of the novel object, varying from a avoidance, most pronounced in the 
A/J strain, to approach of the object quadrant, which was strongest in the SW/J 
strain, while the two B6 strains seemed to react rather indifferently (Figure 3.5B).
Analysis of the number of entries into the object quadrant relative to baseline also 
showed an effect of strain (Fs^g = 4.17, p = 0.012, and a strain x bin interaction was 
observed (Fi2,i52 = 2.24, p = 0.022). As before, A/J mice showed avoidance of the 
object during the initial three minutes, while a relative increase of entries into the 
object quadrant was seen in the B6/ChR strain, and both the B6/ChR and the SW/J 
strains differed from A/J mice during the first two time bins (Figure 3.5C).
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Novel object exploration
Time Spent in the Object Quadrant 
During the First 3 Min
##
*  *  *
♦  *  *  change
*  *  *
B
B6/ChR B6/J SW/J A/J
Time Spent in the Object Quadrant
100
M
I
I
I
-50
-100
10-12 13-154-6 7-91-3
— B6/CHR 
1— B6/J
— SW/J
— A/J
bin (min)
Entries in the Object Quadrant
100
###
50
§
-50
-100
10-12 13-154-6 7-91-3
bin (min)
Figure 3.5 Strain dependent differences in novel object exploration: strains differed in quadrant 
preferences during the first 3-min time bin following exposure to the object (A), and in the relative 
change from baseline in terms of the time spent in the object quadrant (B) and the number of entries 
made into that quadrant (C). The dotted line in (A) represents chance performance, while the dotted 
lines in (B) and (C) indicate baseline levels. Data are presented as means, with error bars denoting 
SEMs; **, p < 0.010; ***, p < 0.001, significant difference compared to SW/J mice; *^ ,p < 0.050; p 
< 0.001, significant difference compared to A/J.
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Vogel conflict task
There was an effect of strain on the number of shocks delivered during the conflict 
session (Fi,28 = 3.50, p = 0.028; Figure 3.6A). SW/J mice received significantly more 
shocks than A/J mice did. No significant difference was found for the latency to start 
the session measure (Fi,28 = 0.95, p = 0.432; Figure 3.6B).
Hole board exploration
Strains differed in the distance travelled on the hole board (F3,4 i = 31.90, p < 0.001). 
Again, A/J animals were hypoactive compared to the other three strains (Figure 
3.7A). Likewise, an effect of strain was found in the number of rearings (F3,4 i = 
10.15, p < 0.001), with the A/J strain being the least active (Figure 3.7B). Analysis of 
the total number of nose pokes also revealed an effect of strain (F3,4 i = 16.26, p < 
0.001), with SW/J mice visiting more holes than the other strains. A/J mice did not 
differ from the two B6  strains on this measure (Figure 3.7C).
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Figure 3.6 Strain dependet differences in conflict behaviour: number of shocks received (A) and 
latency to start the session (B). Data are presented as means, with error bars denoting SEMs; *, p < 
0.050, significant difference between SW/J and A/J.
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Conditioned fear
When the relative time not moving during re-exposure to the CS was analysed, 
MANOVA showed a strain x minute interaction (Fi2,i32 = 4.89, p < 0.001). Further 
analysis revealed that all strains displayed a comparable rise in the time not moving 
following presentation to the CS (approximately 25% increase from baseline; Figure 
3.8). However, strains showed different degrees of extinction to the stimulus. Thus, 
activity in the two B6 strains started to return to baseline after the first minute, while 
extinction was retarded in the SW/J strain compared to both B6 strains. Although 
SW/J mice again reached baseline at the end of the session, they spent significantly 
less time moving than B6/J mice during the second, third and fourth minutes, and 
also differed from B6/ChR mice during minute three. In contrast, A/J mice did not 
return to baseline and differed from the two B6 strains from the third minute 
onwards. No significant differences were found between the two B6 strains or 
between A/J and SW/J strains.
Analysis of the change in the distance travelled relative to baseline also revealed a 
strain x time interaction (Fi2,i32 = 6.35, p < 0.001). Post hoc testing showed a pattern 
similar to the one described for the time not moving measure (data not shown).
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Figure 3.7 Strain dependent differences in hole board exploration: distance travelled (A), number of 
rearings (B) and number of nose pokes (C) made during a 30 min session are shown. Data are 
presented as means, with error bars denoting SEMs; ***, p < 0.001, significant difference compared to 
SW/J; p < 0.050; p < 0.001, significant difference compared to A/J.
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Conditioned Fear
Time not Moving
— B6/ChR
- - B6/J 
- -  SW/J 
• — A/J
50 -
25 -
-25 -
-50
2 4 53
time (min)
Figure 3.8 Strain dependent differences in conditioned fear: change in the time not moving during re­
exposure to the light relative to baseline (dotted line). Data are presented as means, with error bars 
denoting SEMs, * p < 0.05 compared to B6/J, # p < 0.05 compared to B6/ChR.
Hot plate
During the hot plate test, no jumping was observed. Latencies to lick the feet were 
significantly different between strains (F3,3g = 10.61, p < 0.001; Table 3.1), and a 
lower pain threshold was seen in SW/J mice compared to the other strains.
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Inescapable Swim Stress
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Figure 3.9 Strain dependent difference in immobility time during inescapable swimming: immobility 
time during the last three minutes of testing. Data are presented as means, with error bars denoting 
SEMs; *, p < 0.050; ***, p < 0.001, significant difference compared to SW/J, * , p <  0.050, significant 
difference compared to B6/J.
Table 3.1: Water intake and pain threshold in four mouse strains.
B6/ChR B6/J SW/J A/J
water intake (ml) 3.5 ±0.1 4.0 ± 0.3 5.4 ±0.5* 3.5 ±0.2
hot plate latency (sec) 8.5 ±0.8 8.6 ± 0.5 4.6 ±0 . 5* 7.6 ±0.5
Data are presented as means, with error bars denoting SEMs; *, p < 0.050, significant different to the 
other strains.
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Inescapable Swim stress
An effect of strain was also seen for immobility time (Fi,37 = 7.90, p < 0.001), and 
SW/J mice spent more time immobile than B6/ChR and A/J animals. Furthermore, 
immobility time was increased in B6/J mice relative to immobility in the A/J strain 
(Figure 3.9).
Discussion
In general, SW/J mice were the most active strain in terms of locomotor activity 
(distance travelled), while locomotor activity was intermediate in the two B6 strains. 
A/J mice were the least active. A comparable rank order was found when the 
numbers of rearing were compared in the different paradigms. Although clear strain- 
dependent effects were also seen in measures of anxiety-related behaviour, the rank 
order of strain effects was more variable and task-dependent, which suggests that the 
different tasks may measure different aspects of anxiety-related behaviour 
independent of differences on locomotor activity.
Differences between the two B6 sublines were absent with two exceptions: B6/J 
mice spent more time burying in the home cage and made more entries into the 
illuminated part of the light dark box than B6/ChR mice, but did not differ 
significantly fi*om each other in any other measure. This suggests that both sublines 
display comparable level of anxiety-related behaviour.
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B6 mice of both lines were the least anxious on the elevated plus maze. No 
differences where found between the SW/J and the A/J mice in terms of open arm 
exploration. The A/J mice, however, spent more time on the central platform than the 
three other strains. These results are comparable to those reported by others 
comparing B6/J and A/J mice on this task (Trullas and Skolnick, 1993). The two B6 
strains also displayed relatively low levels of anxiety-related behaviour in the fear 
conditioning paradigm, while A/J mice showed strongest responses. Likewise, A/J 
mice spent more time grooming in the home cage, spent less time in the object 
quadrant than the other strains during exploration of a novel object -  in fact seemed 
to avoid this quadrant -  and had the lowest number of licks in the Vogel conflict 
paradigm. These results support earlier findings that A/J mice display high level of 
anxiety-related behaviour when compared with other mouse strains (Brodkin et al., 
1998; Crawley et al., 1997; Crawley and Davis, 1982). Although it could be argued 
that A/J mice showed reduced anxiety-related behaviour in the light dark box in 
terms of the relative activity in the illuminated compartment, which would contrast 
earlier reports of enhanced anxiety-related behaviour of A/J mice on this task 
(Crawley and Davis, 1982), it should be noted that locomotor activity of A/J mice 
was very low in the present study. Thus, starting the mice in the illuminated part of 
the box may have skewed the data towards a “preference” for the illuminated area.
According to time spent in the object quadrant during novel object exploration, a 
rank order of SW/J<B6/ChR=B6/J<A/J was found. A similar rank order was seen for 
the number of licks in the Vogel paradigm.
71
Since responses in the Vogel conflict and conditioned fear paradigms are potentially 
confounded by differences in pain threshold, nociception was tested on the hot plate. 
These results suggest that the SW/J mice have a reduced pain threshold compared to 
the other strains. This in turn indicates that the increase in the time not moving in the 
conditioned fear paradigm seen in SW/J mice could be confounded by altered 
nociception. However, this explanation could not account for the performance in the 
Vogel conflict task, where SW/J mice received most shocks. Motivational factors, 
however, could have affected the number of licks in SW/J mice in this task, as 
enhanced water intake was seen in this strain. Thus, the two tasks based on 
punishment would not allow firm conclusions about anxiety levels of the SW/J 
strain. However, SW/J showed higher explorative activity on the hole board, while 
general activity did not differ from that of B6 mice, which would again suggest that 
SW/J mice are less anxious than B6 animals.
Interestingly, the analysis of immobility time in the swimming paradigm also showed 
a rank order of SW/J>B6>A/J. Immobility is unlikely to simply reflect locomotor 
activity, as a reversed rank order would have been expected. Immobility time has 
been suggested to be a useful predictor for antidepressant activity (Porsolt et al., 
1977). However, many antidepressant drugs are also potent anxiolytic substances 
(Uhlenhuth et al., 1999), and immobility has also been reported to increase after 
treatment with benzodiazepines such as diazepam or flurazepam at doses which were 
not muscle relaxant (Nagatani et al., 1987). Moreover, struggling in the swimming 
paradigm has been reported to be negatively correlated with anxiety-related 
behaviour (Ferre et al., 1994). Thus, it is possible that immobility time in this task 
also depends on the degree of anxiety-related behaviour.
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It could be argued that repeated testing of the animals might have affected 
performance. However, Me Ilwain and colleagues (2001) have shown that test 
battery mice and naive mice show similar levels of anxiety-related responses in an 
open field test, light dark exploration task but also in conditioned fear response. 
Furthermore, the authors state that a test battery approach is the best strategy for 
obtaining the most amount of information using the fewest number of mice, which is 
especially important when subjects are difficult to obtain which is the case when 
mutants are being used.
In summary, the data indicated that locomotor activity was independent of the 
paradigm employed, while the rank order of strain-dependent effects on anxiety- 
related behaviour changed as a function of the task under study. This indicates that 
different anxiety paradigms tax different aspects of anxiety, suggesting that a battery 
of different tests is beneficial in studies of anxiety-related behaviour.
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Chapter 4
Task-dependent effects of chronic citalopram 
on treatment on murine anxiety-related
behaviour
Introduction
SSRI’s have become a standard treatment for depression and anxiety disorders over 
the past years. Efficacy has been demonstrated for obsessive compulsive disorder, 
panic disorder and social phobia (Goodman et al., 1989; Lecrubier et al., 1997; Stein 
et al., 1998; Nutt et al., 1999). Results from small studies also suggest efficacy in 
posttraumatic stress disorder and generalised anxiety disorder (van der Kolk et al., 
1994; Rocca et al., 1997; Marshall et al., 1998).
Preclinical data, however, are conflicting, varying from anxiolytic to anxiogenic 
effects after SSRI treatment (for review see: Griebel, 1995). This variability is 
probably due to a number of factors, including administration route (Treit, 1991), 
dose range (Soderpalm et al., 1989), species differences (Barrett and Gleeson, 1991), 
gender effects (Hughes, 1993), environmental effects (Wettstein, 1992) and level of 
stress exposure before testing (Keeney and Hogg, 1999; Berton et al., 1999). 
However, different effects in different anxiety tasks may also be seen because 
different anxiety paradigms assess different aspects of anxiety. In order to investigate
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whether the effects of SSRI’s are task specific, we treated mice with citalopram, 
which is the one of the most selective SSRI’s, and investigated anxiety-related 
behaviour in a murine anxiety test battery. With this protocol, results obtained from 
the different paradigms can be compared. Since clinical evidence indicates that the 
anxiolytic effects of SSRI’s generally occur after long-term treatment and that 
anxiogenic effects can be seen early in the course of treatment, we tested the effects 
of chronic administration of citalopram on anxiety-related behaviour in mice. From 
the results from the previous study, it was decided to use Swiss Webster mice as test 
subjects.
Material and Methods 
Animals
Male Swiss Webster mice (n = 10-11 per group; 8 - 9  weeks of age) were supplied 
by Harlan Winkelman (Borchen, Germany).
Treatment
Animals were treated chronically with citalopram (racemic, kindly donated by 
Lundbeck, Copenhagen, Denmark) at a dose of 0, 10 and 20 mg/kg po. The drug was 
administered orally in pellet form derived from drying a mixture of powdered mouse 
food (Altromin 1311, Altromin GmbH, Lage, Germany), citalopram and water, 
which was stored for a maximum of four days at 5° C. Animals received 1 g pellets 
per day between 17.00 and 17.30 h, placed directly into the home cage, in addition to 
their normal food (access to normal food between 8.30 -  17.00 h). Pilot experiments 
had shown that mice show a preference for these pellets and tend to consume
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immediately after delivery. Furthermore, no pellets were found before testing, 
indicating that all was consumed.
Behavioural analysis
After being treated for three weeks with citalopram, animals were tested on the 
elevated plus maze. Next, animals were tested in the light dark exploration paradigm. 
Locomotor activity was assessed in a 30 minutes open field session, after which the 
response to the introduction of a novel object in a familiar environment was 
investigated in the novel object exploration paradigm. Conflict behaviour was 
investigated in the Vogel conflict task, after which exploratory behaviour was 
assessed in the hole board paradigm. Furthermore, animals were tested in the 
conditioned fear paradigm. Next, pain threshold was assessed using the hot plate test. 
Finally, animals were exposed to inescapable swim stress, of which the immobility 
time during the last three min of testing was scored. At least 5 days lapsed between 
tests.
The animals were weighed before (day 1) and after 31 days of chronic treatment. 
Percentage body weight relative to day 1 was calculated.
Results
Elevated plus maze
Locomotor activity was not affected by treatment in terms of total number of arm 
entries {¥2,29-  L457, p > 0.05; Figure 4.1 A) or of the number of closed arm entries 
{ ¥ 2,29=  0.168, p > 0.05; data not shown). Open arm entries, however, were reduced
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by chronic treatment with citalopram (¥2,29= 3.491, p = 0.044; Figure 4.IB), although 
post hoc testing did not indicate significant differences between groups. Furthermore, 
the time spent on the central platform was significantly increased by treatment { ¥ 2,29 
= 3,956, p = 0.030; Figure 4.1C). Post hoc analysis revealed that animals treated with 
20 mg/kg citalopram spent significantly more time on the central platform compared 
to vehicle treated mice (p < 0.05).
Light dark exploration
Chronic treatment with citalopram reduced locomotor activity as measured by the 
total distance travelled ( ¥ 2,29 = 3.696, p = 0.037; Table 4.1). Post hoc analysis 
indicated that the total distance travelled was significantly reduced in animals treated 
with 20 mg/kg citalopram compared to controls (p < 0.05). Rearing was not affected 
by treatment ( ¥ 2,29 = 1.059, p > 0.05; Table 4.1). No effect of treatment was found in 
terms of time spent in the light compartment ( ¥ 2,29 = 0.758, p > 0.05; Table 4.1). 
Moreover, citalopram failed to affect the relative distance travelled and relative 
number of rearings made in the light ( ¥ 2,29 = 0.956, p > 0.05 and. ¥ 2,29 = 1.168, p > 
0.05, respectively; Table 4.1).
Novel Object Exploration
Citalopram failed to significantly affect the distance travelled during the 30 min 
habituation session (F(2,29)= 1.804, p > 0.05; Table 4.1), although a tendency similar 
to the effects on locomotor activity observed in the L/D box was seen. The number 
of rearings made were also not significantly affected (p2,29 = 2.665, p > 0.05; Table
4.1). Furthermore, the relative distance travelled in the centre and the time spent in 
the centre during the first 5 min remained unaffected by treatment (F2,29 = 1.598, p > 
0.05 and F2,2 9 = 1.216, p > 0.05, respectively; Table 4.1).
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Figure 4.1 Effects of chronic citalopram treatment on elevated plus maze exploration; total arm 
entries (A), entries into the open arms (B) and time spent on the central platform (C) are shown. Data 
are presented as means, with error bars denoting SEMs; *, p < 0.05 significant differences between 
groups.
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After the habituation session, the novel object was introduced. As presented in Table 
4.1, the relative time spent in the object quadrant was above change level during the 
early testing phase, after which it returned to change level. However, no significant 
treatment x bin interaction (p4,54 = 0.360, p > 0.05) or overall difference between 
groups (p2,27 = 0.435, p > 0.05) were found for this parameter. Moreover, no 
significant treatment x time interaction (p4,54 = 0.911, p > 0.05, Table 4.1) or overall 
group difference (p2,27 = 1.314, p > 0.05) were found when relative entries in the 
object quadrant (Table 4.1) were considered.
Hole board exploration
Total distance travelled (Pigure 4.2A) did not significantly differ between groups 
(p2,29 = 1.583, p > 0.05). Moreover, the number of rearings (Pigure 4.2B) were not 
significantly altered by treatment (p2,29 = 3.149, p > 0.05). However, the number of 
nose pokes (Pigure 4.2C) was dose-dependently increased by treatment (p2,29 = 
4.814, p = 0.016). Post hoc testing revealed that animals treated with 20 mg/kg 
citalopram made more nose pokes compared to vehicle treated animals (p < 0.05).
Vogel Conflict Task
Conflict behaviour was not significant altered by treatment, neither in terms of 
number of shocks received (p2,24 = 0.046, p > 0.05; Table 4.1), nor in latency to start 
the session (p2,2 4 = 1.421, p > 0.05; Table 4.1).
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Table 4.1 Effects of chronic citalopram treatment on behaviour in the light dark exploration paradigm, 
open field, novel object exploration task, Vogel conflict paradigm and pain threshold. Data are 
presented as means ± SEMs; *, p < 0.05 significant difference compared to vehicle treated animals.
Paradigm Parameter Vehicle 10 mg/kg 20 mg/kg
LD-Exp P Distance travelled (cm) 1402 + 83 1246 ± 5 3 1163 ± 4 0 *
LD- Exp P Number of rearings 49.0 ± 7.4 42.7 ± 4 .9 37.3 ± 3.5
LD- Exp P Time in light (sec) 121 ± 1 6 106±  17 91 ± 1 8
LD- Exp P Rel. distance in the light 35.6 ± 4.3 31.2 ± 5 .0 26.3 ± 4 .8
LD- Exp P Rel. number of rearings in 
the light
38.5 ± 5.9 31.3 ±6 .3 25.1 ±6 .3
Open field Distance travelled (cm) 9 3 6 8 ± 1015 8310 ± 4 4 3 7510 ± 3 6 6
Open field Number of rearings 276 ± 28 254 ± 1 6 204 ± 21
Open field Rel. distance travelled in the 
centre
17.4 ± 1 .5 18.6±1.1 14.4 ±1 .6
Open field Time spent in the centre 
(sec)
242 ±21 260 ± 18 194 ± 2 4
NOE Rel. time in object quadrant 
min 1-3
34.9 ± 5.3 40.2 ±2 .9 40.3 ± 5.6
NOE Rel time in object quadrant 
min 4-6
33.9 ± 3.8 35.3 ±2 .2 33.0 ±3 .5
NOE Rel. time in object quadrant 
min 7-9
24.6 ± 4.3 29.9 ± 3.2 28.6 ±4 .3
NOE Rel. entries in object 
quadrant min 1-3
27.0 ±1.7 29.1 ±1 .9 27.7 ±1 .9
NOE Rel. entries in object 
quadrant min 4-6
29.8 ±1.2 30.4 ± 1.3 31.8 ± 1.6
NOE Rel. entries in object 
quadrant min 7-9
21.4 ±3 .5 27.2 ±1 .5 27.6 ± 2.8
Vogel
conflict
Number of shocks 34.1 ± 14 36.9 ± 10 40.2 ± 1 7
Vogel
conflict
Latency to start the session 
(sec)
347 ± 78 215 ± 3 4 255 ± 5 6
Hot plate Latency (sec) 8.7 ±0 .9 9.6 ± 0.9 8.5 ±1.1
LD-Exp P: light dark exploration paradigm, Rel: relative, NOE; novel object exploration.
80
Conditioned fear
The response during re-exposure to the CS was analysed by studying the relative 
time not moving and distance travelled, both calculated relative to baseline (Figure 
4.3). No treatment x bin interaction was seen when the relative time not moving was 
considered (Fs,u6 = 0.911, p > 0.05), but overall, this measure tended to by reduced 
by treatment, just failing to reach significance (¥2,29 = 3.14, p = 0.058). Furthermore, 
ANOVA revealed an overall effect on the relative distance travelled (F2,29 = 4.223, p 
= 0.025), but no treatment x bin interaction was seen (Fg.ne = 1.573, p > 0.05). Post 
hoc testing revealed that animals treated with 20 mg/kg citalopram showed reduced 
relative distance travelled compared to vehicle treated animals (p < 0.05).
Hot plate
During the hot plate test, no jumping was observed. Latency to lick the feet (Table
4.1) was not significantly affected by chronic treatment (F2,2s = 0.356, p > 0.05).
Body weight
Body weight, presented in Table 4.2, was significantly increased after chronic 
treatment with citalopram (F2,2s = 3.543, p < 0.042). Post hoc testing revealed that the 
relative body weight of animals treated with 20 mg/kg citalopram was significantly 
higher than that of control animals.
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Figure 4.2 Effects of chronic citalopram treatment on hole board exploration: total distance travelled 
(A), total number of rearings (B) and total number of nose pokes (C) are shown. Data are presented as 
means, with error bars denoting SEMs; *, p < 0.05 significant differences between groups.
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Figure 4.3 Effects of chronic citalopram treatment on conditioned fear: relative time not moving (A) 
and relative distance travelled (B) are shown. Data are presented as means, with error bars denoting 
SEMs.
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Table 4.2 Effect of chronic citalopram treatment on body weight.
Treatment Relative body weight
Vehicle 105 + 1.14
10 mg/kg 109 ±1.63
20 mg/kg 110 + 1.20'
*, p < 0.05 significantly different compared to controls
Discussion
The results fi*om this experiment show that chronic treatment with citalopram results 
in an increased emotional response to the cue in the conditioned fear paradigm. On 
the plus maze, citalopram increases the time spent on the central square and tends to 
decrease open arm arm entries, suggesting increased anxiety-related behaviour. In 
addition, a similar trend in increased anxiety-related behaviour was found in the light 
dark box, however, failed significance. No effects of treatment on anxiety-related 
behaviour were found in the open field, novel object exploration paradigm and Vogel 
conflict task. Furthermore, citalopram treatment resulted in an increase in 
exploratory behaviour in terms of nose pokes made on the hole board, whereas a 
mild reduction in locomotion was found. Finally, increment in body weight was 
higher in citalopram treated animals compared to untreated mice.
In a recent review, Griebel (Griebel, 1995) summarised 72 studies in which the 
effects of SSRI’s on anxiety-related behaviour were studied. Of these studies, 26 
reported anxiogenic effects, 27 were reported to be ineffective, and 19 reported
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anxiolytic effects. Studies were compared in which rats and mice were used, drugs 
were administered acutely or chronically, and a variety of tests were used. The data 
presented here suggest that the effects on anxiety-related behaviour of chronic 
administration in mice are task dependent, e.g. results in an anxiogenic profile in 
some tasks, whereas it is without effect in others.
This is in line with the hypothesis that different types of anxiety-related behaviour 
can be distinguished in rodents, and underlines that the use of a battery of anxiety 
tasks is advantageous to study aspects of anxiety.
Long-term treatment with citalopram induced a two-sided profile on anxiety-related 
behaviour: No effect on anxiety-related behaviour was found in light dark 
exploration task, novel object exploration and Vogel conflict task. In contrast, the 
increased time spent on the central platform and the overall effect of citalopram on 
open arm entries on the elevated plus maze suggest increased anxiety-related 
behaviour after chronic citalopram treatment. Likewise, the increased time spent on 
the platform of the elevated plus maze also suggests increased anxiety-related 
behaviour (Holmes, Rodgers, 1999). One possible explanation for this discrepancy 
found in the different tasks could be the difference in time of testing in connection 
with the treatment schedule. Give that long-term treatment would have failed to 
result in steady state drug levels, drug levels might have been higher during plus 
maze testing at night than during testing in the other tasks during the day. However, 
it should be noted that a significant effect of treatment was found in the conditioned 
fear paradigm, also suggesting increased anxiety-related behaviour. Furthermore, a 
similar tendency in treatment induced reduction of locomotor activity was found in
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all paradigms, which reached significance in the light dark exploration paradigm, 
again suggesting treatment effects being independent of time of testing. Thus, the 
effects of citalopram on anxiety-related behaviour seems to depend on task and not 
on time of testing.
Since responses in the Vogel conflict and conditioned fear paradigm are potentially 
confounded by alterations in pain threshold, nociception was tested on the hot plate, 
but results suggest that performance in the Vogel conflict and conditioned fear 
paradigm was not affected by altered pain threshold. Possible alteration in learning or 
memory abilities, however, cannot be ruled out as potential interfering factors in the 
conditioned fear paradigm.
The present data are in contrast to clinical findings in patients suffering from anxiety 
disorders. One could speculate that SSRI’s have anxiolytic properties only in animals 
with increased emotionality. Several preclinical studies support this hypothesis. For 
example, Keeney and Hogg (1999) recently reported that chronic treatment with 
citalopram is ineffective in non-stressed mice, whereas it has anxiolytic-like 
properties in chronically stressed animals. Furthermore, pre-treatment with the SSRI 
fluoxetine diminished social defeat-induced hypophagia, weight loss and anxiety 
without affecting these variables in control animals (Berton et al., 1999). Along 
similar lines, it has been demonstrated that chronic stress can evoke an 
immunosuppressive response, and fluoxetine has been reported to attenuate the 
adverse effects of stress, without significantly affecting the immune system in 
unstressed mice (Freire-Garabal et al., 1997). In the present study, we have studied 
the effects of chronic treatment with citalopram in non-stressed animals. In order to
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model anxiety-related disorders with more resemblance to what is seen in the clinic, 
it might be of advantage to use subjects with increased emotionality. Possible 
methods could be chronic stress models, or the use of mouse mutants which display 
enhanced anxiety disorder, e.g. CRH overexpressing mice (Stenzel-Poore et al., 
1994) (Heinrichs et al., 1997b).
Locomotor activity was not significantly affected by treatment in the majority of 
tasks, but a comparable tendency for hypolocomotion was found in all tests 
following treatment with citalopram. Moreover, in the light dark exploration 
paradigm, locomotor activity was significantly decreased. These results suggest that 
long-term treatment with citalopram induce mild hypoactivty. Conversely, 
citalopram dose-dependently increased the number of nose pokes made in the hole 
board paradigm. Nose poking has been suggested to be a kind of exploratory 
behaviour which is independently of locomotor activity in rats (Escorihuela et al., 
1999) and mice (Rogers et al., 1999). This in turn indicates increased exploratory 
activity following chronic treatment with citalopram.
Furthermore, the effects of citalopram on body weight merit discussion. In the 
present study, we observed a dose-dependent increase in body weight. We have 
found similar effects on body weight after chronic treatment with the SSRI 
paroxetine in another mouse strain (Van Gaalen and Steckler, unpublished result). 
This is in contrast with another preclinical study, in which weight decreasing 
properties of the SSRI fluoxetine in mice and rats were shown (Yen. Fuller, 1992). In 
the clinic, effects of SSRIs on body weight seem to differ depending on the patient 
population: Chronic treatment with citalopram or sertraline did not alter body weight
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in patients suffering from major depression (Stahl, 2001). On the other hand, SSRI’s 
have been demonstrated to be beneficial in female obese patients (Fiji et al., 1991), 
and effective in patients suffering fi*om bulimia nervosa and anorexia nervosa (Kaye 
et al., 1998; Ferguson et al., 1999). To find out whether the effects of chronic 
treatment with SSRI’s are also dependent on other factors, as for example the 
emotional state of the animal, further investigation is needed.
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Chapter 5
Effects of life-long overproduction of CRH on 
anxiety-related behaviour in mice
Introduction
Citalopram turned out to have anxiogenic properties in some murine anxiety 
paradigms after long-term treatment. This contrasts clinical findings, where it has 
been shown to have anxiolytic properties in addition to its antidepressive actions. As 
explanation for this discrepancy, it was suggested that citalopram might show an 
anxiolytic action in murine models which bear some similarities to symptoms seen in 
patients suffering from anxiety disorders (see Chapter 4). Because dysregulation in 
CRH systems has been suggested to play a role in a variety of stress related 
psychiatric disorders, such as anxiety and depression, a mouse mutant with a 
disrupted CRH system might be of interest. Therefore, a mouse overproducing CRH 
was chosen.
This mouse has been developed in order to examine the effects of chronic CRH 
excess (Stenzel-Poore et al., 1992). These animals have been reported to display
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enhanced anxiety-related behaviour when tested on the elevated plus maze (Stenzel- 
Poore et al., 1994) or in a light dark exploration paradigm (Heinrichs et al., 1997b), 
both paradigms measuring innate anxiety. It is unclear whether overproduction of 
CRH also results in alteration in other types of anxiety tasks. Therefore, the present 
set of experiments extended these studies and included tests of innate anxiety (light 
dark exploration), but also conflict behaviour (Vogel conflict paradigm), a learned 
response (conditioned fear), exploration of a novel open field, hole board 
exploration, and forced swimming
In fact, hypoactivity of transgenic mice exploring a novel environment has been 
reported (Stenzel-Poore et al., 1994). However, studies investigating effects of 
central administered CRH revealed that the effect on locomotor activity depend on 
novelty/familiarity of the environment (for review see: Dunn and Berridge, 1990; 
Steckler, Holsboer, 1999). Therefore, we also investigated the effects of CRH 
overproduction in the home cage, in a novel and a familiar open field. Furthermore, 
sensorimotor performance was tested on a rotarod.
Several studies have reported the abilities of benzodiazepines to attenuate the 
anxiogenic effects of central CRH administration (for review see Dunn and Berridge, 
1990). Conversely, local CRH administration increased GAB A release via receptors 
present on GABA-containing neurons (Sirinathsinghji and Heavens, 1989), 
suggesting possible interactions between the GABA / benzodiazepine and CRH 
systems. Furthermore, it has been shown that chlordiazepoxide, a benzodiazepine 
with both anxiolytic and amnestic properties, attenuated a water maze place learning 
deficit in transgenic mice overexpressing CRH (Heinrichs et al., 1996). The authors
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argued that the beneficial effects of the drug could best be explained by its effects on 
heightened anxiety/arousal, which could have confounded water maze performance 
in transgenic mice. To further dissociate the effects of CRH overproduction on open 
field exploration, the effect of diazepam on locomotor activity was studied.
Material and Methods 
Animals
CRH transgenic mice, originally generated on C57BL/6 x SJL background in one 
line of mice by M. P. Stenzel-Poore (1992), were backcrossed onto C57BL/6 for 
seven generations. 13 Heterozygous male transgenic mice and 17 male wildtype 
littermates were used in experiment 1, 12 heterozygous male transgenic mice and 12 
male wildtype littermates were used in experiment 2, all aged between 2 to 3 months, 
and bred and reared in the animal house of the Max Planck Institute. The CRH 
transgene was composed of the rat genomic CRH gene, with the 5’ regulatory region 
being replaced by the murine metallothionein-1 gene. The 3’ untranslated region of 
the human growth hormone gene was ligated to the 3’ end of the CRH gene in order 
to ensure adequate RNA processing of the fusion gene (Stenzel-Poore et a l ,  1992). 
Animals were housed individually and maintained on a 12:12 h light/dark cycle 
(lights on at 06:00 hours) with ad lib water and food unless mentioned differently in 
experiment description.
Experiment 1
After placing the animal in a confinement for 1 min, spontaneous behaviour was 
analysed in the home cage for ten minutes. The total distance travelled over the full
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session was analysed with a video tracking system (VideoMot2, TSE, Germany). 
Furthermore, time spent rearing, grooming and digging in the bedding were scored 
manually over two 5 min bins. Next, animals were tested in the light dark exploration 
paradigm. Locomotor activity was assessed in a 30 minutes open field session 
without prior habituation (novel open field). The first 5 min of the session were 
analysed on time spent and relative distance travelled in the centre of the open field 
as a measure for anxiety-related behaviour.
Conflict behaviour was investigated in the Vogel conflict task. Further, exploratory 
behaviour was analysed in the hole board paradigm, after which conditioned fear was 
studied. Furthermore, pain threshold was assessed in using the hot plate test, and 24- 
hour water intake was measured. Sensorimotor skills were assessed by testing the 
animals on a rotarod for three sessions, each spaced with 2 hours. Finally, animals 
were exposed to inescapable swim stress. Immobility time during the last three min 
of testing was scored. At least 5 days lapsed between tests.
Experiment 2
New groups of animals were repeatedly tested in an open field (same apparatus used 
for open field testing in experiment 1). Animals were tested once a day. First, 
animals were habituated for 5 sessions, one 30 min session per day (familiar open 
field). Then, animals were re-tested in the open field after receiving saline or 
diazepam (0.5, 2.5 and 7.5 mg/kg, intraperitonial (i.p.)). Each dose of drug was 
compared with saline vehicle utilising a Latin-square design (the sequence of 
treatments were randomised). Between treatment sessions, animals were tested for 
one session without vehicle/drug administration. Relative distance travelled after
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treatment was calculated, with the distance travelled at habituation session 5 taken as 
baseline.
To control for possible alterations in water intake in a novel environment, animals 
(experiment 2) were tested for two sessions spaced by one week. Prior to testing, 
animals were water deprived for 24 hours. The testing procedure on session 1 was 
similar as in experiment 1, except that no shock was delivered. Session 2 was similar 
to the original lick suppression protocol. The percentage of response inhibition was 
calculated from the number of episodes completed during sessions 1 and 2 in order to 
control for motivational differences. Furthermore, the relative change in latency to 
start the session was calculated from the latencies obtained during sessions 1 and 2.
Conditioned fear
The same apparatus and procedure was used as in experiment one, except now 
animals were exposed to the test box, 1 hour after conditioning.
At least one week lapsed between tests.
Results 
Examination of spontaneous behaviour
Locomotor activity in the home cage, as measured by total distance travelled, was 
significantly decreased in transgenic animals (Fi,2s = 35.62, p < 0.001; Figure 5.1 A).
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Figure 5.1 Effects of overproduction of CRH on spontaneous behaviour in the home cage. Distance 
travelled (A) was analysed over 10 min. The times spent rearing (B), grooming (C) and digging (D) 
were analysed over two successive 5-min time bins. Data are presented as means, with error bars 
denoting SEMs; group differences: ** p < 0.01; *** p < 0.001.
Overall, time spent rearing was also decreased in transgenics (Fi,28 = 35.62, p < 
0.001; Figure 5. IB). Although a genotype x bin interaction was found for the latter 
measure (Fi,2s = 6.77, p = 0.015), post hoc testing failed to reveal significant 
differences. No genotype x bin interaction was found in time spent grooming (Fi,28 = 
1.28, p > 0.05; Figure 5.1C), but the overall time spent grooming tended to be 
increased in transgenic animals (F%,28 = 3.23, p = 0.083). Furthermore, transgenic 
mice spent less time digging than wildtype animals (Fi,2s = 8.03, p = 0.008; Figure 
5.ID), but no genotype x bin interaction was found (Fi,28 = 2.94, p > 0.05).
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Light dark exploration
Transgenic animals showed reduced activity compared to wildtype animals in term 
of distance travelled (Fi,28 = 23.55, p < 0.001; Figure 5.2A) and number of rearings 
made (Fi,28 = 12.93, p = 0.010; Figure 5.2B). Furthermore, latency to enter the light 
compartment was increased in transgenic mice (F%,28 = 12.65, p = 0.001; Figure 
5.2C) which also spent less time in lit area (Fi,2s = 11.31, p = 0.002; Figure 5.2D), 
indicating increased anxiety-related behaviour. Moreover, moving time and relative 
distance travelled in the light compartment were decreased in transgenic animals 
(Fi,28 = 15.91, p < 0.001 and Fi,2s = 13.02, p = 0.001; Figures 5.2E, F), suggesting 
that the reduced exploration of the illuminated compartment was not due to altered 
locomotor activity.
Novel open field
Overall, mutants travelled a significantly shorter distance (F%,28 = 13.94, p < 0.001; 
Figure 5.3A), but no genotype x bin effect was found (F^ ^Mo = 2.32, p > 0.05), 
although visual inspection of the data suggested that the major differences were seen 
during the first 10 min of exploration. Parameters possibly indicating anxiety-related 
behaviour were analysed during the first five minutes, but no significant differences 
were found in terms of time spent (Fi,28 = 2.18, p > 0.05; Figure 5.3B) and relative 
distance travelled (Fi,28 = 2.07, p > 0.05; Figure 5.3C) in the centre of the open field.
Familiar open field: effects of diazepam
There was a significant effect of session during the five habituation session in 
distance travelled (F4,gg = 14.68, p < 0.001): activity of animals was higher during 
session 1, but did not differ thereafter. No effect of genotype (Fi,22 = 0.12, p > 0.05),
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Figure 5.2 Effects of overproduction of CRH on light dark exploration: the total distance travelled 
over 5 min (A), the total number of rearings (B), latency to enter the light compartment (C), the time 
the animal spent in the illuminated part (D), the time the animal spent moving in the illuminated part 
(E), the relative distance travelled in the light (E) and the relative distance travelled in the illuminated 
area (F) are shown. Data are presented as means, with error bars denoting SEMs; **, p < 0.01; ***, p < 
0 .001 .
96
Novel Open Field
A 1400
1200 -
Î 1000 ■
800
I
h  600
400 WT
TGI 200 -
1-5 6-10 11-15 16-20 21-25 26-30
B
bin (min)
c u 20
Figure 5.3 Effects of overproduction of CRH on behaviour in a novel open field: the total distance 
travelled over 30 min (A), the time spent in the centre of the open field during the first 5 min (B) and 
the relative distance travelled in the centre during the first 5 min (C) are shown. Data are presented as 
means, with error bars denoting SEMs.
97
or genotype x session interaction (p4,88 = 0.95, p > 0.05) was found during this 
habituation stage (data not shown). Diazepam administration dose-dependently 
reduced the relative distance travelled in both groups (F3,g4 = 13.47, p < 0.001; Figure 
5.4). Furthermore, a group difference was found after treatment(Fi,84 = 25.15, p < 
0.001), although no genotype x treatment effect was found (F3,s4 = 2.03, p > 0.05).
Hole board exploration
Again, transgenic mice showed an overall decreased locomotor activity, comparable 
to what has been observed in the open field (Fi,28 = 14.05, p < 0.001; data not 
shown). However, genotypes failed to differ in the number of nose pokes made (F%,28 
= 1.47, p > 0.05; Figure 5.5). No genotype x bin interaction was seen for this 
measure (F5J 40 = 2.07, p > 0.05). However, visual inspection of the data suggested a 
possible genotype effect on the number of nose pokes made in the early testing 
phase. Therefore, the first 5 min of exploration were analysed separately, which 
indicated that transgenic mice made significantly less nose pokes during this period 
compared to wildtype mice (Fi,28 = 4.77, p = 0.037), whereas no significant group 
differences were found in the number of rearings.
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Figure 5.4 Effects of overproduction of CRH in a familiar open field: The relative distance travelled 
from baseline (dotted line) after vehicle / diazepam treatment is shown. Data are presented as means, 
with error bars denoting SEMs
Lick suppression
Transgenic mice showed a decreased latency to start the session compared to 
controls (Fi,2? = 6.72, p = 0.015; Figure 5.6A). The number of finished episodes, 
however, was not significantly different between groups (Fi,2? = 0.17, p > 0.05; 
Figure 5.6B).
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Repeated exposure to the lick suppression chamber in experiment 2 revealed that the 
number of completed episodes decreased from session 1 (without shock) to session 2 
(with shock; wildtype 25.8% ± 9.9, transgenic 21.2% ± 11.9). However, no effects of 
genotype were seen when the relative number of episodes were considered (Fij? = 
98.78, p > 0.05). The latency to start a session was decreased upon re-testing 
(wildtype 17.2% ±21.7, transgenic 43.6% ± 13.5), but again, no significant effect of 
genotype was seen (Fj^u = 1.01, p < 0.050), suggesting that lack of difference in 
conflict behaviour between mutants and wildtype animals is not due to altered 
motivational drive.
Conditioned fear
The relative time not moving was analysed after re-exposure of the cue. A significant 
effect of bin was found when animals were re-tested 1 h after conditioning 
(experiment 2; F4J2 = 13.94, p < 0.001; Figure 5.7). Overall, the relative resting time 
after re-exposure to the cue was lower in transgenic animals compared to wildtype 
mice (Fi,i8 = 5.91, p = 0.026), but no genotype x bin interaction was observed (F4J 2 = 
46.98, p > 0.05).
Re-exposure to the cue 24 h after conditioning also revealed an effect of time bin 
(experiment 1; F4,ioo = 37.79, p < 0.001; Figure 5.8). No effect of genotype (Fi,25 = 
0.49, p > 0.05) or a genotype x bin interaction (F4,ioo = 1.86, p > 0.05) were seen.
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Figure 5.5 Effects of overproduction of CRH on hole board exploration: number of nose pokes made 
during a 30 min session are shown. Data are presented as means, with error bars denoting SEMs.
Hot plate
During the hot plate test, no jumping was observed. Latencies to feet licking were 
not significantly different between groups (Fi,2? = 2.32, p > 0.05; Table 5.1).
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Figure 5.6 Effects of overproduction of CRH on conflict behaviour: latency to start the session (A) 
and number of finished episodes (B), are shown. Data are presented as means, with error bars 
denoting SEMs; *, p < 0.05.
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Figure 5.7 Effects of overproduction of CRH on conditioned fear 1 h after conditioning : change in 
the time not moving during re-exposure to the light relative to baseline (dotted line) is shown. Data 
are presented as means, with error bars denoting SEMs.
Water intake
Twenty-four hour water intake was significantly higher in transgenic animals 
compared to wildtype (Fi,28 = 49.72, p < 0.001; Table 5.1).
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Figure 5.8 Effects of overproduction of CRH on Conditioned fear 24 h after conditioning: change in 
the time not moving during re-exposure to the light relative to baseline (dotted line) is shown. Data 
are presented as means, with error bars denoting SEMs.
Table 5.1: Effects of overproducion of CRH on pain threshold and water intake.
WT TG
Pain threshold 11.9 ±2.4 13.6 ±3.5
Water intake 3.8 ±0.1 5.8 ± 0.3***
Data are presented as means ± SEMs; ***, p < 0.01, significant different to the other strains.
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Figure 5.9 Effects of overproduction of CRH on rotarod performance: time spent on the rotarod in 
successive sessions is shown. Data are presented as means, with error bars denoting SEMs; *, p < 
0.05.
Sensorimotor skills
There was an effect of bin (¥2,52 =  7.62, p = 0.004; Figure 5.9) on time spent on the 
rotarod, indicating that mice improved performance over sessions. There was also a 
genotype x session effect (F2,s2 = 4.23, p = 0.034), and an overall genotype effect was 
observed (F%,26 = 6.17, p = 0.020), with transgenic mice being impaired relative to 
wildtype animals. Further post hoc testing indicated that the groups only differed in 
the third session (P < 0.05).
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Figure 5.10 Effects of overproduction of CRH on inescapable swim stress: immobility time during 
the last three minutes of testing is shown. Data are presented as means, with error bars denoting 
SEMs; ***,p< 0.001.
Inescapable swim stress
Transgenic animals spent less time immobile compared to controls (Fi,2 6 = 67.58. p < 
0.001; Figure 5.10).
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Discussion
The main findings of the present study are that transgenic mice displayed increased 
anxiety-related behaviour in some, but not all, anxiety tasks. Furthermore, these 
animals were hypoactive in novel environment, whereas no difference in locomotor 
activity was found after being habituated to a test environment. Finally, CRH 
overexpressors were less susceptible to the sedative effect of diazepam.
Transgenic mice showed increased anxiety-related behaviour in the light dark 
exploration task, which is in line with finding fi*om Heinrichs and colleagues 
(1997b). The anxiety-like effects observed were not likely to be due to hypoactivity, 
as relative activity in the illuminated compartment in the light dark exploration task 
was also reduced. A tendency of increased anxiety-related behaviour in transgenic 
mice was found in terms of time spent grooming in the spontaneous behaviour 
paradigm and in anxiety parameters assessed in the open field. Results from the 
Vogel conflict task did not reveal a difference between CRH transgenic mice and 
wildtype littermates, but this lack of difference could be due to altered motivation as 
transgenic mice have an increased water intake. The results obtained in the second 
experiment, in which relative shock-induced response suppression was assessed, also 
failed to reveal a difference between groups, which would argue against this 
possibility. The unaltered conflict behaviour displayed by CRH overexpressing mice 
is in contrast to the reported anxiogenic effects of acute centrally administered CRH 
in conflict tasks (Britton et al., 1985, 2000). This suggests that challenging of the 
CRH system can affect conflict behaviour, whereas chronic hyperactivation does not
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alter conflict behaviour, in contrast to anxiety-related behaviour in innate test of 
anxiety as for example the light dark exploration task.
In addition, no genotype differences were found in conditioned fear when tested 24 h 
after conditioning. Strikingly, a reduced emotional response of the transgenics to the 
CS was found when tested 1 hour after conditioning. However, the conditioned fear 
experiment presented in Chapter 3 show that the emotional response, in terms of 
locomotor inhibition, occurs in the first min after representation of the cue. Visual 
inspection of the data of the fear conditioning experiments presented here, indicate 
that the emotional response is comparable when measured 24 hours or 1 hour after 
training. This suggests that conditioned fear is not different in CRH overexpressors. 
However, an effect of CRH overproduction on learning and memory cannot be 
excluded. For example, several studies have shown that centrally administered CRH 
or its displacement form CRH-binding protein enhances memory in multiple learning 
tasks (Koob, Bloom, 1985; Liang, Lee, 1988; Behan et al., 1995; Heinrichs et al., 
1997), whereas i.c.v. administration before the memory test seems to impair memory 
(Diamant, de Wied, 1993). More recently, Radulovic and colleagues (1999) showed 
that centrally administered CRH can either enhance or impair learning depending on 
the region of administration, and the authors suggested that CRH acted on memory 
consolidation. These findings make it difficult to speculate whether life-long 
overproduction of CRH would alter learning in the present experiment. This question 
was assessed by Heinrichs and colleagues (1996), who reported that CRH 
overproducing mice show impaired performance in a place navigation task. 
However, this deficit was attenuated by administration of the benzodiazepine 
chlordiazepoxide, whilst treatment impaired the performance of control animals. The
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authors postulate that deficits in place navigation in CRH overproducing mice might 
not be due to impaired spatial learning / memory per se, but is possibly due to the 
increased arousal / anxiety. In addition, the results from both fear conditioning 
experiments indicate that mutants can learn to associate CS with the US, however, no 
increased emotional response, as may be expected, was found.
Footshock might, however, be experienced as more aversive by transgenics. This 
gains additional relevance in the Vogel conflict, which might also be influenced by 
nociception. However, results of the hot plate experiment suggest that nociception is 
not altered in transgenics. This is in line with the failure of CRH to affect nociception 
on the hot plate and in the tailflick test when administered centrally (Britton et al., 
1985; Sherman, Kalin, 1986).
Interestingly, the number of nose pokes made in the hole board was only reduced 
during the early testing phase. Nose pokes are believed to be an index for exploratory 
behaviour, and can be assessed independently of locomotor activity in rats 
(Escorihuela et al., 1999) and mice (Rogers et al., 1999). It is possible that the 
reduction in number nose pokes made were confounded by altered anxiety. For 
example, it has been shown that the number of hole visits on a hole board can be 
increased after administration of anxiolytic compounds, whereas anxiogenic
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compounds as well as restraint stress decrease the number of visits in mice (Takeda 
et al., 1998). Therefore, the reduction in exploratory behaviour (nose pokes) during 
the early testing phase might be due to increased anxiety displayed by transgenic
mice.
Mice overexpressing CRH were more active compared to wildtype littermates when 
exposed to inescapable swim stress. Similar testing conditions have been used by 
Heinrichs and co-workers (Heinrichs et al., 1996), but in these experiments latency to 
immobility was measured. No genotype-dependent difference was found, which was 
interpreted as no difference in latency to tire. However, acute centrally administered 
CRH has been reported to reduce immobility time (Butler et al., 1990). The authors 
proposed that these measures possibly reflect possible anxiety. This is in line with 
findings from Ferre and colleagues (1964), who demonstrated that murine anxiety- 
related behaviour on the plus maze and immobility time in a forced swimming task 
show a reversed correlation. In addition, data presented in Chapter 3 point in the 
same direction. Therefore, it might be that the decreased immobility time of the 
transgenic mice might be due to increased anxiety.
Difference in locomotor activity was depending on the context of the testing 
environment. Thus, CRH transgenic mice displayed hypoactivity activity when tested 
in a novel environment (open field, light dark exploration, and hole board 
exploration) or under conditions of enhanced arousal in the modified home cage. 
This is in agreement with previous work from Stenzel-Poore and colleagues (1994), 
showing that CRH overexpressors are hypoactive in a novel environment. Similar 
results have been found after acute i.c.v. administration of CRH (Sutton et al., 1982;
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Sherman and Kalin, 1986; Britton et al., 1986; Conti et al., 1994; Jones et al., 1998). 
The hypolocomotor activity of transgenics, seen when tested in the novel 
environments, was no longer apparent when animals were habituated to the test 
conditions in the familiar open field. This contrasts the effects of acute CRH on 
locomotor activity, in a familiar environment, where acute CRH administration 
increases activity (Sutton et al., 1982; Sherman and Kalin, 1986; Britton et al., 1986).
Also of note, transgenic animals did not display hypoactivity under forced 
conditions. For example, on the rotarod, both groups performed equally well during 
the first session. However, wildtype animals improved performance over sessions, in 
contrast to transgenic mice. On possibility is that CRH disrupts performance at the 
level of the cerebellum, an area which plays an important role in fine locomotor 
function and in which strong expression of CRHRl receptors has been reported 
(Chalmers et al., 1995; Bishop et al., 2000).
Taken together, overexpression of CRH induces effects that are in part comparable to 
the effects of acute CRH administration, whereas others are not. Such differences 
between acute and long-term CRH exposure may be due to CRH-induced alteration 
in other neurotransmitter system. -----
Administration of diazepam in the familiar open field dose-dependently reduced 
locomotor activity. However, transgenics were less susceptible to the sedative effects 
of diazepam. Diazepam enhances GABA neurotransmission by acting on the 
GABAa receptor. Other agents that have such property are barbiturates, 
benzodiazepines, steroid anaesthetics and ethanol (see for example Zorumski and
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Isenberg, 1991). Barbiturates and benzodiazepines are well known for their 
anxiolytic properties. Several studies have reported the abilities of benzodiazepines 
to attenuate the anxiogenic effects after central CRH administration (Dunn and 
Berridge, 1990). Furthermore, repeated benzodiazepine administration results in 
reduction of CRH receptor binding (Grigoriadis et al., 1989), and prenatal exposure 
to diazepam leads to a decrease in CRH-immunoreactivity in cells within the PVN of 
adult rats (Inglefield et al., 1993). In addition, local CRH administration increases 
GABA release via receptors present on GABA-containing neurons (Sirinathsinghji 
and Heavens, 1989). Taken together, this indicates that the GABA / benzodiazepine 
and CRH systems may interact.
This indicates, that using models of chronic CRH excess may increase the 
understanding in the pathology of disease in which hyperactivity of the CRH system 
plays a role, such as depressive illness. Furthermore, one might speculate that 
chronic CRH excess may increase some, but not all, aspects of anxiety. Finally, the 
present data again underline that a range of anxiety task is necessary to study 
anxiety-related behaviour in detail.
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Chapter 6
Transgenic Mice Overexpressing 
Corticotrophin-Releasing Hormone show 
reduced responsiveness in plasma 
corticosterone after a 5-HTlA receptor
challenge
Introduction
Data presented in the previous chapter support the hypothesis that chronic excess of 
CRH increases some, but not all, aspects of anxiety. This is in line with the known 
anxiogenic properties of CRH. However, patients suffering from depression often 
show increased anxiety, and alterations in the CRH system have been found in these 
patients. Furthermore, the serotonergic system, in particular the 5-HTia receptor, has 
been implicated in the modulation of anxiety and depression. Therefore, in the
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present experiment, the consequences of long-term CRH overproduction on 5-HTia 
receptor function were studied in transgenic mice overexpressing CRH.
5-HTiA receptors serve both somatodendritic autoreceptor- and postsynaptic 
heteroreceptor function. In mice, 8-OH-DPAT-induced hypothermia has been 
attributed to activation of somatodendritic 5-HTia autoreceptors (Bill et al., 1991), 
while there is strong evidence to suggest that increased secretion of ACTH and 
corticosterone following 8-OH-DP AT administration results, at least in part, from 
stimulation of postsynaptic 5-HTia receptors at the level of the PVN (Pan, Gilbert, 
1992).
Material and Methods
Individually housed female transgenic mice oveiproducing CRH (Stenzel-Poore et 
al., 1992) were compared to age-matched wildtype littermates (n = 5 - 9 per group, 2 
to 4 months of age). In the first experiment, corticosterone levels were estimated 
under basal conditions (trunkblood sampling between 8.00 and 9.00 hours) and 20 
min after s.c. CRH injection (30 microgram / kg).
In the second experiment, rectal temperature was recorded over 4 seconds (Thermo- 
electra, Pijnacker, The Netherlands), after which animals received a s.c. injection of 
either 8-OH-DP AT (0.5 mg/kg) or saline and were returned to their homecage for 20 
min, followed by another measurement of rectal temperature. Subsequently, 
trunkblood was collected for corticosterone plasma estimation.
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Results 
Experiment 1
Plasma corticosterone levels were overall increased in transgenic mice (Fi,24 = 48.25, 
p < 0.001; Figure 6.1). CRH injection resulted in an increase in plasma 
corticosterone levels (Fi,24 = 50.10, p < 0.001), whereas no genotype x treatment 
interaction was found (Fi,2 4 = 0.36, p > 0.05).
Plasma Corticosterone levels
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Figure 6.1 Effects of overproduction on plasma corticosterone levels, under basal conditions and 20 
min after injection of CRH (30 pg/ kg), wt: wildtype; tg: transgenic. Data are presented as means ± 
SEMs.
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Experiment 2
Body temperature was increased after injection / handling / insertion of temperature 
probe induced stress independently of genotype (Figure 6.2). There was a significant 
time X treatment effect (Fi,24 = 94.7, p < 0.001) on body temperature after 8-OH- 
DP AT administration, but no significant time x genotype (Fi,24 = 0.12, p > 0.05) or 
time X genotype x treatment (Fi,24 = 0.60, p > 0.05) interactions were observed 
(Figure 6.2). Post hoc testing revealed that saline injection increased body 
temperature (p < 0.001), whereas 8-OH-DP AT reduced body temperature (p < 
0 .001).
Both genotype (Fi,24 = 22.6, p < 0.001) and treatment (Fi,24 = 7.92, p < 0.010) 
affected plasma corticosterone levels, ANOVA also revealed a significant genotype x 
treatment interaction (Fi,24 = 94.7, p < 0.010; Figure 6.3). Additional post hoc testing 
indicated that plasma corticosterone levels were higher in wildtype animals treated 
with 8-OH-DP AT than in all other groups, while 8-OH-DP AT had no effect in CRH 
overexpressing mice.
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Figure 6.2 Effects overproduction of CRH on Body temperature measured under basal conditions 
(pre-treatment) and 20 min after treatment (post-treatment), wt: wildtype; tg: transgenic. Data are 
presented as means ± SEMs.
Discussion
Central GRH administration is known to induce hyperthermic responses, and both 
stress and CRH-induced hyperthermia can be blocked by a-helical CRH(9-41), a 
non-selective CRH antagonist (Morimoto et al., 1993), suggesting a key role for 
CRH in stress induced hyperthermia. The fact that stress-induced hyperthermia did 
not differ between transgenic and wildtype mice suggests that CRH overproduction 
did not affect this measure, or that compensatory mechanisms are operating to 
maintain hyperthermic responses induced by stress in the face of CRH
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Figure 6.3 Effects of overproduction of CRH on plasma corticosterone levels, 20 min after injection 
of saline or 8-OH-DPAT (0.5 mg/kg), wt: wildtype; tg: transgenic. Data are presented as means ± 
SEMs. *** p < 0.001 compared to all other three groups.
hypersecretion. 8-OH DPAT-induced hypothermia also failed to differ between 
groups, suggesting that presynaptic 5-HTia receptor function remained intact in 
transgenic mice.
Basal corticosterone plasma levels were elevated in transgenic animals, which is in 
line with a previous report from Stenzel-Poore and colleagues (1992). However, no 
differences between groups were seen on this measure following mild stress (saline 
administration and body temperature measurements) in the present study. This is in 
agreement with a recent study, reporting a blunted response of HPA axis activity
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after swim stress in transgenic mice overexpressing CRH (Heinrichs et al., 1997), 
despite the fact that anxiety-like behaviour is increased in these animals (Heinrichs et 
al., 1997; Stenzel-Poore et al., 1994; Chapter 5). Thus, although the hyperthermic 
response remained unaffected in transgenic mice, HPA axis reactivity after mild 
stress was blunted in these animals, suggesting distinct mechanisms involved in 
adjusting to increased CRH activity.
CRH injection, at a dose that has been shown to increase HPA-axis activity after 
peripheral injection (Barden et al., 1997), elevated corticosterone plasma levels in 
both wildtype and transgenic mice, demonstrating that HPA axis activity is sensitive 
to CRH stimulation in both groups. Administration of 8-OH DP AT, however, 
increased plasma corticosterone levels in wildtype animals, but not in transgenics. 
Since elevation of plasma ACTH levels induced by 5-HTia receptor activation may 
be mediated by 5-HTia receptors affecting the release of CRH fi*om the PVN (Pan, 
Gilbert, 1992), it may be speculated that the blunted HPA response seen after 8-OH- 
DPAT administration in transgenic mice is due to desensitisation of 5-HTia receptors 
at the level of the PVN.
Several clinical studies have demonstrated that administration of 5-HTia agonists 
results in a decrease in body temperature and an increase in cortisol release in 
human. Different profiles were found when the responses to 5-HTia receptor 
challenge were studied in affective disorders. Thus, patients diagnosed as suffering 
from unipolar or major depression exhibit significantly decreased cortisol responses 
to the partial 5-HTia agonist ipsapirone, while basal cortisol secretion is increased 
when compared to controls (Lesch et al., 1990; Meltzer, Maes, 1995). Despite altered
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HPA responsivity to 5-HTia challenge, no significant differences were observed in 
ipsapirone-induced hypothermia (Meltzer, Maes, 1995). This contrasts with data 
fi*om patients with bipolar depression, who did not differ in cortisol release (Shiah et 
al., 1998), and patients with mania, who showed increased cortisol release after 
ipsapirone challenge (Yatham et al., 1999). Hypothermic responses were not 
different from controls in both patients groups. Patients suffering fi*om obsessive 
compulsive disorder, on the other hand, showed no differences after 5-HTia 
challenge in either parameter (Lesch et al., 1991), whereas attenuation of both 
thermoregulation and cortisol release was seen in patients with panic disorder (Lesch 
et al., 1992). Thus, the responses seen in mice overproducing CRH strikingly 
resemble those observed in depression, and suggest that blocking CRH action may be 
beneficial in depression and help to restore serotonergic neurotransmission in 
patients.
In summary, the data indicate that 5-HTia receptor challenge results in reduced 
responsiveness in plasma corticosterone levels in mice overproducing CRH, whereas 
body temperature changes after stress or following 5-HTia receptor challenge is 
unaltered. Extrapolating this situation to the human, these data open the possibility 
that the desensitisation of 5-HTi a receptors seen in the brains of depressed subjects 
may result from hyperactivity of the CRH system frequently seen in these patients 
(Steckler and Holsboer 1999).
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Chapter 7
Effects of chronic treatment with citalopram on 
anxiety-related behaviour depends on 
emotionality state of test subject
Introduction
Data presented in Chapter 4 shows that long-term treatment with citalopram 
increases some anxiety-related behaviour. This is in contrast to clinical findings 
where citalopram and other SSRI’s are known for their anxiolytic actions after long­
term treatment. Here, the hypothesis that SSRI’s might only have anxiolytic 
properties in animals with increased emotionality was addressed further. Therefore, 
the effects of long-term citalopram treatment on anxiety-related behaviour was 
compared between mice overproducing CRH and wildtype littermates. Mice 
overproducing CRH are know to show increased anxiety-related behaviour (Stenzel- 
Poore et al., 1994; Heinrichs et al., 1997b), although this seems to be task dependent 
(see Chapter 5). Furthermore, results presented in Chapter 6 show that these animals 
have an altered response in HPA-axis activity after 8-OH DP AT challenge. 
Therefore, it was investigated whether chronic citalopram treatment would also 
normalise the effects of 5-HTia receptor stimulation on HPA axis activity. This may
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be of particular relevance as it has been suggested that anti-anxiety or antidepressant 
effects of antidepressants might be mediated via enhancement of serotonergic 
neurotransmission due to desensitisation of 5-HTia autoreceptors (Albert et ah, 
1996). Given that 5-HTia autoreceptor function can be assessed using the 8-OH 
DP AT induced hypothermia test, it was investigated whether desensitisation of the 5- 
HTia autoreceptor function, which occurs after chronic treatment with 
antidepressants (Bill et ah, 1991; Goodwin, 1989), would be affected by long-term 
overproduction of CRH.
Material and methods 
Animals
Individually housed male transgenic mice overproducing CRH (Stenzel-Poore et ah, 
1992) were compared to age-matched wildtype littermates (n = 10 per group).
Treatment
Animals were treated chronically with citalopram (racemic, kindly donated by 
Lundbeck, Copenhagen, Denmark) at a dose of 20 mg/kg or vehicle po (as described 
in detail in Chapter 4). Animals received treatment between 17.00 and 17.30 h.
Behavioural analysis
After being treated for three weeks with citalopram, animals were first tested in the 
light dark exploration paradigm. Subsequently, locomotor activity was assessed in 
the open field for 30 min. Then, hole board exploration was assessed for 30 min.
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Finally, conditioned fear was assessed 24 h after conditioning. At least 5 days lapsed 
between tests.
8-OH DPAT induced hyperthermia and HPA-axis activation
Prior to the experiment, animals were weighed and rectal temperature was recorded 
over 4 seconds. Immediately afterwards, animals received a s.c. injection of either 8- 
OH-DPAT (0.5 mg/kg dissolved in saline) or saline, and were returned to their 
homecage for 20 min, followed by another measurement of rectal temperature. 
Subsequently, animals were anaesthetised with isofluran and decapitated within 15 
seconds. Trunk blood was collected for ACTH and corticosterone measurement.
Body weight
The animals were weight before (day 0) and after chronic treatment (day 32). 
Statistics
Data were analysed by multiple analyses of variance (MANOVA), followed by post 
hoc Tukey test, if appropriate.
Results
Light dark exploration
Total distance travelled was decreased in transgenic mice (F%,34= 42.58, p < 0.001; 
Figure 7.1 A), but was not affected by treatment (Fi,s4= 2.63, p > 0.05). Furthermore, 
a genotype x treatment interaction was found (Fi,34= 5.77; p = 0.022). Post hoc 
testing revealed that treatment reduced locomotor activity in wildtype animals (p <
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0.050), but not in transgenic mice. Overall, time spent in the illuminated 
compartment was decreased in transgenic mice (Fi,34 = 7.34, p = 0.010), whilst no 
overall effect of treatment was found (Fi,34 = 2.73, p > 0.05; Figure 7.IB). 
Furthermore, a genotype x treatment interaction was found (Fi,34 = 2.73, p = 0.017). 
Post hoc testing revealed that time spent in light compartment was decreased by 
treatment in wildtype animals (p > 0.010). A tendency for an increase in time spent 
in the light compartment was found after treatment in mutants, but failed to reach 
significance. Likewise, relative distance travelled was decreased in mutants (Fi,34 = 
7.71, p = 0.009), while no overall treatment effect was found (F%,34= 1.72, p > 0.05, 
Figure 7.1C). However, a genotype x treatment interaction was found (F%,34 = 5.69, p 
= 0.023). Post hoc testing revealed that citalopram treatment tended to reduce 
relative distance travelled in the light compartment in wildtype animals (p = 0.052), 
whereas treatment seemed to have an opposite effect in mutants, although this failed 
to reach significance.
Open field
Distance travelled in the open field was reduced in mice overproducing CRH (Fi,33 = 
23.22, p < 0.001). No overall effect of treatment (Fi,33 = 0.50) or genotype x 
treatment interaction (Fi,3s = 2.31) were found (both p’s > 0.050; Figure 7.2A). 
Likewise, transgenics made less rearings compared to wildtype animals (F%,33 = 6.23, 
p = 0.018). Again no effect of treatment was observed (treatment effect F%,33 = 6.22; 
genotype x treatment effect Fi,33 = 1.34, both p’s < 0.050; Figure 7.2B).
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Figure 7 .1  Effects of chronic citalopram treatment in CRH overproducing and wildtype mice on light 
dark exploration: the total distance travelled over 5 min (A), the time the animal spent in the 
illuminated part (B), and the relative distance travelled in the light (C) are shown. Data are presented 
as means, with error bars denoting SEMs.
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Hole board exploration
Overall, transgenic mice made less nose pokes compared to wildtype littermates 
(Fi,33 = 5,98 p = 0.020). Treatment did not affect this measure (treatment effect F133 = 
1.86; genotype x treatment effect Fi,33 = 0.44 both p’s > 0.050; Figure 7.3).
Conditioned fear
The overall response to the cue in term of relative resting time was significantly 
different between groups (F%,32= 10.91, p < 0.002 Figure 7.4). Visual inspection of 
the data revealed that wildtype animals showed an increased relative resting time 
compared to transgenic mice. No significant session time dependent effects were 
found (genotype x bin effect F3,96 = 0.58; treatment x bin effect F3,96= 1.09; genotype 
X treatment x bin F3,96= 0.48, all p’s > 0.05) in terms of relative resting times after re­
exposure to the cue. Although there was no overall effect of treatment (Fi,32= 0.00, p 
> 0.05), a significant genotype x treatment interaction was found (Fi,32= 4.46, p = 
0.043). Post hoc testing revealed transgenic mice treated with citalopram showed a 
lower response to re-exposure to the cue compared to wildtype animals treated with 
citalopram (p < 0.050).
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Figure 7.2 Effects of chronic citalopram treatment in CRH overproducing and wildtype mice on 
behaviour in an open field: the total distance travelled (A) and the number of rearings made (B) are 
shown. Data are presented as means, with error bars denoting SEMs.
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Figure 7.3 Effects of chronic citalopram treatment in CRH overproducing and wildtype mice on hole 
board exploration: number of nose pokes made during a 30 min session are shown; Data are presented 
as means, with error bars denoting SEMs.
8-OH DPAT induced hypothermia
Chronic treatment with citalopram attenuated 8 -OH DPAT induced hypothermia 
(treatment x bin effect F 1,33= 5.21, p = 0.029; Figure 7.5). No effect of transgenesis 
(genotype x bin; F%,33= 1.20, p > 0.05) or genotype x treatment x bin interaction 
(Fi,33= 0.43, p < 0.050) was found. Furthermore, transgenic mice had an overall 
increased body temperature compared to wildtype littermates (Fi,33= 16.23, p < 
0.001).
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Figure 7.4 Effects of chronic citalopram treatment in CRH overproducing and wildtype mice on 
conditioned fear: change in the relative time not moving during re-exposure to the light relative to 
baseline (dotted line) 24 h after conditioning is shown. Data are presented as means, with error bars 
denoting SEMs.
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Figure 7.5 Effects of chronic citalopram treatment in CRH overproducing and wildtype mice on body 
temperature measured under basal conditions (temp 1) and 20 min after treatment (temp 2). wt: 
wildtype; tg: transgenic. Data are presented as means ± SEMs.
8-OH DPAT induced HPA-axis activation
8-OH DPAT-induced ACTH release was significantly lower in transgenic animals 
compared to wildtype mice (Fi,3o = 60.18, p > 0.001). No effects of treatment (Fi,3o = 
0.63) or a genotype x treatment interaction were found (Fi,3o = 0.16; both p’s > 
0.050; Figure 7.6A). Likewise, 8-OH DPAT induced corticosterone release was
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significantly lower in transgenic animals compared to wildtype mice (Fi,32 = 18.25, p 
> 0.001). No effects of treatment (Fi,32 = 2.63) or genotype x treatment interaction 
(Fi,32 = 0.01) were found (both p’s > 0.050; Figure 6 B). Strikingly, however, the 
corticosterone levels were 1.4 times higher in wildtype mice compared to 
transgenics, whilst for ACTH the difference was 3.7.
Body weight
Body weight did not differ as a factor of genotype or treatment (genotype effect Fi,33 
= 0.07; treatment effect F133 = 1,13; both p’s > 0.050). However, a significant 
genotype x treatment interaction was found (Fi,33 = 4.93, p = 0.033; Figure 7.7). Post 
hoc testing revealed that mutant mice did not differ in body weight when treated with 
vehicle, but CRH overexpressing mice treated chronically with citalopram had 
significantly lower body weights than wildtype littermates which received the same 
treatment.
Discussion
In this study, it was demonstrated that effects of long-term treatment with citalopram 
has opposite effects on anxiety-related behaviour in mice overproducing CRH 
compared to wildtype littermates. Thus, in the light dark exploration task, citalopram 
increases anxiety-related behaviour in wildtype animals, whereas in transgenics, 
which already displayed increased anxiety-related behaviour in this task under basal 
conditions, it decreased anxiety-related behaviour. Likewise, citalopram treatment 
induced opposite effects on anxiety-related behaviour measured in the conditioned 
fear paradigm, although transgenic animals did not display significant altered respon-
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Figure 7.6 Effects of chronic citalopram treatment in CRH overproducing and wildtype mice on 
plasma ACTH (A), and corticosterone (B) levels, 20 min after injection of 8-OH-DPAT (0.5 mg/kg), 
wt: wildtype; tg: transgenic. Data are presented as means ± SEMs.
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Figure 7.7 Effects of chronic citalopram treatment in CRH overproducing and wildtype mice on body 
weight before and 32 days after beginning of treatment, wt: wildtype; tg: transgenic. Data are 
presented as means ± SEMs.
sivity to the CS without treatment in this task. The results from the light dark 
exploration are in line with a recently reported study by Keeny and Hogg (1999). The 
authors showed that chronic treatment with citalopram reduces anxiety-related 
behaviour in light dark exploration after mice having been chronically socially 
defeated, whereas it was without effect in controls.
Citalopram did not affect locomotor activity in terms of distance travelled or number 
of rearings made in the open field, and, as already demonstrated in Chapter 5, 
transgenics were hypoactive. Furthermore, transgenics displayed overall reduced
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exploratory behaviour in the hole board paradigm, whereas in Chapter 5 the reduced 
exploratory behaviour was limited to the early testing session. Citalopram tended to 
increase exploratory behaviour, as it did in Swiss Webster mice (Chapter 4).
Citalopram treatment resulted in desensitisation of 5-HTia autoreceptors, as 
indicated by the attenuated hypothermic response to 8-OH DPAT administration. 
This effect was independent of genotype. Such a desensitisation is believed to result 
in an increase of serotonergic neurotransmission. In animal paradigms, it is often 
seen that reduction of serotonergic neurotransmission is accompanied by reduction of 
anxiety-related behaviour (Handley, 1995). For example, exposure of a rat to an 
elevated plus maze increases hippocampal serotonin. Pre-treatment with diazepam 
prevents this increase and reduces anxiety-related behaviour on the maze (Wright et 
al., 1992). This suggests that an increase in serotonergic neurotransmission may 
result in an increase in anxiety. However, in depression, it is believed that 
serotonergic function is reduced (Maes and Meltzer, 1995). Furthermore, increased 
anxiety is often observed in depressed patient. Besides, treatment with SSRI’s is 
effective in depression, but also in several anxiety disorders. This suggests that both 
increased or decreased serotonergic may result in increased anxiety. This is in line 
with the hypothesis that imbalanced serotonergic neurotransmission may contribute 
to both depression and anxiety disorders (Eison, 1990).
Changes found in behaviour and neuroendocrinology in CRH overproducing mice 
bears some similarities with symptoms of depression, such as increased anxiety. 
Furthermore, it has been demonstrated that long-term i.c.v. administration of CRH 
decreases serotonin release in the hippocampus after stress exposure in rats
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(Linthorst et al., 1997). Therefore, it is possible that chronic CRH excess in these 
mice also results in reduced serotonergic function. This in turn opens the possibility 
that dissociative effects of citalopram treatment on anxiety-related behaviour are 
related to increasing serotonergic transmission in CRH overexpressing animals 
which would be beneficial, comparable to the situation seen in depressive patients. In 
contrast, citalopram may be anxiogenic due to imbalancing the serotonergic system 
in wildtype mice.
Alternatively, the opposite effects of treatment on anxiety-related related behaviour 
could also be due to an CRH induced difference in sensitivity or density of 5-HT 
receptors other than the 5-HTia autoreceptor. If this occurs, increase in serotonergic 
transmission would augment different postsynaptic 5-HT receptors, which play 
distinct roles in anxiety-related behaviour (Griebel 1995). A likely candidate is the 
postsynaptic 5-HTia receptor, as CRH transgenics are less susceptible to 8-OH 
DPAT induced HPA-axis activation, a phenomenon which is, at least in part, 
mediated via post-synaptic 5-HTia receptors (Chapter 6). However, other subtypes 
cannot be excluded.
However, it is also possible that the effects of SSRI’s on anxiety-related behaviour 
are secondary to it’s effect on serotonin modulation. For example, it has been 
hypothesised that antidepressants, rather than acting through a specific 
pharmacological mechanism, may trigger a long cascade of events which then 
converge to act through a final common pathway (Delgado et al, 1999). 
Furthermore, it has been shown that tianeptine, a 5-HT re-uptake enhancer, and 
fluoxetine, a 5-HT re-uptake blocker, both exhibit good efficacy for treatment of
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depressive disorders, which also supports the idea that the primary effect of anti­
depressant-induced changes on uptake transport is remote from the therapeutically 
relevant action (Loo et al., 1999). Taken together, this suggests that therapeutic 
effects of treatment with SSRI’s may be due to secondary effect and not due to 
enhancement of serotonergic neurotransmission per se. Further experiments are 
needed in order to draw conclusions which system(s) may underlie the alterations in 
anxiety-related behaviour following long-term CRH excess.
Interestingly, diminished HPA-axis activation after 5-HTia receptor challenge is 
known in depressives, which also occurs in CRH overexpressing mice. This may 
open the possibility that citalopram affects anxiety-related behaviour via HPA-axis 
normalisation. However, chronic treatment affected anxiety-related behaviour and 
the serotonergic system, whereas HPA-axis activation after 8-OH DPAT 
administration remained unaffected, suggesting that the anxiogenic effects of long­
term CRH excess are independent from HPA-axis activity.
The citalopram-induced increase in body weight observed in Chapter 4 was not seen 
in this study. In fact, all groups gained body weight during the experiment, except for 
the transgenic mice that received citalopram. Clinical studies have indicated that the 
effects of SSRI treatment on body weight depend on the neurobiology of the 
depressive illness (Harvey and Bouwer, 2000). The results from this study suggest 
that the different effects of SSRI’s on body weight may depend on the activity of the 
CRH system.
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Chapter 8
Effects of overproducing CRH on attention in
mice
Introduction
In the previous chapters it was demonstrated that long-term CRH excess increases 
some aspects of anxiety-related behaviour (Chapter 5 ,1) .  Furthermore, this type of 
behaviour could be diminished by chronic treatment with SSRI’s (Chapter 7). Thus, 
the phenotype of CRH overexpressing mice has resemblance with that seen in 
depressive patients. In addition, the attenuated HPA-axis response to 5-HTia 
challenge, with the unaltered response in body temperature, is also comparable 
(Chapter 6). This, together with the finding that the CRH system is hyperactive in 
depressive illness, suggests that CRH excess may be the cause of symptoms seen in 
depression.
Apart of its known effects on anxiety, CRH is also known to mediate arousal. 
Arousal can be defined as a state which optimises the processing of sensory stimuli 
in the cerebral cortex (Hebb, 1955) and is therefore related to attentional function
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(Robbins, Everitt, 1994). This in turn suggests that CRH plays a more general role 
than just to mediate responses to aversive events, but maintains attention towards 
events or cues of biological significance, regardless of the nature of the reinforcer 
(Merali et al., 1998).
Patients suffering from major depression display attentional deficits (Mialet et al., 
1996; Rief and Hermanutz, 1996; Lemelin et al., 1997; Williams et al., 2000). 
Whether disruption of attentional processes is due to alteration in CRH activity is 
unknown. CRH receptors, in particular the CRHRl, occur in brain areas that play a 
role in attentional processes (see Chapter 1). Furthermore, high degrees of co­
localisation of choline-acetyltransferase and CRH receptor-like immunoreactivity 
have been observed in both the murine basal forebrain and brainstem (Sauvage and 
Steckler, 2001). The prefrontal cortex (Muir et al., 1996), the superior colliculi 
(Overton and Dean, 1988) and the cholinergic basal forebrain (Muir et al., 1992a; 
1994; Robbins et al., 1989) have been implicated in the mediation of different types 
of attention, and the cholinergic brainstem nuclei have been also demonstrated to 
control arousal and attentional functions (Garcia-Rill, 1991; Steckler et al., 1994). 
Moreover, in rats, intracerebroventricular (i.c.v.) CRH produces stimulation of Fos 
expression within the basal forebrain and brainstem nuclei (Bittencourt and 
Sawchenko, 2000), and ICV, but not peripheral, injections of CRH increase 
hippocampal ACh release (Day et al., 1998a, 1998b). Taken together, these 
observations support the idea that CRH might play a prominent role in the 
modulation of attentional processes.
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In this chapter, the possibility that CRH affects attentional processes is addressed 
using transgenic mice overproducing CRH. CRH overexpressing transgenics have 
been reported to be impaired in learning forced-choice alternation and water maze 
place navigation tasks. Paradoxically, however, this place navigation deficit was 
attenuated by administration of the benzodiazepine chlordiazepoxide (CDP), which 
by itself is known for its amnestic properties. This in turn suggests that heightened 
anxiety or overarousal possibly confounds the navigation deficit seen in transgenic 
animals (Heinrichs et al., 1996).
If it is true that these transgenic animals suffer fi*om overarousal, impairments to 
detect relevant stimuli and to process them would be expected. To test this 
hypothesis more directly, we trained transgenic mice overexpressing CRH and 
wildtype littermates on a murine version of a 5-choice serial reaction time task (5- 
CSRTT).
Material and methods 
Animals
15 heterozygous male CRH overexpressing mice and nine male wildtype littermates, 
bred and reared in the animal house of the Max Planck Institute (for more detail see 
Chapter 5) were used. Animals were housed individually and maintained on a 12:12 
h light/dark cycle (lights on at 06:00 hours) with ad lib water throughout. They were 
maintained at 85-90% of their free feeding weight, starting one week prior to the 
beginning of the experiment by restricting the laboratory chow access to 3.0-3.5 g /
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day / mouse (depending on the number of pellets eaten during testing). All 
experiments were conducted during the light phase of the cycle.
Behavioural procedure
Animals were trained as described in detail in Chapter 2. In brief, animals were 
habituated to the testing apparatus until they reliably ate all the pellets presented (2 
per hole). Next, mice were trained on the autoshaping procedure. Seven sessions 
were scheduled during this experimental stage. Then, the animals were trained to 
acquire a simple visual discrimination (see protocol Chapter 2). After stable 
performance was reached, the stimulus duration was gradually reduced (i.e., 8 s, 4 s, 
2 s, 1 s, 0.5 s), with 5 sessions per stimulus duration.
Cued detection
Once animals reached stable performance, predictability of the stimulus was 
enhanced by introduction of a pre-sound (1.2 kHz, 76 dB), presented during the 500 
ms preceding light stimulus onset (cued detection). Eight sessions were scheduled 
using this procedure, followed by an additional nine sessions without tone cue.
Manipulations of basic task parameters
Next, a series of manipulations of the basic task were made which were designed to 
increase the attentional load. First, the ITI durations were gradually reduced (5.0, 2.5, 
1.0 seconds) after which they were increased (5.0, 7.5, 10 seconds). This is believed 
to increase the attentional load by disrupting the temporal predictability of the 
stimulus onset. During this phase, ITI respondings were not analysed.
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Drug treatment
Subsequently, drug treatment commenced. Animals were first treated with diazepam 
(Sigma Chemicals, Deisenhofen, Germany), dissolved in saline plus 3 % tween 20 
(0.0, 0.5, 1.0, 2.5, 5.0, 7.5, 10.0, 15.0 mg/kg i.p., 20 min prior to test). At least two 
days lapsed between drug testing in order to allow for sufficient wash-out and 
recovery of the animals. This was followed by treatment with various doses of the 
acetylcholinesterase inhibitor physostigmine (0.0, 0.05, 0.10, 0.25, 0.50 mg/kg i.p., 
dissolved in saline, 20 min prior to test;). Subsequently, the effect of acute 
administration of the CRHRl antagonist R121919 (using saline plus 3 % tween 20 as 
vehicle) was studied with various doses (0.0, 10.0, 20.0, 40.0 mg/kg i.p., 20 min 
prior to test). Finally, animals were treated with the muscarinic antagonist 
scopolamine (0.0, 0.1, 0.5, 1.0 mg/kg i.p., 20 min prior to test; dissolved in saline). 
All treatments were given in ascending order.
Results 
Autoshaping procedure
All wildtype animals completed the 20 trials within the time limits of 20 min from 
the first session onwards, while transgenic mice responded at slightly lower level 
(average 19.01 trials completed per session; genotype effect F 1,22 = 4.57, p = 0.044) 
(Figure 8.1A). However, there,was no effect of session (session effect Fô,i32 = 0.55, p 
> 0.05) or interaction between session and genotype (genotype x session effect F6,i32 
= 0.55, p > 0.05), indicating that both groups of animals maintained their level of 
responding. This reduction in responsivity in transgenic mice was also reflected in
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the average number of nose-pokes made during the ITI (genotype effect F 1,21 = 
12.08, p = 0.002). Again no effects of session (session effect Fe,u6 = 0.98, p > 0.05) 
and no interaction (genotype x session effect Fô,i26 = 1.75, p > 0.05) were observed 
on this measure (Figure 8.IB). Consequently, both the time needed by transgenic 
animals to complete a trial (genotype effect Fi,2i = 16.04, p = 0.001; session effect 
Fô,i26 = 1.44; genotype x session effect F6,i26 = 0.87, both p’s > 0.050) and the 
average response latency (genotype effect Fi,2 i = 42.72, p < 0.001; session effect 
F6.126 = 2.06; genotype x session effect F6,i26 = 2.03, both p’s > 0.050) were 
increased relative to wildtype performance (Figures 8.1C, D). Moreover, transgenic 
mice completed less trials prior to the end of the limited hold (i.e., within the 5 s 
prior to pellet delivery) than wildtype mice (genotype effect Fi,2i = 14.04, p = 0.001), 
and both a session (session effect Fô.uô = 4.05, p = 0.005) and genotype x session 
interaction (genotype x session effect Fô.uô = 7.48, p < 0.001) were observed for this 
measure, with groups showing increasing differences during late sessions. Thus, 
groups differed in that wildtype mice, but not transgenic mice, started to associate the 
light stimulus with reinforcement towards the end of the autoshaping session (Figure 
8.IE), although both groups clearly had associated the response holes with reward, as 
indicated by the response level maintained over sessions.
Acquisition of a simple visual discrimination
During the initial stage of visual discrimination, the attentional load was kept to a 
minimum by presentation of a salient stimulus (an illuminated hole in an otherwise 
dark operant chamber) of long duration (maximally 8 s). Both groups of animals 
responded above chance from the first session onwards, indicating that they had 
already learned to associate the light stimulus with reinforcement during
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autoshaping, and continued to improve percentage correct responses made over 
sessions (session effect p 8,i44 = 9.76, p < 0.001) (Figure 8.2B). Overall, however, 
transgenic mice performed below wildtype level (genotype effect Fijg = 8.24, p = 
0.010), while no genotype x session interaction was observed (genotype x session 
effect Fg,i44 = 0.53, p > 0.05), indicating a parallel shift (Figure 8.2B). At the same 
time, transgenic mice made more errors of omission (genotype effect Fi,i9 = 26.28, p 
< 0.001; session x genotype effect Fg,is2 = 1.87, p > 0.05) and earned less reinforcers 
(genotype effect F 1,20 = 47.75, p < 0.001), but this effect declined with time on task 
(session x genotype effect Fg,i6o = 2.93, p = 0.030) (Figures 8.2A, C). Moreover, the 
number of ITI responses made was decreased in CRH overexpressors (genotype 
effect F 1,20 = 36.63, p < 0.001; session x genotype effect Fgjeo = 2.54, p = 0.037) 
(Figure 8.2D). There was a tendency for transgenic animals to have longer correct 
response latencies (genotype effect Fi,i7 = 4.17, p = 0.057; session x genotype effect 
Fg,i36 =1.17, p > 0.05), and an interaction was seen for the incorrect response latency 
measure (genotype effect Fijg = 0.29, p > 0.05; session x genotype effect Fg,H4 = 
3.46, p = 0.007) (Figures 8.2E, F). Genotypes differed during the initial two sessions 
but not thereafter in incorrect response latency. In addition, biased responding was 
increased in transgenic animals (genotype effect Fij? = 6.30, p = 0.022; session x 
genotype effect Fg,i36 = 0.91, p > 0.05) (Figure 2G).
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Figure 8.1 Effects of oveiproduciton of CRH on performance during autoshaping procedure. Animal 
were tested for 7 successive sessions, (wt) wildtype mice, (tg) CHR overexpressing mice. (A) Number 
of trials completed, (B) ITI responses per trial, (C) time to complete a trial, (D) average response 
latency and (E) trials completed prior to pellet delivery. Data are presented as means, with error bars 
denoting SEMs.
Reduction of stimulus duration
Decreasing the stimulus duration led to a decrease in percentage correct responses 
(stimulus duration effect p3,6o = 67.58, p < 0.001) and decreased the number of 
reinforcers earned (stimulus duration effect = 4.70, p = 0.028) (Figures 8.3A, 
B). Despite an increasing attentional load, errors of omission also declined with 
decreasing stimulus duration (stimulus duration effect Fs.eo = 36.23, p < 0.001) 
(Figures 8.3C).
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The number of responses made during the ITI remained unaffected by stimulus 
duration (stimulus duration effect Fs^ go = 2.22, p > 0.05), while both correct and 
incorrect latencies decreased with decreasing stimulus duration (stimulus duration 
effect p3,6o = 155.15, p < 0.001 and p3,6o = 27.93, p < 0.001, respectively) (Figures 
8.3E, F). Moreover, biased responding increased as a consequence of decreasing 
stimulus duration (stimulus duration effect p3,6o = 4.26, p < 0.011) (Figure 8.3G).
Although accurate responding remained unaffected by genotype during this 
experimental stage (genotype effect F 1,20 = 1.50; genotype x stimulus duration effect 
p3,60 = 0.77; genotype x stimulus duration x session effect Fi2,240 = 0.43, all p’s > 
0.050) (Figure 8.3B), transgenic mice continued to earn less reinforcers (genotype 
effect F 1,20 = 21.78, p < 0.001; genotype x stimulus duration effect p 3,6o = 1.45; 
genotype x stimulus duration x session effect Fi2,240 = 2.17, both p’s = 0.062) and 
made more errors of omission (genotype effect Pi,2o = 42.63, p < 0.001; genotype x 
stimulus duration effect p3,6o = 1.06; genotype x stimulus duration x session effect 
Fi2,240 = 0.81, all p ’s > 0.050) (Figures 8.3A, C). CRH overexpressors continued to 
make less ITI responses (genotype effect F 1,20 = 23.47, p < 0.001; genotype x 
stimulus duration effect F3,go = 2.22; genotype x stimulus duration x session effect 
F 12,240 = 1.59, both p’s > 0.050) (Figure 8.3D). However, the effect of genotype on 
correct response latencies now gained significance (genotype effect Fi,2o = 6.62, p = 
0.018; genotype x stimulus duration effect F3,6o = 145; genotype x stimulus duration 
X session effect F%2,24o = 0.78, both p’s > 0.050), while no effect was seen on 
incorrect response latencies (genotype effect Fi,i6 = 0.71; genotype x stimulus 
duration effect F3,4g = 1.15; genotype x stimulus duration x session effect Fi2,i92 = 
0.50, all p’s > 0.050) (Figures 8.3E, F). Biased responding also remained increased
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in transgenics (genotype effect Fi,2o = 4.54, p = 0.046; genotype x stimulus duration 
effect F3,6o = 1.64, p > 0.05; genotype x stimulus duration x session effect F 12,240 = 
0.83, p > 0.05) (Figures 8.3G).
Extended testing with short stimulus durations
When animals were tested for an extended period of 17 sessions with shortest 
stimulus duration (0.5 s), ANOVA revealed a mild but significant impairment in 
percentage correct responding (genotype effect F 1,20 = 12.91, p = 0.002; genotype x 
session effect F 15,320 = l.H , p > 0.05) (Table 8.1). Transgenics continued to earn less 
reinforcers (genotype effect F 1,20 = 130.39, p < 0.001) and an interaction between 
session and genotype was observed for this measure (genotype x session effect F 15,320 
= 2.69, p = 0.016). Post-hoc analysis indicated that groups differed during all 
sessions except for the second session with short stimulus duration. Likewise, errors 
of omission remained increased in transgenics (genotype effect F 1,20 = 52.38, p < 
0.001; genotype x session effect Fi5,320 = 0.73, p > 0.05), while ITI responses 
remained unaffected by transgenesis (genotype effect F 1,20 = 0.16; genotype x 
session effect F 15,320 = 0.71, both p’s > 0.050) (Table 8.1).
Transgenic mice also continued to have longer correct response latencies (genotype 
effect F 1,20 = 4.61, p = 0.044; genotype x session effect Fi5,320 = 0.70, p > 0.05), 
while incorrect latencies did not differ between groups (genotype effect Fi,2o = 1.21; 
genotype x session effect F 15,320 = 0.62, both p’s > 0.050). Furthermore, 
overexpressors show increased biased responding (genotype effect Fi,2o = 11.41, p = 
0.003; genotype x session effect F 15,320 = 113, p > 0.05) (Table 8.1).
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Table 8.1 5-CSRRT performance in CRH overexpressing transgenic mice under basal conditions and 
following cued detection (data are expressed as means ± SEMs).Significant differences between 
groups are indicated by grey shadings.
Measure Baseline performance 
(17 sessions)
Cued detection 
(8 sessions)
Baseline performance 
(9 sessions)
no. reinforcers earned wt: 25.21 ±0.67 wt: 22.94 ± 1.70 wt: 23.81 ±1.32
tg: 15.66 ± 0.50 tg: 14.13 ±1.28 tg: 16.28 ± 1.00
% correct responses wt: 55.32 ± 1.85 wt: 61.55 ± 2.94 wt: 61.21 ±2.32
tg: 46.99 ± 1.40 tg: 48.75 ± 2.22 tg: 55.01 ± 1.75
errors of omission wt: 14.10 ± 1.29 wt: 22.92 ± 2.79 wt: 21.40 ±1.97
tg: 25.69 ±0.98 tg: 29.86 ±2.11 tg: 29.69 ±1.49
ITI responses wt: 1.50 ± 0.12 wt: 1.15 ± 0.11 wt: 1.24 ± 0.11
tg: 1.44 ± 0.09 tg: 1.09 ±0.09 tg: 1.19 ±0.08
corr. resp. latency wt: 1.18±0.15 wt: 1.10 ±0.15 wt: 1.27 ± 0.14
(sec) tg: 1.58 ±0.11 tg: 1.62 ±0.11 tg: 1.55 ±0.11
inc. resp. latency (sec) wt: 2.89 ±0.18 wt: 2.49 ± 0.30 wt: 3.30 ± 0.17
tg: 3.15 ±0.15 tg: 3.12 ±0.23 tg: 3.36 ±0.13
bias (Index Y) wt: 0.24 ± 0.04 wt: 0.22 ± 0.04 wt: 0.25 ± 0.03
tg: 0.39 ± 0,03 tg: 0.39 ± 0.03 tg: 0.32 ± 0.02
No.: number; Corr. Resp. Lat.: correct response latency; Incorr. Resp. Lat.: incorrect response latency.
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Cued detection
When light stimulus presentation was preceded by a brief tone stimulus, performance 
of the animals remained essentially unchanged. Thus, wildtype mice continued to 
earn more reinforcers (genotype effect F 1,20 = 17.13, p = 0 .0 0 1 ; genotype x session 
effect F7,i4o = 1.25, p > 0.05), performed more accurate than transgenics (genotype 
effect F 1,20 = 12.05, p = 0 .0 0 2 ; genotype x session effect F7J 40 = 0.29, p > 0.05), had 
shorter correct response latencies (genotype effect Fi,2o = 7.97, p = 0.011; genotype x 
session effect F7J40 = 0.47, p > 0.05), and exhibited lower biased responding 
(genotype effect Fi,2o = 1 2 .2 1 , p = 0 .0 0 2 ; genotype x session interaction effect F7J40 
= 0.81, p > 0.05), while the number of ITI responses made (genotype effect F 1,20 = 
0.12; genotype x session effect F7J 40 = 0.81, both p’s > 0.050) and incorrect response 
latencies (genotype effect F 1,20 = 2.84; genotype x session effect F7,i4o = 0 .8 6 , both 
p’s > 0.050) failed to show a difference. Errors of omission showed a tendency for an 
increase in transgenic animals only (genotype effect Fi,2o = 3.93, p = 0.061; genotype 
X session effect F7J 40 = 0.91, p > 0.05) (Table 8.1).
Subsequently, animals received nine more sessions under basal conditions, i.e., 
without tone presentation. Again, CRH overexpressing mice displayed an accuracy 
deficit (genotype effect F 1,20 = 4.57, p = 0.045; genotype x session effect Fg.ieo = 
1.00, p > 0.05), earned less pellets (genotype effect Fi,2o = 20.62, p < 0.001; genotype 
X session effect Fg.ieo = 2.84, p = 0.043) and made more errors of omission (genotype 
effect F 1,20 = 11.27, p = 0.003; genotype x session effect Fgjeo = 1.19, p > 0.05). 
Analysis of biased responding revealed a tendency for a group difference (genotype 
effect F 1,20 = 3.47, p = 0.077; genotype x session effect Fg,i60 = 1 03, p > 0.05). 
Genotypes did not differ from each other in terms of the number of ITI responses
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(genotype effect F 1,20 = 0.17; genotype x session effect Fg.ieo = 121, both p’s > 
0.050). Furthermore, there was no more effect on response latencies (correct 
response latency, genotype effect F 1,20 = 2.43; genotype x session effect Fg.ieo = 1.37; 
incorrect response latency, genotype effect Fi,2o = 0.08; genotype x session effect 
Fg,i60 = 0.58, all p’s > 0.050) (Table 8.1).
Effects of mild stress
Comparison of the last session under baseline conditions with the first session where 
animals received an i.p. saline injection prior to testing revealed that stress exposure 
induced a small reduction in the number of reinforcers earned (session effect Fi,2o = 
32.64; p < 0.001) and increased the number of errors of omission (session effect Fi,2o 
= 18.44; p < 0.001), while percentage correct responding even increased (session 
effect F 1,20 = 7.01; p = 0.015) (Figures 8.4A -  C). Furthermore, there was a tendency 
for incorrect response latencies to decrease as a result of stress exposure (session 
effect F 1,20 = 4.27; p = 0.052). Other parameters remained unaffected by this 
manipulation (all p’s > 0.100).
Although transgenic mice continued to differ fi’om controls in terms of reinforcers 
earned (genotype effect Fi,20 = 22.15; p < 0.001) and percentage correct responding 
(genotype effect F 1,20 = 7.92; p = 0.011) (Figures 8.4A, B), there were no interactions 
between genotype and stress (reinforcers earned, genotype x session effect F 1,20 = 
2.25; percentage correct responses, genotype x session effect Fi,2o = 0.39; both p’s > 
0.050). Groups did not differ in errors of omission (genotype effect F 1,20 = 2.81; 
genotype x session effect Fi,2o = 1.08, both p’s > 0.050), ITI responses (genotype 
effect F 1,20 = 0.74; genotype x session effect Fi,2o = 0.31, both p’s > 0.050), response
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latencies (correct, genotype effect Fi,2o = 1.32; genotype x session effect Fi,2o = 0.54; 
incorrect, genotype effect Fi,2o = 0.07; genotype x session effect Fi,2o = 0.12, all p’s 
> 0.050), or response bias (genotype effect F 1,20 = 0.03; genotype x session effect 
Fi,20 = 0.18, both p’s > 0.050) (Figures 8.4D -  G).
Effects of acute diazepam treatment
Overall, transgenic mice continued to earn less reinforcers (genotype effect: Fi,i9 = 
98.69, p < 0.001), to perform less accurate (genotype effect: Fi,i9 = 11.42, p = 0.003), 
made more errors of omission (genotype effect: Fi,i9 = 32.24, p < 0.001), made more 
ITI responses (genotype effect: Fi,i9 = 12.04, p = 0.003), and had stronger side bias 
(genotype effect: Fi,i9 = 7.63, p = 0.012). Although groups still failed to differ in
correct response latency (genotype effect: F1J 9 = 2.95, p > 0.05), transgenic mice
now had significantly shorter incorrect response latencies (genotype effect: F149 = 
2.22, p = 0.003).
Diazepam caused a dose-dependent increase in the number of reinforcers earned 
(treatment effect F7433 = 5.08, p = 0.006), but no genotype x treatment interaction
effect was found for this measure (genotype x treatment effect F7J 33 = 1.80, p > 0.05)
(Figure 8.5B). Although a significant genotype x treatment interaction effect was 
seen in errors of omission (genotype x treatment effect F7J 33 = 4.05, p < 0.014), this 
effect failed to reach significance in the post hoc analysis, and an overall effect of 
treatment on omissions also just to reach failed significance (treatment effect F7J 33 = 
2.75, p = 0.0505) (Figure 8.5C). The percentage correct response remained 
unaffected by diazepam (treatment effect F7J 33 = 1.65, p > 0.05) and no genotype x 
treatment inter-
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action was observed (genotype x treatment effect F7J33 = 1.57, p > 0.05) (Figure 
8.5A). Treatment also failed to affect ITI responses (treatment effect F7J 33 = 1,12, p 
> 0.05). However, an interaction between genotype and treatment with diazepam was 
found (genotype x treatment effect F7J 33 = 6,78, p < 0.001) (Figure 8.5D). Post hoc 
analysis indicated that the two groups failed to differ at low doses up to 1.0 mg/kg, 
but that transgenic mice showed significantly increased ITI responding at higher 
doses, which may be indicative for behavioural disinhibition. No effects of treatment 
were seen on latencies or biased responding (correct latency: treatment effect F7J 33 = 
1.11; genotype x treatment effect F7J 33 = 1.73; incorrect latency: treatment effect 
F7J 33 = 1.81, genotype x treatment effect F7J 33 = 0.50; biased responding: treatment 
effect F7433 = 1.26; genotype x treatment effect F7J 33 = 1.51, all p’s > 0.050).
Effects of acute R121919 treatment
Transgenic mice continued to perform below wildtype level, i.e., earned less 
reinforcers (genotype effect Fi,i5 = 12.51, p = 0.003) and percentage correct 
responses were lower (genotype effect Fijg = 25.78, p < 0.001). There was a strong 
tendency for transgenics to make more omission (genotype effect: Fi,i5 = 1.78, p = 
0.0501), while ITI responses (genotype effect Fijg = 0.14, p > 0.05) and side bias 
(genotype effect F145 = 0.49, p > 0.05) again failed to differ between groups. 
However genotypes continued to differ in response latencies (correct response 
latencies: genotype effect Fi,i5 = 25.78, p = 0.021; incorrect response latencies: 
genotype effect Fijg = 6.90, p = 0.020).
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Figure 8.5 Effects of diazepam on 5-CSRTT performance in mice overproducing CRH. Diazepam 
was administered at dosages of 0.0, 0.5, 1.0, 2.5, 5.0, 7.5, 10.0 and 15.0 mg/kg i.p., 20 min prior to 
testing. Treatment given in ascending order. (A) Percentage correct responding, (B) number of 
reinforcers earned, (C) number of errors of omission, (D) ITI responses per trial. Data are presented as 
means, with error bars denoting SEMs.
Blockade of CRHRl by R121919 gradually reduced the number of reinforcers 
earned (treatment effect F3,4s = 5.28, p < 0.013), but no interaction between genotype 
and treatment was observed (genotype x treatment effect F3,45 = 2.41 p > 0.05) 
(Figure 8.6B). At the same time, CRHRl blockade increased the number of errors of 
omission made (treatment effect F3,4s = 6.35, p = 0.007) but, again, no genotype x 
treatment interaction effect was found (genotype x treatment effect F3,4s = 1.76, p > 
0.05) (Figure 8.6C). R121919 had no effects on percentage correct responding 
(treatment effect F3,45 = 0.34; genotype x treatment effect F3,45 = 0.44, both p’s > 
0.050) (Figure 8.6C). Likewise, treatment with R121919 failed to affect ITI 
responses (treatment effect F3,4$ = 1.53; genotype x treatment, F3,45 = 1.57, both p’s >
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0.050), correct (treatment effect p3,45 = 1 32; genotype x treatment, p3,45 = 3,03, both 
p’s > 0.050) and incorrect response latencies (treatment effect p3,45 = 0.97; genotype 
X treatment, p3,45 = 3.64, both p’s > 0.050), and biased responding (treatment effect 
p3,45 = 1.75; genotype x treatment effect p3,45 = 0.62, both p’s > 0.050).
Effects of acute scopolamine treatment
Percentage correct responses (genotype effect Fi.n = 5.33, p = 0.038) and the number 
of reinforcers earned (genotype effect Fi,i3 = 18.32, p = 0.001) continued to be lower 
in transgenic animals during this experimental stage. Transgenic animals again made 
significantly more errors of omission (genotype effect Fi,i3 = 7.86, p = 0.016), while 
no difference was seen in any of the other measures (ITI responses Fi,i3 = 0.62; side 
bias Fi,i3 = 4.50, correct response latencies Fi,i3 = 1.79; incorrect response latencies 
Fi,13 = 0.57; all p’s >0.050).
There was an overall effect of treatment on percentage correct responding, with 
scopolamine leading to reduced accuracy (treatment effect p3,39 = 4.90, p = 0.014), 
and this effect was comparable between the two groups (genotype x treatment effect 
p3,39 = 0.40, p > 0.05) (Figure 8.7A). Likewise, scopolamine reduced the number of 
reinforcers earned (treatment effect p3,39 = 60.76, p < 0.001). In addition, an 
interaction between genotype and treatment was seen (treatment F3 3 9  = 3.76, p = 
0.040). Although post hoc testing revealed significant group differences at every 
dose of scopolamine tested, further inspection of the data indicated that wildtype 
mice showed a steeper dose-dependent decline in reinforcers earned than transgenic
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Figure 8.6 Effects of R121919 on 5-CSRTT performance in mice overproducing CRH. R121919 was 
administered at dosages of 0.0, 10.0, 20.0 and 40.0 mg/kg i.p., 20 min prior to testing. Treatment 
given in ascending order. (A) Percentage correct responding, (B) number of reinforcers earned, (C) 
number of errors of omission. Data are presented as means, with error bars denoting SEMs.
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animals (Figure 8.7B). Scopolamine also increased errors of omission, but this effect 
was again similar in both groups (treatment effect Fs,39 = 57.59, p < 0.001; genotype 
X treatment effect F3 3 9  = 1.25, p > 0.05) (Figure 8.7C). ITI responses were decreased 
by treatment (treatment effect F3,39 = 20.88, p < 0.001), but no genotype x treatment 
interaction was observed (genotype x treatment effect F3,39 = 1.14, p > 0.05). Overall, 
there was no effect of treatment on correct response latencies (treatment effect F3,39 = 
1.68, p > 0.05). A genotype x treatment interaction was observed for this measure 
(genotype x treatment effect F339  = 3.53, p = 0.049), but post hoc analysis again 
failed to reveal further differences (Figure 8.7D). Treatment with scopolamine had 
no effect on incorrect response latencies (treatment effect F33 9  = 1.57; genotype x 
treatment effect F3,39 = 0.72, both p’s > 0.050) or biased responding (treatment effect 
F3,39 = 2.88; genotype x treatment effect F339  = 1.79, both p’s > 0.050).
Effects of acute physostigmine treatment
Overall effects of genotype were comparable to the previous stage of testing: 
percentage correct responses continued to be lower in transgenics (genotype effect 
Fi,i5 = 9.03, p = 0.009), whereas the number of reinforcers earned was decreased in 
the mutants (genotype effect Fijg = 6.88, p = 0.018). No significant differences 
between groups were found in terms of ITI responses (genotype effect Fi,i6 = 2.00), 
side bias (genotype effect Fi,i4 = 0.14), correct response latencies: (Fi,i6 = 3.97), and 
incorrect response latencies (genotype effect Fi,i6 = 0.04) (all p’s > 0.050). Only 
errors of omission again failed to significantly differ between groups (genotype 
effect Fi,i6 = 0.22, p > 0.05).
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Figure 8.7 Effects of scopolamine on 5-CSRTT performance in mice overproducing CRH. 
Scopolamine was administered at dosages of 0.0, 0.1, 0.5 and 1.0 mg/kg i.p., 20 min prior to testing. 
Treatment given in ascending order. (A) percentage correct responding, (B) number of reinforcers 
earned, (C) number of errors of omission, (D) ITI responses per trial. Data are presented as means, 
with error bars denoting SEMs.
At high physostigmine doses (0.5 mg/kg), wildtype animals earned less reinforcers 
than transgenic mice, suggesting again decreased sensitivity of CRH overexpressors 
to cholinergic manipulation, i.e., to the response depressing effects of the drug 
(Figure 8.8A). This suggestion was confirmed by the errors of omission measure: the 
number of errors of omission was affected by treatment (treatment effect F4,64 = 
79.13, p > 0.001), and there was a significant genotype x treatment interaction effect 
(genotype x treatment effect F4,64 = 14.07, p > 0.001). Post hoc testing revealed that 
wildtype animals made less errors of omission after saline and 0.05 mg/kg 
physostigmine administration, while groups did not differ after treatment with 
intermediate doses (0.1 and 0.25 mg/kg) of physostigmine. However, wildtype
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animals made more errors of omission after the high dose (0.5 mg/kg) administration 
(Figure 8.8C). Consequently, the number of reinforcers earned was decreased by 
treatment (treatment effect F4,64 = 93.03, p < 0.001). A genotype x treatment 
interaction effect was observed (genotype x treatment effect F4,64 = 22.93, p < 0.001), 
and post hoc testing revealed that wildtype animals earned more reinforcers after 
saline and low dose (0.05 mg/kg) physostigmine administration than transgenic mice, 
while groups did not differ at intermediate doses (0.1 and 0.25 mg/kg) of 
physostigmine (Figure 8.8A). Furthermore, ITI responses were dose-dependently 
decreased after AChE blockade (treatment effect F4,64 = 24.50, p < 0.001), while no 
genotype x treatment interaction effect was found (genotype x treatment effect F4,64 = 
1.10, p > 0.05) (Figure 8.8D). Because of the high number of omissions made under 
treatment with 0.5 mg/kg physostigmine, data obtained under this treatment were 
excluded from analysis of percentage correct responses and latencies. The highest 
dose of physostigmine analysed (0.25 mg/kg) left percentage correct responding 
unaffected (treatment effect Fs,45 = 0.12; genotype x treatment effect F3,4s = 0.42, 
both p’s > 0.050) (Figure 8.8B). Both correct (treatment effect F3,4s = 1.46; genotype 
X treatment effect F3,4g = 2.16, both p’s > 0.050) and incorrect choice latencies 
(treatment effect F3,4g = 0.16, p > 0.05; genotype x treatment effect F3,4g = 1.64, both 
p’s > 0.050) also remained unaffected by treatment with physostigmine. Finally, 
biased responding increased as a function of treatment (treatment effect F3,42 = 4.56, 
p < 0.024), and again no genotype x treatment interaction effect was seen (genotype 
X treatment effect F3,42 = 1.80, p > 0.05).
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Figure 8.8 Effects of physostigmine on 5-CSRTT performance in mice overproducing CRH. 
Physostigmine was administered at dosages of 0.0, 0.05, 0.10, 0.25 and 0.50 mg/kg i.p., 20 min prior 
to testing. Treatment given in ascending order. Data is shown for (A) percentage correct responding, 
(B) number of reinforcers earned, (C) niunber of errors of omission, (D) ITI responses per trial. Data 
are presented as means, with error bars denoting SEMs.
Discussion
CRH overexpressing mice showed impaired autoshaping of a nose-poke response to 
a light stimulus, as indicated by retarded, but not absent, association between the 
stimulus and reward and reduced responsivity. Although subsequent simultaneous 
discrimination training indicated that transgenic animals had learned some 
association as they performed above chance level from the first session onwards, 
they clearly performed below wildtype level. However, both groups of animals 
improved performance over session, indicating the ability to leam the discrimination 
in transgenic animals, although they continued to respond with lower accuracy. At
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least part of this may be due to different baselines carried over from autoshaping. In 
addition, biased responding was increased during acquisition and subsequent 
experimental stages, indicating that transgenic animals reverted to a more simple 
response strategy.
Extended training with long stimulus durations revealed that transgenic animals were 
able to reach similar accuracy levels as wildtype animals, although responsivity 
continued to be reduced, as indicated by a reduction in the number of reinforcers 
earned, increased errors of omission, decreased responsivity during the ITI, and 
increased response latencies. Once transgenic mice had reached an accuracy level 
that was comparable to wildtype performance, they were also able to maintain 
accuracy to similar degree as wildtypes over a wide range of different stimulus 
durations. This indicates that learning the discrimination was retarded but 
remembrance of the response rule appeared to be intact once the discrimination was 
acquired. Increasing attentional load by decreasing the stimulus duration led to a 
decrease in percentage correct responses and increased biased responding in both 
groups.
When animals were tested for an extended period of 17 sessions with shortest 
stimulus duration (0.5 s), a mild but significant impairment in percentage correct 
responding re-emerged in transgenic animals. This was accompanied by longer 
correct response latencies, while incorrect latencies (which were longer than correct 
response latencies in both genotypes) did not differ between groups. This accuracy 
deficit was independent on whether or not a pre-sound was present, suggesting that
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CRH overexpressing mice did not benefit from this manipulation guiding stimulus 
detection (cued detection, Bushnell, 1995).
Exposure to a mild stessor (i.p. injection of saline) impaired performance on 5- 
CSRTT, as indicated by a reduction in the number of reinforcers earned and an 
increase in errors of omission. Interestingly, this resulted in an overall increase in 
percentage correct responding. In other words, animals showed a stronger tendency 
to refi*ain from responding, which consequently led to a net decrease in reinforcers 
earned but, at the same time, animals responded more accurately once responses 
occurred. However, this effect was mild, questioning the behavioural significance of 
this effect.
The effects of diazepam were small, leaving accuracy unaffected and, if at all, 
causing release of responding, as evidenced by an increase in the number of 
reinforcers earned and an effect on errors of omission which just failed significance.
Administration of the CRHRl antagonist R121919 reduced responsivity, as indicated 
by increased omissions and decreased reinforcers earned. However, R121919 failed 
to improve performance in transgenic animals, suggesting that the deficit seen in the 
overexpressors was not mediated through overactivation of this receptor subtype.
Manipulation of the cholinergic system, however, affected both transgenic and 
wildtype animals to different degree. Although the effects of scopolamine on 
accuracy were comparable between groups, the effects of scopolamine on the 
number of reinforcers earned were more pronounced in wildtype mice. Likewise,
163
physostigmine had stronger effects in wildtype than in transgenic animals at high 
doses (0.5 mg/kg), suggesting again decreased sensitivity of CRH overexpressors to 
cholinergic manipulation, i.e., to the response depressing effects of the drug. This 
suggestion was confirmed by the errors of omission and the number of reinforcers 
measures. Since transgenic mice were hyporeactive to both blockade and indirect 
stimulation of cholinergic receptors, the possibility of downregulation of cholinergic 
receptors due to CRH-induced increases in cholinergic activity (Day et al., 1998a,b) 
must be considered, although direct evidence is missing.
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Chapter 9
Effects of lack of CRH on
5-choice serial reaction time task performance
Introduction
Overproduction of CRH resulted in mild disruption of visuospatial attentional 
processes, assessed in the 5-CSRRT (Chapter 8). Therefore, lack of CRH might 
result in an improvement in these processes. An alternative possibility, however, 
could be that overproduction of CRH might induce overarousal, whereas a lack of 
CRH might result in an insufficient arousal state, again impairing attentional 
processes. In this chapter, the necessity of CRH in attentional processes is addressed 
by investigating the performance of mice lacking CRH in the 5-CSRTT. 
Furthermore, the effects of lack of CRH may be more distinct after a stressful 
situation, because such situations activate the CRH system. Therefore, 5-CSRTT 
performance was also assessed after two distinct stressors: social defeat and 
inescapable swim stress.
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Material and methods 
Animals
Breeding stock for wildtype mice and knockout male mice for the null CRH allele 
were derived from heterozygote breeding pairs (purchased from the Jackson 
Laboratory (mixed background 129SV/J C57BL/6), originally generated by Muglia 
and colleagues (1995), bred and reared in the animal house of the Max Planck 
Institute. Animals, both groups 7 males, were housed individually and maintained on 
a 12:12 h light/dark cycle (lights on at 06:00 hours) with ad lib water throughout. 
They were maintained at 85-90% of their free feeding weight, starting one week 
prior to the beginning of the experiment by restricting the laboratory chow access to 
3.0-3.5 g / day / mouse (depending on the number of pellets eaten during testing). All 
experiments were conducted during the light phase of the cycle.
Behavioural procedure 
5-CSRRT
Testing took place during the light phase of the light/dark cycle. Animals were 
trained to stable baseline performance as described in Chapters 2 and 8.
Manipulations of basic task parameters
After animals reached stable performance, a series of manipulations of the basic task 
were made which were designed to increase the attentional load. First, the ITI 
durations were gradually reduced (5.0, 2.5, 1.0 seconds) after which they were
166
increased (5.0, 7.5, 10 seconds). Second, the effects of the presence of a distractor (a 
white noise stimulus (1.2 kHz, 76 dB), presented during the 500 ms preceding the 
stimulus onset, were studied.
Effects of social defeat on 5-CSRTT performance
Animals were place in the homecage of an older single caged mouse (resident) for 15 
min. The mice were separated by a metal wire fence, directly after the first 
aggressive interaction. After the period of 15 min, animals were returned to their 
home cage for an additional 20 min, after which they were tested in the 5-CSRRT.
Effects of inescapable swim stress on 5-CSRRT performance
Animals were exposed to inescapable swim stress for 6 min (see Chapter 2), after 
which they were returned to their home cage for an additional 20 min, followed by a 
session in the 5-CSRRT.
Effects of acute scopolamine treatment
Finally, animals were treated with the muscarinic antagonist scopolamine (0.0, 0.1, 
0.5, 1.0, 2.0 mg/kg i.p., 20 min prior to test; treatment given in ascending order, with 
saline as vehicle). At least two days lapsed between drug testing in order to allow for 
sufficient wash-out and recovery of the animals.
Results
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Autoshaping procedure
The number of trials completed did differ between groups (Fi,i2 = 154, p > 0.05). No 
effect of session was found (session effect Fô,72 = 0.50; genotype x session effect 
Fô,72 = 1.00, all p’s > 0.050) (Figure 9.1 A). Likewise, no difference in ITI responses 
per trial were found (genotype effect Fi,i2 = 0.49; session effect Fô.ôô = 1.55; 
genotype x session effect Fg,66 = 1 64, all p’s > 0.050) (Figure 9.IB). Furthermore, no 
genotype, session effect, or interaction of both was found in terms of the time to 
complete a trial, (genotype effect Fi,io = 0.49; session effect Fe.eo = 1.82; genotype x 
session effect Fô,6o = 1.57, all p’s > 0.050) and trials completed prior to pellet 
delivery (genotype effect Fi,i2 = 0.49; session effect Fa,66 = 0.30; genotype x session 
effect Fô,66 = 1.04, all p’s > 0.050) (Figures 9.1C, D).
Simple visual discrimination learning
During the initial stage of visual discrimination, the stimulus duration was 8 sec. 
Both groups of animals responded above chance from the first session onwards, 
indicating that they had already learned to associate the light stimulus with 
reinforcement during autoshaping. Although both groups reached at least at 70 % 
correct, respondings during the last two sessions, the session effect just failed to 
reach significance (session effect F6,72 = 3.77, p = 0.054) (Figure 9.2B). No 
significant group effect (Fi,i2 = 2.52), or genotype x session interaction was observed 
(F(6,72) = 2.14, both p’s > 0.050) for this parameter. Likewise no significant 
differences were found in terms of errors of omission (genotype effect Fi,i2 = 2.48; 
session x genotype effect Fô,72 = 1.32), reinforcers earned (genotype effect Fi,i2 =
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Figure 9.1 Effects of lack of CRH on performance during autoshaping. Animal were tested for 7 
successive sessions, (wt) wildtype mice, (ko) CHR knockout mice. (A) number of trials completed, 
(B) ITI responses per trial, (C) time to complete a trial, (D) trials completed prior to pellet delivery. 
Data are presented as means, with error bars denoting SEMs.
2.96; session x genotype effect p6,72 = 2.42), ITI responses (genotype effect Fi,i2 = 
0.61; session x genotype effect F6,?2 = 21.45), correct response latency (genotype 
effect Fi,i2 = 0.70; session x genotype effect, F6j 2 = 1.69) and incorrect response 
latency (genotype effect, Fi,i2 = 4.69; session x genotype effect, p6,72 = 0.88) (all p’s 
> 0.05,Figures 9.2A, C, D, E, F). In addition, although no overall groups difference 
was found in biased responding (genotype effect Fi,i2 = 1.11, p > 0.05), a session x 
genotype interaction was found (effect p6,72 = 3.41, p = 0.023). Post hoc testing 
revealed that CRH ko mice showed reduced biased responding, during sessions 5 and 
6 (both p’s < 0.050).
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Reduction of stimulus duration
Next, the stimulus was decreased (4, 2, 1 and 0.5 sec, 5 trials per stimulus duration). 
Overall, percentage correct responses (p3,33 = 88.22, p < 0.001) and number of 
reinforcers earned (stimulus duration effect p3,33 = 9.48, p < 0.001) decreased in a 
manner dependent on stimulus duration (Figures 9.3A, B). Despite the increasing 
attentional load, errors of omission also declined with decreasing stimulus duration 
(stimulus duration effect F333 = 12.99, p < 0.001) (Figure 9.3C). The number of 
responses made during the ITI remained unaffected by stimulus duration (F333 = 
2.04, p > 0.05), while both correct and incorrect latencies decreased with decreasing 
stimulus F3,33 = 35.79, p < 0.001 and F333 = 7.22, p < 0.006, respectively) (Figures 
9.3D, E, F). Moreover, biased responding increased as a consequence of decreasing 
stimulus duration (F333 = 8.61, p < 0.003) (Figure 9.3G).
No genotype-dependent differences were found during this experimental: percentage 
correct responding (genotype effect Fi,n = 0.62; genotype x stimulus duration effect, 
F333 = 1.59; genotype x stimulus duration x session effect F12J 32 = 1.27), reinforcers 
earned (genotype effect Fi,n = 0.09; genotype x stimulus duration effect p3,33 = 0.29; 
genotype x stimulus duration x session effect Fi2,i32 = 1.48), errors of omission made 
(genotype effect Fi,n = 0.00; genotype x stimulus duration effect p3,33 = 0.55; 
genotype x stimulus duration x session effect Fi2,i32 = 1.34), number of ITI responses
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Figure 9.2 Five-choice simultaneous discrimination in mice lacking CRH. Animals were tested for 7 
successive sessions, with a stimulus duration of 8 sec. (wt) wildtype mice, (ko) CHR knockout mice. 
(A) Number of reinforcers earned, (B) percentage correct responding, (C) number of errors of 
omission, (D) ITI responses per trial, (E) correct response latency, (F) incorrect response latency, and 
(G) biased responding (index Y). Data are presented as means, with error bars denoting SEMs.
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(genotype effect Fi,n = 1.71; genotype x stimulus duration effect = 0.40; 
genotype x stimulus duration x session effect Fi2,i32 = 0.89), correct response latency 
(genotype effect Fi,n = 2.45; genotype x stimulus duration effect Fg^s = 1.03; 
genotype x stimulus duration x session effect Fu.uz = 1.36), incorrect response 
latencies (genotype effect F i,n  = 0.05; genotype x stimulus duration effect Fg,gg =  
0.14; genotype x stimulus duration x session effect Fn.isz = 0.89) and biased 
responding (genotype effect F i,n  = 0.05; genotype x stimulus duration effect Fg,gg =  
0.48; genotype x stimulus duration x session effect Fnjgz = 0.55) (all p’s > 0.05; 
Figures 9.3A-G).
Baseline performance
Subsequently, mice received fifteen more sessions with 0.5 s stimulus duration. Over 
repeated testing with this stimulus duration (twenty sessions, including the first 5 
sessions), no significant differences were found in the performance of knockout mice 
compared to wildtype littermates (Table 9.1).
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Table 9.1 5-CSRRT performance in mice lacking CRH under basal conditions (data are expressed as 
means ± SEMs).
measure wildtype knockout genotype effect 
F i j i
genotype x 
session
F 19,209
Reinforcers Earned 22.07 ± 1.21 22.18 ±1.61 0.00 1.31
% Correct Responses 51.13 ±1.77 51.19 ±2.60 0.00 1.34
Errors of Omission 16.59 ±1.40 16.70 ±1.60 0.00 0.91
No. ITI Responses 0.15 ±0.02 0.13 ±0,02 0.51 0.59
Corr. Resp. Lat. (sec) 1.49 ±0.07 1.30 ±0.09 2.98 1.33
Incorr. Resp. Lat. (sec) 3.16 ±0.12 2.94 ±0.18 1.11 1.40
Bias (Index Y) 0.32 ± 0.04 0.27 ± 0.03 0.66 0.71
All p’s > 0.050; No.: number; Corr. Resp. Lat.: correct response latency; Incorr. Resp. Lat.: incorrect 
response latency.
White noise distractor
Presenting white noise before the start of a trial did not affect the overall number of 
reinforcers earned (Fi,n = 0.73, p > 0.05). The errors of omission, however, were 
increased by introduction of white noise (Fi,n = 8.31, p = 0.015), whereas the 
percentage correct respondings tended to be increased, but just failed significance 
(Fiji = 3.83, p = 0.076) (Figures 9.4A, B). Correct response latency was not affected 
by the auditory disturbance (Fiji = 0.02, p > 0.05), whilst incorrect response latency
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tended to be increased (noise effect F iji = 4.44, p = 0.059) (Figures 9.4C, D). 
Presentation of white noise did not affect ITI responses (Fiji = 0.21, p > 0.05) and 
biased responses (Fijo = 0.12, p > 0.05).
No differences of genotype were found in this experimental phase: percentage 
correct responding (genotype effect F iji = 0.21; genotype x noise effect Fiji = 1.31), 
reinforcers earned (genotype effect F iji = 0.00; genotype x noise effect F iji = 0.12), 
errors of omission made (genotype effect F iji = 0.06; genotype x noise effect F iji = 
0.40), correct response latency (genotype effect F iji = 0.02; genotype x noise effect 
F i j i  =  0.05), incorrect response latency (genotype effect F i j i  =  0.90; genotype x 
noise effect F iji = 0.15), ITI responses (genotype effect F iji = 1.49; genotype x 
noise effect F iji = 0.02) and biased responses (genotype effect F iji = 1.73; genotype 
X noise effect F iji = 0.13) (all p’s > 0.050).
Alterations of ITI duration
Increasing the ITI duration reduced the number of reinforcers earned F2,22 = 5.76, p < 
0.050) (Figure 9.5B). Post hoc analyses revealed no significant differences between 
individual ITI durations. Reducing the ITI duration had no effect on the reinforcers 
earned (F2,22 = 2.22, p > 0.05) (Figure 9.5A). Furthermore, altering the ITI did not 
affect other parameters: percentage correct responding (ITI reduction effect F2,22 = 
0.16; ITI increment effect F2.22 = 1.22), errors of omission (ITI reduction effect F2,22 
= 2.10; ITI increment effect F2.22 = 3.81), correct response latency (ITI reduction 
effect F2,22 = 0.16; ITI increment effect F2,22 = 0.59), incorrect response latency (ITI 
reduction effect F2,22 = 0.79; ITI increment effect F2,22 = 0.55), and biased responding 
(ITI reduction effect F2.22 = 0.60; ITI increment effect F2.22 = 0.55) (all p’s > 0.050).
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Figure 9.4 Effects of white noise distraction on 5-CSRTT performance inmice lacking CRH. (A) 
percentage correct responding, (B) number of errors of omission, (C) correct response latency, (D) 
incorrect response latency. Data are presented as means, with error bars denoting SEMs. * p < 0.050.
A significant genotype effect was found during the ITI duration reduction phase in 
terms of correct response latency (Fiji = 0.79, p < 0.050). However, post hoc 
analyses did not reveal any significant differences between individual ITI durations 
(Figure 9.5C). Visual inspection of the data revealed that during this phase the most 
distinct difference between groups was found when animals were tested with an ITI 
of 5 seconds, suggesting that reducing the ITI is not the cause of the group difference 
found. No genotype x ITI reduction interaction was found (F2,22 = 0.20, p > 0.05) nor 
effects of increasing the ITI duration (genotype effect F iji = 0.86; genotype x ITI 
increment effect F2,22 = 0.07, both p’s > 0.050) for this parameter. No further 
differences were found between groups for the other parameters: percentage correct 
responding when the ITI duration was reduced (genotype effect F iji = 0.79; 
genotype x ITI reduction effect F2.22 = 0.55) or increased (genotype effect F iji =
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0.79, genotype x ITI increment effect p2,22 = 0.55), reinforcers earned when the ITI 
duration was reduced (genotype effect F iji = 0.56, genotype x ITI reduction effect 
F2,22 = 0.76) or increased (genotype effect F iji = 0.44; genotype x ITI increment 
effect F2,22 = 1.72), errors of omission when the ITI duration was reduced (genotype 
effect F iji = 1.41; genotype x ITI reduction effect p2,22 = 2.34) or increased 
(genotype effect F iji = 0.28; genotype x ITI increment effect p2,22 = 2.35), incorrect 
response latency (genotype effect F iji = 0.19; genotype x ITI reduction effect F2,22 = 
2.14) or increment (genotype effect F iji = 0.08; genotype x ITI increment effect F2.22 
= 0.84) and biased responding during ITI duration reduction (genotype effect F iji 
=0.69; genotype x ITI reduction effect p2,22 = 0.18) or increment (genotype effect 
F iji = 0.00; genotype x ITI increment effect F2.22 = 1.22) (all p’s > 0.05).
Effects of social defeat
Mice were exposed to a social defeat procedure prior to testing. No effects on 
performance were found: percentage correct responding (Fiji =0.04), reinforcers 
earned (Fiji = 0.86), errors of omission (Fiji = 1.72), correct response latency (Fiji 
= 0.00), incorrect latency (Fiji = 3.03), biased responding (Fiji = 0.43), and ITI 
responding (Fiji = 4.40) (all p’s > 0.05).
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Figure 9.5 Effects of alteration of ITI duration on 5-CSRTT performance in mice lacking CRH. 
Treatment given in ascending order. (A) number of reinforcers earned, reduction of ITI duration (B) 
number of reinforcers earned increment of ITI duration, (C) correct response latency, reduction of ITI 
duration (D) correct response latency, increment of ITI duration. Data are presented as means, with 
error bars denoting SEMs.
No differences depending on genotype were found in this experimental stage; 
percentage correct responding (genotype effect F iji = 0.50; social defeat x genotype 
effect Fij i = 0.13), reinforcers earned (genotype effect F iji = 1.07, social defeat x 
genotype effect F iji = 0.65), errors of omission (genotype effect F iji = 1.16; social 
defeat x genotype effect Fiji = 0.59), correct response latency (genotype effect F iji 
= 0.12; social defeat x genotype effect F iji = 2.25), incorrect latency (genotype 
effect F iji = 0.94; social defeat x genotype effect F iji = 0.13), biased responding 
(genotype effect F iji = 1.25; social defeat x genotype effect F iji = 0.74), and ITI 
responses (genotype effect F iji =0.17; social defeat x genotype effect F iji = 0.06) 
(all p ’s > 0.050; Table 9.2).
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Table 9.2 Effect of social defeat in mice lacking CRH on 5-CSRTT performance (data are expressed 
as means ± SEMs).
Measure wildtype
basal
Knockout
Basal
wildtype 
social defeat
Knockout 
social defeat
No. Reinforcers 14.00 ±3.43 17.83 ±3.44 14.14 ±3.51 19.83 ±2.76
Earned
% Correct Responses 50.67 ±3.86 53.66 ± 4.67 50.20 ± 5.60 55.36 ± 3.62
Errors of Omission 33.57 ±4.58 27.23 ± 5.84 32.57 ±5.06 23.50 ±5.33
No. ITI Responses 0.11 ±0.02 0.12 ±0,03 0.09 ±0.01 0.10 ±0.02
Corr. Resp. Lat. (sec) 1.20 ±0.14 1.37 ±0.15 1.41 ±0.13 1.15 ±0.11
Incorr. Resp. Lat. 4.11 ±0.50 3.62 ±0.19 3.52 ±0.30 3.25 ±0.36
(sec)
Bias (Index Y) 0.37 ± 0.08 0.21 ± 0.06 0.27 ± 0.09 0.23 ± 0.09
All p’s > 0.050; No.: number; Corr. Resp. Lat.: correct response latency; Incorr. Resp. Lat.: incorrect 
response latency
Effect of Forced swimming on 5-CSRRT
Although forced swimming did not affect percentage correct (Fiji = 0.06, p > 0.05), 
the number of reinforcers earned was significantly increased (Fiji = 12.37, p = 
0.005), and concomitantly, the errors of omission were reduced (Fiji = 12.16, p = 
0.005) (Figures 9.6A, B, C). No further forced swimming-induced differences were 
found in correct response latency (Fiji = 2.70), incorrect latency (Fiji = 0.28), 
biased responding (Fiji = 1.06) or ITI responses (Fiji = 1.05) (all p ’s > 0.050).
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Forced swimming did not induce any genotype-dependent differences: percentage 
correct responding (genotype effect F iji = 0.11; forced swimming x genotype effect 
Fiji = 0.13), reinforcers earned (genotype effect F iji = 1.43; forced swimming x 
genotype effect F iji = 0.03), errors of omission (genotype effect F iji = 1.67; forced 
swimming x genotype effect F iji = 0.44), correct response latency (genotype effect 
Fiji = 1-16; forced swimming x genotype effect F iji = 2.57), incorrect latency 
(genotype effect F iji = 0.03; forced swimming x genotype effect F iji = 0.59), biased 
responding (genotype effect F iji = 0.21; forced swimming x genotype effect F iji = 
3.35), and ITI responding (genotype effect F iji = 3.77; forced swimming x genotype 
effect Fiji = 0.77) (all p’s > 0.050).
Effect of acute scopolamine treatment
There was an overall effect of treatment on percentage correct responding, with 
scopolamine leading to reduced accuracy (F4,4o = 5.44, p = 0.026) (Figure 9.7B). This 
effect was independent of genotype (genotype effect Fijo = 1.25; genotype x 
treatment effect F4,4o = 0.38, both p’s > 0.050). Likewise, scopolamine reduced the 
number of reinforcers earned (treatment effect F4,4o = 41.45, p < 0.001). Although no 
genotype x treatment interaction was found (treatment x genotype effect F4,4o = 1.03, 
p > 0.05), CRH knockout animals earned overall more reinforcers compared to 
wildtype littermates (genotype effect Fijo = 13.89, p = 0.004) (Figure
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Figure 9.6 Effects of forced swimming 5-CSRTT in mice lacking CRH. (A) number of reinforcers 
earned, (B) percentage correct responding, (C) number of errors of omission. Data are presented as 
means, with error bars denoting SEMs.
9.7A). Scopolamine treatment resulted in an increase of errors of omission (F4 ,4o = 
96.26, p < 0.001). Again no genotype x treatment interaction was found (F4,4o = 0.46, 
p > 0.05), but CRH knockout animals were less disrupted by treatment in terms of 
overall reduced errors of omission (Fijo = 5.08, p < 0.048) (Figure 9.7C). Correct 
response latency was not affected by treatment (F4,4o = 0.86, p > 0.05), and no 
difference depending on genotype was found (genotype effect Fijo = 0.19; treatment
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X genotype effect F4,4o = 1.90, both p’s > 0.050). Furthermore, no effect of treatment 
was found in terms of incorrect response latency (treatment effect F4,4o = 2.48; 
treatment x genotype effect F4,4o = 0.44, both p’s > 0.050). Strikingly, a genotype- 
dependent effect was found for this parameter, just reaching significance (Fijo =
5.14, p = 0.049; Figure 9.7D). Visual inspection revealed that the group difference 
varied between dosages, but more or less at random. Scopolamine also affected the 
ITI responses made (F4,4q = 10.49, p = 0.004), whereas no genotype-dependent effect 
was found (genotype effect Fijo = 0.14; treatment x genotype effect F4,4o = 0.34, 
both p’s > 0.050) (Figure 9.7D). Furthermore, scopolamine treatment had no effect 
on biased responding (treatment effect F4,4o = 0.66; treatment x genotype effect F4,4o 
= 1.15, both p’s > 0.050), but again a genotype effect was found (Fijo = 8.74, p =
0.016). Visual inspection revealed that wildtype animals showed increased biased 
responding (Figure 9.7F).
Discussion
Both groups performed equally well during autoshaping and simple visual 
discrimination learning, with exception of a mild decrease of biased responding of 
CRH knockout mice, suggesting that lack of CRH does not affect learning capacity 
in this task. Although no effect of session was found during the autoshaping 
procedure, both groups performed well above chance from the first session of the
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Figure 9.7 Effects of scopolamine on 5-CSRTT in mice lacking CRH. Scopolamine was administered 
at dosages of 0.0, 0.1, 0.5 1.0 and 2.0 mg/kg i.p., 20 min prior to testing. Treatment was given in 
ascending order. (A) number of reinforcers earned, (B) percentage correct responding, (C) number of 
errors of omission, (D) incorrect response latency, (E) ITI responses per trial (F) Biased responding 
(index Y). Data are presented as means, with error bars denoting SEMs.
simple visual discrimination learning phase onwards, suggesting animals learned the 
association between the stimulus and reward. By reducing the stimulus duration, 
reinforcers earned and percentage correct responding were decreased. Although the 
attentional load was increasing, less errors of omission were made, and both correct 
and incorrect response latencies decreased, whilst biased responding increased. Both 
groups performed still equally well during this phase. Furthermore, when animals
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were tested for an extended period of 20 sessions with shortest stimulus duration (0.5 
s), no differences depending on genotype were found, suggesting that lack of CRH 
does not affect visuospatial attention under these testing circumstances.
It has been demonstrated that effects of manipulations can depend on the attentional
*
load. For example, rats with ceruleo-cortical noradrenaline loss perform equally well 
compared to control animals under basal conditions, whereas lesioned animals were 
impaired in presence of white noise in terms of accurate responding (Carli et al., 
1983). Presentation of white noise did not induce group difference. In fact, it resulted 
in an increase in percentage correct responding and in errors of omission, without 
affecting the number of reinforcers earned. Altering ITI duration had no clear effects 
on performance in both groups of animals.
The CRH system is activated after stressors. Therefore it was investigated whether 
performance was differently affected by stressors. Data from this chapter and chapter 
8 indicate that the effects of stress before testing depends on the kind of stressor to 
which the animals are exposed. Thus, i.p. saline injection increased accurate 
responding, but in the same time it reduced reinforcers earned, and increased errors 
of omission made. In other words, animals showed a stronger tendency to refrain 
from responding, which consequently led to a net decrease in reinforcers earned but 
when animals responded, they responded more accurate.
In the present study, the effect of lack of CRH on 5-CSRTT performance after two 
distinct types of stressors was investigated: physical/physiological stress (inescapable 
swim stress) and psychological stress (social defeat). Social defeat failed to affect
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performance, whereas forced swim stress prior to testing resulted in an increase in 
reinforcers earned, a decrease in errors of omission, but leaving parameters that 
reflect attentional performance unaffected. Therefore, swim stress seemed to affect 
non-specific factors. This indicates that performance in the 5-CSRTT is a robust 
phenomenon and those physical/physiological and psychological stressors have 
distinct effect on performance. Furthermore, no differences between groups were 
found after exposure to stress, this in contrast to the impairments on performance in 
mice overproducing CRH (Chapter 9). Stressful stimuli have been shown to increase 
the apparent release of CRH in the central amygdaloid nucleus (Pich et al., 1993), 
and it has been demonstrated that social defeat evoked an elevation of CRH in the 
hypothalamus in rats (Skutella et al 1994). This suggests that long-term hyperactivity 
of the CRH system reduces sustained and divided attention, whereas acute CRH 
increase does not. However, it cannot be ruled out that inescapable swim stress or 
social defeat leads to an inadequate level of stress after, and that therefore CRH 
levels were not adequately high. This is unlikely because inescapable swim stress 
strongly activates HPA-axis activity that is CRHRl mediated (Timple et al., 1998). 
Alternatively, it is possible that CRH disrupts attentional processes after long-term 
hyperactivity.
Muscaric receptor blockade resulted in disruption in performance as indicated by the 
reduction in accuracy and reinforcers earned and an increase of errors of omission 
made, in a similar fashion as presented in Chapter 8. Strikingly, the disruptive effects 
of scopolamine treatment were stronger in wildtype animals compared to knockout 
littermates. This indicates again that long-term of the CRH system affects other 
neurotransmitter system.
185
In summary, lack of CRH does not result in altered sustained and divided attention. 
In addition, exposure to stress does not result in genotype dependent effects, 
suggesting that, in contrast to the disturbing effects on attentional process after long­
term excess of CRH described in Chapter 9, acute increase in CRH activity does not 
affect attentional function. However, it is possible that lack of CRH could be 
compensated by other ligands of the CRH peptide family, for example UCN, UCNII 
or UCNIII, which also stimulate CRH receptors. Therefore, investigation of the role 
of CRHRl and CRHR2 is necessary to fully understand the role of CRH in attention.
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Chapter 10
Effects of reduced CRHRl activity on five- 
choice serial reaction time performance in mice
Introduction
The experiments presented in Chapter 8 indicated that chronic CRH excess may 
disrupt visuospatial attentional processes as measured in transgenic mice 
overproducing CRH, performing on an operant 5-CSRTT. In contrast lack of CRH 
did no result in any disturbance in these processes (Chapter 9). However, CRH is not 
the only ligand that stimulates the CRH receptors. To further elucidate the possibility 
that these effects are mediated via CRHRl activation, the effects of acute blockade 
or life-long loss of CRHRl was studied. In a first experiment, the effects of acute 
administration of a non-peptidergic, selective CRHRl antagonist (R121919) were 
tested, with and without concomitant cholinergic blockade by the muscarinic 
antagonist scopolamine.
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R121919 is a 3-phenyl-pyrazolo-pyrimidine with high affinity to human and rat 
CRHRl (Ki = 3.15 nmol/1). R121919 has been reported to reduce ^^^I-oCRH binding 
density in brain regions expressing CRHRl, while leaving binding to CRHR2 
unaffected (Keck et al., 2001). Oral bioavailability is 10 -  20% in rats (Wilcoxen et 
al., 2000). Ex vivo, R121919 occupies approximately 50% of CRHRl in rat cortex 
one h after an oral dose of 2.5 mg/kg, while a 20 mg/kg dose results in almost a 
complete receptor occupancy (Langlois and Jurzak, Janssen Research Foundation 
unpublished results). EC50 for inhibition of CRH-stimulated ACTH release has been 
reported to be at 20 nmol/1 (Wilcoxen et al., 2000). Furthermore, systemic 
administration of R121919 blunts the responsivity of the HP A axis following 
exposure to mild stress and has anxiolytic properties in rats bred for increased 
anxiety-related behaviour (Keck et al., 2001). The effects of acute administration of 
R121919 were tested over a wide dose range and the interaction of this compound 
with cholinergic blockade by the muscarinic antagonist scopolamine was studied.
In a second experiment, the effects of long-term loss of CRHRl on visuospatial 
attention was studied in mice deficient for CRHRl performing the 5CSRTT. These 
mutants exhibit increased exploratory activity and reduced anxiety-related behaviour 
(Timpl et al., 1998). It remains a possibility that these behavioural alterations are, at 
least in part, a consequence of altered arousal and/or attention directed towards 
contextual cues in these animals.
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Material and methods 
Animals
Two months old male C57BL/6CrlBR mice were purchased from Charles River, 
Sulzfeld, Germany for the first experiment. These animals were first trained to stable 
baseline. Mice were between four and six months old at the time of testing. For the
second experiment, eight two-months-old male homozygous Crhrl"^" mutants and 
thirteen littermate wildtype (+/+) mice were generated by intercross from 129/Ola x 
CD-I FI hybrids (Timpl et al., 1998). This CRHRl-deficient mouse line was 
established by deleting the coding sequences of the transmembrane regions V, VI 
and VII, including the G-coupling domain and the intracellular cytoplasmatic tail. 
This results in a truncated protein unable to activate the adenylate cyclase second 
messenger system or to transmit any ligand-induced signals. In both experiments, 
animals were housed individually and maintained on a 12:12 h light/dark cycle 
(lights on at 06:00 hours) with ad libitum water throughout. They were maintained at 
85-90% of their free feeding weight, starting one week prior to the beginning of the 
experiment.
5-CSRRT
Testing took place during the light phase of the light/dark cycle. Five sessions were 
scheduled per week (one session per day, Monday-Friday). Animals were trained as 
described in detail in Chapter 2. In brief, animals were habituated the testing 
apparatus until they reliably ate all the pellets presented (2 per hole), after which they 
were trained on the autoshaping procedure. Seven sessions were scheduled during 
this experimental stage. This was followed by training the animals following the
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visual discrimination learning protocol until stable performance was reached. Next, 
the stimulus duration was gradually reduced (i.e., 8 s, 4 s, 2 s, 1 s, 0.5 s), with 5 
sessions per stimulus duration.
Effects of R121919 on baseline schedule
Once baseline responding was established at 0.5 s stimulus duration, 5 sessions were 
scheduled where animals received i.p. saline injections prior to test. R121919 (kindly 
donated by Janssen Research Foundation, Beerse, Belgium) was dissolved in vehicle 
(3 % Tween 20 in saline) and injected i.p. in a volume of 10 ml/kg, 20 min before 
testing (0.0, 0.5, 1.0, 2.5, 10.0, 20.0, 40 mg/kg). Treatment was given in ascending 
order. At least two days lapsed in-between drug sessions in order to allow for 
sufficient washout of the drug.
Effects of R121919 in the presence of white noise
Subsequently, the effects of CRHRl blockade in the presence of a distractor (a white 
noise stimulus (1.2 kHz, 76 dB), presented during the 500 ms preceding the stimulus 
onset, were studied. Only the high dose (40 mg/kg) versus vehicle was tested.
Effects of scopolamine on baseline performance
Scopolamine hydrochloride (Sigma Chemicals, Deisenhofen, Germany) was 
dissolved in saline and injected i.p. in a volume of 10 ml/kg, 20 min before testing 
(0.0, 0.1, 0.5, 1.0 mg/kg). Again, treatment was given in ascending order, and at least 
two days lapsed in-between drug sessions.
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Interaction between R121919 and scopolamine
Finally, animals received concomitant treatment with both scopolamine (0.5 mg/kg
i.p., 20 min prior to test) and R121919 (40 mg/kg, i.p., 20 min prior to test). Drugs 
were administered according to a Latin square design and animals were tested under 
baseline conditions.
Effects of CRHRl knockout on task acquisition
Autoshaping was analysed in CRHRl knockout mice in the second experiment. This 
was followed by training animals on simple discrimination with stimuli of long 
duration (8 s). Subsequently, the effects of gradually reducing stimulus duration was 
investigated. Animals were tested on shortest stimulus duration for 14 sessions 
before proceeding to the next stage.
Effects of CRHRl knockout under conditions of altered stimulus predictability
Temporal predictability of the stimulus was altered during six sessions by
introduction of ITIs of various duration, first three sessions during which ITI
durations were shortened (5, 2 and 1 s), followed by three sessions with longer ITIs
(ranging from 5, 10, to 20 s).
Results
Effects of acute administration of R121919
R121919, in the dose range tested, failed to affect accuracy in terms of percentage 
correct responses -  0.62, p > 0.05) (Figure 10. IB). However, there was a
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tendency for a reduction in the number of reinforcers earned with higher doses (F6,72 
= 2.31, p = 0.067), and a concomitant increase in errors of omission was observed 
(F6,72 = 4.12, p = 0.009) (Figures 10.1 A, C). Further analysis revealed that animals 
made significantly more errors of omission with doses of 10.0 mg/kg and higher 
when compared to vehicle. Treatment had no significant effect on ITI responses 
(Fô,72 = 0.31), correct or incorrect response latencies (Fô,72 =1.11 and Fô,72 = 117, 
respectively), or biased responding (Fô,72 = 0.83; all p’s > 0.050) (Figures lO.lD-G).
Effects of acute administration of R121919 in the presence of white noise
The high-dose of R121919 also failed to affect percentage correct responses in the 
presence of white noise (Fi,i2 = 0.11, p > 0.05) (Figure 10.2B). However, the 
difference between vehicle treatment and treatment with 40 mg/kg R121919 now 
reached significance in terms of the number of reinforcers earned (Fij2 = 5.90, p = 
0.032) (Figure 10.2A). There was also a small effect on the errors of omission 
measure, which just about reached significance (Fij2 = 4,76, p = 0.050) (Figure 
10.2C). Again, treatment had no effect on ITI responses (Fij2 = 1.01, p > 0.05) or 
biased responding (Fij2 = 0.06, p > 0.05) and left correct response latencies 
unaffected (Fij2 = 0.30, o > 0.050) (Figure 10.2D, E. G). However, there was an 
effect of treatment on incorrect response latency (Fij2 = 6.80, p = 0.023), with 
shortened latency following treatment with R121919 (Figure 10.2F).
Effects of acute treatment with scopolamine
In contrast to R121919, scopolamine induced a dose-dependent accuracy deficit 
(Fs,33 = 15.85, p < 0.001), with both the 0.5 mg/kg and the 1.0 mg/kg dose impairing 
percentage correct responding when compared to animals treated with saline or the
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lowest dose (0.1 mg/kg) of the drug (Figure 10.3B). Furthermore, a dose-dependent 
reduction in the number of reinforcers earned (Fg^ gg = 43,23, p < 0.001) and a 
concomitant increase in errors of omission (Fs,33 = 14.45, p < 0.001) was observed 
(Figures 10.3A, C). ITI responses were just about significantly decreased at the 
lowest dose of scopolamine tested (0 .1  mg/kg), but not with higher doses (¥ 3^ 33 = 
3.22, p = 0.049) (Figure 10.3D). However, inspection of the data suggested that this 
effect was primarily due to a change in baseline under saline treatment as vehicle- 
treated animals in general performed at lower levels throughout the other stages of 
the study (cf. Figures 10.ID, 10.2D, 10.4D). Scopolamine failed to significantly alter 
correct (F3,33 = 1.71, p > 0.05) or incorrect (F333 = 0.94, p > 0.05) response latencies 
(Figures 10.3E, F), but a tendency for an increase in biased responding was noted 
(F3,33 = 3.37, p = 0.059) (Figure 10.3G).
Interaction between R121919 and scopolamine
There was a main effect of treatment with scopolamine which, at a dose of 0.5 
mg/kg, again led to a decrease in accurate performance (Fiji = 42.01, p < 0.001). 
However, there was no effect of R121919 (40 mg/kg) (Fiji = 0.42) and no 
interaction between the two compounds was observed (Fiji = 1.47; both p > 0.05; 
Fig. 4B). In contrast, both scopolamine (Fiji = 10.58, p = 0.008) and R121919 (Fiji 
= 12.76, p = 0.004) led to a decrease in the number of reinforcers earned. The effect 
of combined treatment was additive rather than potentiating, as indicated by the lack 
of significant interaction (Fiji = 0.002, p > 0.05; Figure 10.4A).
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Figure 10.1 Effects of CRHRl antagonism with R121919 on 5-CSRTT performance. (A) reinforcers 
earned, (B) percentage correct responses (C) errors of omission (D) ITI responses (E) correct response 
latency, (F) Incorrect response latency, (G) biased responding. *: significant difference to vehicle, *: p 
< 0.05, p = 0.051 (data are expressed as means and SEMs).
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Figure 10.2 Effects of CRHRl antagonism with R121919 on 5-CSRTT performance in the presence 
of white noise, (A) number of reinforcers earned, (B) percentage correct responding, (C) errors of 
omission, (D) ITI responses, (E) correct response latency, (F) incorrect response latency, (G) biased 
responding; *: significant difference to vehicle, p < 0.05 (data are expressed as means values and 
SEMs).
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Errors of omission were increased following administration of the CRHRl antagonist 
(Fiji = 11.66, p = 0.006), while scopolamine alone (Fi,n = 0.19, p > 0.05) or in 
combination (Fiji = 0.07, p > 0.05) had no additional effect (Figure 10.4C). 
Moreover, an increase in ITI responses was seen following administration of 
scopolamine only (Fiji = 7.12, p = 0.022; Figure 10.4D), while R121919 (Fiji = 
2.79) or its combination with scopolamine (Fiji = 1.01; both p ’s > 0.050) had no 
additional effect on this measure (Figure 10.4D). In addition, scopolamine increased 
correct (Fiji = 5.83, p = 0.034), but not incorrect (Fiji = 0.24, p > 0.05) response 
latencies (Figures 10.4E, F). A tendency for R121919 to increase correct response 
latencies (Fiji = 3.92, p = 0.073) was also noted, while blockade of CRHRl had no 
effect on incorrect latency (Fiji = 1.70, p > 0.05). However, the interaction between 
scopolamine and R121919 reached significance for the correct response latency 
measure (Fiji = 8.33, p = 0.015), indicating that combined treatment was more 
effective than single treatment to increase response latencies (Figure 10.4E). 
Incorrect response latency was not significantly altered by the drug combination, but 
a tendency was observed (Fiji = 3.55, p = 0.086). Finally, bias remained unaffected 
by all drug combinations (scopolamine effect F iji = 0.74; R121919 effect F iji = 
0.007; scopolamine x R121919 effect F iji = 0.27; all p’s > 0.050; Figure 10.4G).
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Figure 10.3 Effects of scopolamine on 5-CSRTT performance, (A) number of reinforcers earned, (B) 
percentage correct responding, (C) errors of omission, (D) ITI responses, (E) correct response latency,
(F) incorrect response latency, (G) biased responding; *: significant difference to vehicle, p < 0.05 
(data are expressed as means and SEMs).
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Autoshaping in CRHRl knockout mice
All animals completed the 20 trials scheduled per session within the time limit of 30 
min. Groups did not differ in the number of responses made until the illuminated 
(correct) hole was visited (genotype effect Fijg = 1.50; genotype x session effect 
F6,ii4 = 1.69, both p’s > 0.050; Figure 10.5A), in the latency to complete a trial 
(genotype effect Fi,i9 = 0.44; genotype x session effect Fô.ih = 1.38, both p’s > 
0.050; data not shown), in the relative number of trials completed within the limited 
hold of 5 s, i.e., prior to the automatic delivery of a pellet (genotype effect Fijg = 
2.72; genotype x session effect Fô.im = 0.48, both p’s > 0.050; Figure 10.5B) or in 
the number of nose-pokes made during the ITI (genotype effect Fijp = 2.61; 
genotype x session effect Fgjw = 1.28, both p’s > 0.050; Figure 10.5C).
Simple visual discrimination learning in CRHRl knockout mice
During the initial stage of visual discrimination, the stimulus was presented for 
maximally 8  s) No differences were observed between groups in the number of 
reinforcers earned (genotype effect Fij? = 0.67; genotype x session effect Fvjig = 
1.74, both p’s > 0.050), percentage correct responding (genotype effect Fij? = 0.08; 
genotype x session effect Fyjig =  2.01, both p’s >  0.050), or errors of omission 
(genotype effect Fij? = 2.77; genotype x session effect Fyjig = 0.79, both p’s > 
0.050) (Figures. 10.6A -  C). Likewise, there was no difference in the number of ITI 
responses (genotype effect Fijy < 0.01; genotype x session effect Fyjig = 0.44, both 
p’s >  0.050), correct (genotype effect F i j ?  =  0.06; genotype x session effect F7J19 =
1.14, both p’s >  0.050) or incorrect (genotype effect F%,17= 3.36; genotype x session
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Figure 10.4 Interaction between R121919 (40.0 mg/kg) and scopolamine (0.5 mg/kg) on 5-CSRTT 
performance, (A) number of reinforcers earned, (B) percentage correct responding, (C) errors of 
omission, (D) ITI responses, (E) correct response latency, (F) incorrect response latency, (G) biased 
responding; *: significant effect of scopolamine, p < 0.05; significant effect of R121919, p < 0.05; 
significant interaction, p < 0.05 (data are expressed as means and SEMs).
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effect F?,119 = 0.77, both p’s > 0.050) response latencies, or biased responding 
(genotype effect Fi,n = 0.47; genotype x session effect Fyjig = 0,79, both p’s> 0.050; 
Figures 10.6D -  G). Of note, both groups already performed well above chance 
during the first discrimination session, indicating that animals already acquired the 
association between light stimulus and reinforcement during the autoshaping stage.
Effects of reduced stimulus duration on performance of CRHRl knockout mice
The number of reinforcers earned (stimulus reduction effect F3,s4 = 23.29, p < 0.001), 
percentage correct responses (stimulus reduction effect Fs,54 = 52.73, p < 0.001), 
errors of omission (stimulus reduction effect F3,s4 = 4.53, p = 0.017), correct 
(stimulus reduction effect F3,s4 = 76.82, p < 0.001) and incorrect (stimulus reduction 
effect F3,54 = 10.49, p < 0.001) response latencies all declined with decreasing 
stimulus duration (Figures 10.7A -  C, E, F), while the number of responses made 
during the ITI remained unaffected (stimulus reduction effect F3,s4 = 2.22, p > 0.05; 
Figure 10.7D). Biased responding, on the other hand, increased with decreasing 
stimulus duration (stimulus reduction effect F3,$4 = 10.22, p < 0.001; Figure 10.70).
200
Number Responses until Correct5
4
I 3sc
2
1
6 74 532
session
B
Relative Number of Trials Completed
Prior to PelletDelivery35
30
25
20
15
10
5
43 5 6 721
session
ITI Responses
.0
• wt 
•ko
1 2 3 4 5 6 7
session
Figure 10.5 Effects of lack of CRHRl on autoshaping, wildtype mice (wt), CRHRl " ' mutant (ko). (A) 
number of responses made until a nose poke into the illuminated hole was performed, (B), relative 
number of trials completed prior to pellet delivery, (C) number of responses made during the ITI. wt: 
wildtype control, ko: CRHRT " mutant (data are expressed as means and SEMs).
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Figure 10.6 Five-choice simultaneous discrimination in mice lacking CRHRl. Animals were tested 
for 8 successive sessions, with a stimulus duration of 8 sec: wildtype mice (wt), CRHRl' ' mutant 
(ko). (A) Number of reinforcers earned, (B) percentage correct responding, (C) number of errors of 
omission, (D) ITI responses per trial, (E) correct response latency, (F) incorrect response latency, and
(G) biased responding, (data are expressed as means and SEMs).
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Except for the response latencies, there was no effect of genotype on any measure 
during this stage (number of reinforcers earned genotype effect Fijg = 0.006; 
genotype x stimulus duration effect F3,s4 = 1.34; genotype x session effect F4J 2 = 
0.32; genotype x stimulus duration x session effect Fi2,2i6 = 0.42; percentage correct 
responses: genotype effect Fijg = 0.13; genotype x stimulus duration effect Fs,54 = 
2.01; genotype x session effect F4J2 = 0.41; genotype x stimulus duration x session 
effect Fi2,216 = 0.50; errors of omission: genotype effect Fijg = 0.06; genotype x 
stimulus duration effect Fs,54 = 0.64; genotype x session effect F4J 2 = 0.52; genotype 
X stimulus duration x session effect Fi2,2i6 = 0.56; ITI responses: genotype effect 
Fi,i8 = 0.12; genotype x stimulus duration effect Fs,54 = 0.29; genotype x session 
effect F4J 2 = 1.16; genotype x stimulus duration x session effect Fi2,2 i6 = 0.33; bias: 
genotype effect Fijg = 0.07; genotype x stimulus duration effect F3,s4 = 2.20; 
genotype x session effect F4J 2 = 1.74; genotype x stimulus duration x session effect 
Fi2,216 = 0.79, all p’s > 0.050; Figures 10.7A -  D, G). Overall, there was a tendency 
for CRHRl knockout mice to have longer correct response latencies, which just 
failed significance (genotype effect Fi,ig = 4.08, p = 0.059), but ANOVA did not 
reveal any significant interaction effect (genotype x stimulus duration effect F3,s4 -  
2.12; genotype x session effect F4J2 = 1.13; genotype x stimulus duration x session 
effect Fi2,216 = 1.19, all p’s > 0.050; Figure 10.7E). Moreover, overall incorrect 
response latencies were higher in mutants relative to wildtype littermates (genotype 
effect Fi,ig = 5.63, p = 0.029), but again there was no interaction effect (genotype x 
stimulus duration effect F3,54 = 0.83; genotype x session: F4J 2 = 0.96; genotype x 
stimulus duration x session effect Fi2,2 i6 = 1.31, all p’s > 0.050), indicating a parallel 
shift (Figure 10.7F).
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Baseline responding of CRHRl knockout mice
Subsequently, mice received nine more session with 0.5 s stimulus duration. Over 
repeated testing with this stimulus duration a mild but significant accuracy difference 
became apparent in that the relative number of correct responses made by wildtype 
mice was higher than in mice lacking CRHRl (Table 10.1). However, when this 
parameter was analysed over all sessions with 0.5 s stimulus duration (including the 
first 5 sessions), only a strong tendency remained (genotype effect Fi,i9 = 4.34, p = 
0.051), indicating the weakness of this effect. There was no further difference 
between groups (Table 10.1).
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Table 10.1 Baseline performance of CRHRl knockout mice (means ± SEMs, averaged over nine 
sessions).
Measure wildtype knockout genotype
effect
(F(l,19))
genotype x
session
(F(8,152))
No. Reinforcers 28.64 ±1.40 26.40 ±1.78 0.99 0.49
Earned
% Correct Responses 56.72 ±1.69 50.07 ±2.16 5.90* 0.84
Errors of Omission 9.39 ±1.96 6.96 ± 2.50 0.45 0.74
No. ITI Responses 2.11 ±0.22 1.89 ±0,28 0.37 0.20
Corr. Resp. Lat. (sec) 1.17 ±0.06 1.19±0.13 0.02 0.69
Incorr. Resp. Lat. 2.23 ± 0.20 2.47 ±0.16 1.45 1.15
(sec)
Bias (Index Y) 0.18 ±0.02 0.23 ± 0.02 3X%+ 0.56
*P = 0.025; ^  = 0.097; only P-values <0.1 are indicated; No.: number; Corr. Resp. Eat.: correct 
response latency; Incorr. Resp. Eat.: incorrect response latency.
Effects of decreasing the ITI duration
Shortening of the ITI led to a decrease in the number of reinforcers earned (ITI 
reduction effect p2,38 = 20.41, p < 0.001; Figure 10.8A), in percentage correct 
responding (ITI reduction effect F2,3s = 4.31, p = 0.039; Figure 10.8B), increased 
errors of omission (ITI reduction effect F2,3s = 5.13, p = 0.012; Figure 10.8C), correct 
(ITI reduction effect F2,3s = 11.84, p < 0.001; Figure 10.8E) and incorrect (ITI 
reduction effect F2,3s = 21.68, p < 0.001; Figure 10.8F) response latencies, but had no 
significant effect on biased responding (ITI reduction effect F2,3g = 0.34, p > 0.05) 
(Figures 10.8 A -C, D, F). An overall effect of genotype was seen in the number of 
reinforcers earned (genotype effect Fijg = 6.60, p = 0.019) and in percentage correct 
responses (genotype effect Fi,i9 = 5.35, p = 0.032) during this stage of the 
experiment, while no further effect of genotype or genotype x ITI reduction 
interaction was found (reinforcers earned: genotype x ITI reduction effect F2,3g =
206
0.14; percentage correct responses: genotype x ITI reduction effect p2,38 = 0.08; 
errors of omission: genotype effect Fi,i9 = 0.31; genotype x ITI reduction effect F2,3s 
= 0.27; correct response latency: genotype effect Fi,i9 = 0.33; genotype x ITI 
reduction effect F2,3g = 1.66; incorrect response latency: genotype effect Fi,i9 = 0.37; 
genotype x ITI reduction effect F2,3s = 1.59; bias: genotype effect Fi,i9 = 2.89; 
genotype x ITI reduction effect F2,38 = 0.14; all p ’s > 0.050).
Effects of increasing the ITI duration
Conversely, when the length of the ITI was gradually increased from 5 to 20 s, only 
tendencies were seen for the number of reinforcers earned (ITI increment effect F2,3g 
= 3.37, p = 0.062) and for percentage correct responding (ITI increment effect F2,3g = 
3.37, p = 0.064) to change with the duration of the ITI, while no effect of ITI 
duration was observed on any of the other measures (Figures 10.9A -  F). There was 
no group difference in terms of accurate responding when ITI duration was increased 
(genotype effect F2,3g = 0.38; genotype x ITI increment effect F2,3g = 0.38, both p’s > 
0.050; Figure 10.9B), but genotypes differed again in incorrect response latencies 
(genotype effect F2,3g = 5.52, p = 0.03; genotype x ITI increment effect F2,3g = 1.47, p 
> 0.05), with mutant mice performing at higher latencies (Figure 10.9F). There was 
also a tendency for CRHRl knockout mice to make more biased responses (genotype 
effect F2,38 = 3.22, p = 0.088; genotype x ITI increment effect F2jg = 0.08, p > 0.05; 
Fig. 9D), but no other effect was seen (number of reinforcers earned: genotype effect
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Figure 10.8 Effects of decreasing the ITI duration in CRHRl knock out animals. (A) Number of 
reinforcers earned, (B) percentage correct responding, (C) number of errors of omission, (D) biased 
responding, (E) correct response latency, (F) incorrect response latency, (data are expressed as means 
and SEMs).
F2,38 = 0.86, genotype x ITI increment effect p2,38 = 0.19; errors of omission: 
genotype effect p2,38 = 0.73, genotype x ITI increment effect p2,38 = 0.37; correct 
response latency: genotype effect F238  = 0.96, genotype x ITI increment effect F2,3S = 
0.004, all p’s > 0.050). Thus, decreasing the predictability of stimulus onset by 
increasing the ITI had no effect on accurate responding.
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Discussion
Accurate performance as well as response latencies in this task depended on stimulus 
duration and declined with shorter stimuli. Likewise, a reduction in predictability of 
stimulus onset (high rate of stimulus presentation, earlier than expected) led to a
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reduction in accurate responding. Both correct and incorrect response latencies 
increased as a function of reduced stimulus predictability. Interestingly, increasing 
the ITI duration, i.e., a low rate of stimulus presentation, failed to significantly affect 
these measures, suggesting that once animals were expecting the stimulus they were 
attentive and waiting for the stimulus to be presented. In addition, accurate 
performance on this task was sensitive to the disrupting effects of scopolamine, 
comparable to those found in experiments presented in Chapters 8  and 9. White 
noise, on the other hand, left accuracy relatively unaffected (cf. percentage correct 
responses in the dose-response curve in Figure 10.IB with percentage correct 
responses in the presence of white noise in Figure 10.2B), which is also in line with 
earlier findings on the effects of white noise on accurate performance in mice tested 
in a five-choice serial reaction time (Chapter 9; Humby et al., 1999).
Acute administration of the selective CRHRl antagonist R121919 dose-dependently 
increased errors of omission and a concomitant tendency for a dose-dependent 
decrease in the number of reinforcers earned was observed under basal conditions. 
Notably, neither percentage correct responses nor correct response latencies were 
affected by the drug -  measures which both have been suggested to be predictive for 
disrupted attention in this task (Blondel et al., 2000; Carli et al., 1983). This suggests 
that acute blockade of CRHRl has no effect on target scanning, but exerts non­
specific effects on responsivity. This notion receives support by the data obtained 
during presentation of white noise. Again, the high dose of R121919 impaired errors 
of omission and also the number of reinforcers earned, but had no effect on the 
relative number of correct responses or correct response latency.
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The effects of combined treatment with scopolamine and R121919 were mainly 
independent. As before, R121919, at a dose of 40 mg/kg, increased errors of 
omission and decreased the number of reinforcers earned, but had no effect on 
accuracy, while scopolamine at the 0.5 mg/kg dose impaired accuracy and also 
decreased the number of reinforcers earned. Both drugs together had additive effects 
on the latter measure, but drugs failed to potentiate each other. Another interaction 
between scopolamine and R121919 was observed in terms of an increase in correct 
response latencies, while the CRHRl antagonist failed to alter the effects of 
scopolamine on percentage correct responding. Thus, there is, albeit limited, 
interaction between acute CRHRl blockade and the cholinergic system.
Mice lacking CRHRl did not differ from controls during autoshaping or during 
acquisition of the discrimination rule. The only difference during the gradual 
reduction of stimulus duration was an increased response latency in CRHRl 
knockout mice. However, during sessions with shortest stimulus duration (0.5 s), a 
small group difference in accurate responding developed. This difference, albeit 
significant, was marginal (56.72 % vs. 50.07 %). The fact that groups only started to 
dissociate after a few sessions argues against a pure attentional deficit and opens the 
possibility that other factors contributed to these results.
This accuracy deficit was also seen under conditions of short ITI durations, i.e., when 
stimuli were presented at faster rate than expected, but it was independent on the 
length of the ITI, which would also argue against a pure attentional deficit. An 
increase of ITI duration seemed to have even beneficial effects in that groups did no
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longer differ during these latter sessions with the exception of an increase in 
incorrect response latencies in mutant mice.
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Chapter 11
The role of CRHR2 on five-choice serial
reaction time performance in mice
Introduction
Overstimulation of CRH receptors result in an impairment in visuospatial attentional 
processes assessed in 5-CSRTT in mice overexpressing CRH. However, lack of CRH 
does not affect these processes. Acute blockade of CRHRl subtype exerts non­
specific effects on responsivity in this task, whereas life-long lack of CRHRl 
subtype results in mild impairments in 5-CSRTT performance, which is likely not a 
pure attentional deficit. Here, the functional role of the CRHR2 subtype in 
visuospatial attention was investigated.
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Material and Methods 
. Animals
Male CRHR2 deficient mice were provided by M. Stenzel-Poore (10 wildtype, 12 
heterozygote, 12 knockout). Mutants were generated as described previously by 
Coste and colleagues (Coste et al., 2000). In brief, this CRHR2-deficient mouse line 
was established by deleting the coding sequences of the transmembrane regions III 
and IV of the CRHR2 gene. This resulted in a truncated protein unable to activate the 
adenylate cyclase second messenger system or to transmit any ligand-induced 
signals. Animals were housed individually and maintained on a 12:12 h light/dark 
cycle (lights on at 06:00 hours) with ad lib water throughout. They were maintained 
at 85-90% of their free feeding weight, starting one week prior to the beginning of 
the experiment by restricting the laboratory chow access to 3.0-3.5 g / day / mouse 
(depending on the number of pellets eaten during testing). All experiments were 
conducted during the light phase of the cycle.
5-CSRRT
Five sessions were scheduled per week (one session per day, Monday-Friday). 
Animals were trained as described in detail in Chapter 2. After habituation, animals 
were shaped using the autoshaping procedure. Seven sessions were scheduled during 
this experimental stage. Then, animals were trained to the leam visual 
discrimination. After stable performance was reached, the stimulus duration was 
gradually reduced (i.e., 8  s, 4 s, 2 s, 1 s, 0.5 s), with 5 sessions per stimulus duration.
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Manipulations of basic task parameters
After animals reached stable performance, a series of manipulations of the basic task 
were made which were designed to increase the attentional load. First, the effects of 
the presence of a distractor (a white noise stimulus (1.2 kHz, 76 dB), presented 
during the 500 ms preceding the stimulus onset), were studied. Second, the ITI 
durations were gradually reduced (5.0, 2.5, 1.0 seconds) after which they were 
increased (5.0, 7.5, 10 seconds). Third, the stimulus duration was gradually 
decreased (0.5, 0.3, 0.2, 0.1 sec).
Cued detection
The predictability of the stimulus was enhanced by introduction of a pre-sound (1.2 
kHz, 76 dB), presented during the 500 ms preceding light stimulus onset (cued 
detection). Five sessions were scheduled using this procedure.
Effects of pharmacological treatment on baseline performance
Five sessions were scheduled where animals received i.p. saline injections prior to 
test. R121919 was dissolved in vehicle (3 % Tween 20 in saline) and injected i.p. in a 
volume of 10 ml/kg, 2 0  min before testing (40 mg/kg). Scopolamine hydrochloride 
(Sigma Chemicals, Deisenhofen, Germany) was dissolved in saline and injected i.p. 
in a volume of 10 ml/kg, 20 min before testing (0.0, 0.02, 0.10, 0.5 mg/kg). 
Treatment was given in ascending order, and at least two days lapsed in-between 
drug sessions.
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Results 
Autoshaping procedure
All groups completed nearly all 20 trials within the time limits of 20 min form the 
first session onwards. No significant effects of genotype or session were found 
(genotype effect p2,3 = 0.63; session effect Fe.iso = 1.28; genotype x session effect 
Fi2,i80 = 0.80, all p’s > 0.050) (Figure 11.1 A). The number of ITI responses 
decreased over sessions (F6,i80 = 9.54, p < 0.001), however no effect of genotype was 
found (genotype effect ¥ 2,3 = 1/41; genotype x session effect Fi2,i80 = 1.13, both p’s > 
0.050) (Figure 11. IB). Likewise, the time to complete a trial decreased over sessions 
(F6,i80 = 15.96, p < 0.001) (Figure 11.1C). There was a tendency for a gene-dose 
effect for this parameter, i.e. the overall time per trial showed a rank order (knockout 
> heterozygote > wildtype) which, however, just failed significance (p2,3 = 2 .6 8 , p = 
0.085). No genotype x session interaction was found for this parameter (Fi2,180 =
I.64, p > 0.05). Furthermore, no differences of genotype or session were found in 
terms of trials completed prior to pellet delivery (genotype effect ¥ 2,3 = 0.51; session 
effect F6,i8o = 2.12; genotype x session effect Fi2,i8o = 1.15, all p’s > 0.050) (Figure
I I .ID).
Simple visual discrimination learning
Both groups of animals responded above chance from the first session onwards. All 
groups increased performance over sessions in terms of percentage correct 
responding (Fio,3io = 38.78, p < 0.001), although overall performance was dependent 
on genotype (F2,3i = 4.93 p = 0.014), whereas no genotype x session interaction was 
found (F2o,3io = 1.38, p > 0.05) (Figure 11.2B).
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Figure 11.1 Effects of (partial) lack of CRHR2 on autoshaping performance. Animal were tested for 7 
successive sessions, (wt) wildtype mice, (hz) heterozygote mice, (ko) knockout mice. (A) Number of 
trials completed, (B) ITI responses per trial, (C) time to complete a trial, (D) average response latency 
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Post hoc testing revealed that knock mice showed an decreased percentage correct 
responding compared heterozygote animals (p < 0.05), however, compared to 
wildtype animals it just failed significance (p = 0,084). No difference was found 
between heterozygotes and wildtypes. Likewise, reinforcers earned increased over 
sessions session (Fio,3io = 22.64, p < 0.001), whereas no effect of genotype was 
found (genotype effect p2,3i = 0.64; genotype x session effect F2o,3io = 158, both p’s 
> 0.050) (Figure 11.2A). A concomitant decrease in errors of omission occurred over 
sessions (Fio,3io = 2.77, p = 0.032), while no effect of genotype was found (genotype 
effect F2,3 i = 0.00; genotype x session effect F2o,3io = 2.02, both p’s > 0.050) (Figure
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11.2C). Furthermore, correct response latency decreased over sessions (F 10,300 = 3.62, 
p < 0.010), but incorrect response latency did not (F 10,300 = 1.15, p > 0.05) (Figures 
11.2E, F). No effects of genotype was found in terms of correct (genotype effect Fz,3o 
= 0.55; genotype x session effect F]o,3oo = 0.93, both p’s > 0.050), and incorrect 
(genotype effect F],3o = 0.78; genotype x session effect F2o,3oo = 0.68, both p’s > 
0.050) response latency. An increase in ITI responses (Fio,3io = 4.74, p < 0.001) and a 
decrease in biased responding (Fio,3io = 7.08, p < 0.001) was seen over sessions 
(Figures 11.2D, G). For both parameters, the genotype effect failed to reach 
significance (ITI responses: genotype effect F2,3i = 0.05; genotype x session effect 
F2o,3io = 1.38; biased responding: genotype effect F2,3o = 1.91; genotype x session 
effect F2o,30o =1.16, all p’s > 0.050).
Reduction of stimulus duration
Decreasing the stimulus duration led to a decrease in percentage correct responses 
(Fs,93 = 170.52, p < 0.001) and decreased the number of reinforcers (Fs,93 = 30.05, p 
< 0.001) (Figures 11.3A, B). Despite the increasing attentional load, errors of 
omission also declined with decreasing stimulus duration (F3,93 = 17.03, p < 0.001) 
(Figure 11.3C). Furthermore, both correct and incorrect latencies decreased with 
decreasing stimulus duration (F3,93 = 17.24, p < 0.001 and F3,9o = 32.82, p < 0.001, 
respectively) (Figures 11.3E, F). Likewise, the number of responses made during the 
ITI decreased with shorter stimulus duration (effect Fs,93 = 16.38, p < 0.001), 
whereas biased responding increased as a consequence of decreasing stimulus 
duration (F3,93 = 26.66, p < 0.001) (Figure 11.3D, G).
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Figure 11.2 Effects of (partial) lack of CRHR2 on five-choice simultaneous discrimination 
performance. Animals were tested for 11 successive sessions, with a stimulus duration of 8 sec. (wt) 
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No significant differences between groups were found during this testing phase: 
accurate responding (genotype effect p2,3i = 0.53; genotype x stimulus duration 
interaction effect Fô,93 = 0.47; genotype x stimulus duration x session interaction 
effect p24,372 = 1.23), reinforcers earned (genotype effect p2,3i = 1.26; genotype x 
stimulus duration interaction effect p6,93 = 0.19; genotype x stimulus duration x 
session interaction effect p24,372 = 0 .87 ,), errors of omission made (genotype effect 
p2,3i = 1.68; genotype x stimulus duration interaction effect p6,93 = 0.45; genotype x 
stimulus duration x session interaction effect p24,372 =  1.36), number of ITI responses 
(genotype effect Pi,n = 2 .1 2 ;  genotype x stimulus duration interaction effect p3,33 = 
0.12; genotype x stimulus duration x session interaction effect Pi2,i32 = 0 .24), correct 
response latency (genotype effect p2,3i = 0.91; genotype x stimulus duration 
interaction effect p6,93 = 1.22; genotype x stimulus duration x session interaction 
effect p24,372 = 0.50 , all p’s > 0.05), incorrect response latency (genotype effect p2,3o 
= 0.81; genotype x stimulus duration interaction effect p6,9o = 0.84; genotype x 
stimulus duration x session interaction effect p24,360 = 1.07) and biased responding 
(genotype effect p2,3i = 1.38; genotype x stimulus duration interaction effect p6,93 = 
0.60; genotype x stimulus duration x session interaction effect P24372  = 0 .99 ) (Figure 
11.3, all p’s > 0 .0 5 ) .
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Figure 11.3 Effects of gradual reduction of the stimulus duration on 5-CSRTT performance in mice 
(partially) lacking CRHR2. Animals were tested for 5 sessions for each stimulus duration. (A) 
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responding (index Y). Data are presented as means, with error bars denoting SEMs.
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Baseline performance
Subsequently, mice received fifteen more sessions with a stimulus duration of 0.5 
second. Over repeated testing with this stimulus duration (twenty sessions, including 
the first 5 sessions), no significant differences were found in the performance of 
knockout mice compared to wildtype littermates (Table 11.1), except for the errors of 
omission (genotype effect p2,3i = 3.54, p = 0.041). Post hoc testing revealed that 
knockout mice made less errors of omission compared to wildtype littermates ( p < 
0.050).
Table 11.1 Baseline performance in CRHR2 knockout mice (means ± SEMs, averaged over twenty 
sessions).
Measure wildtype heterozygote knockout
genotype
effect
[F(2,31)1
genotype 
X session
[F (2 6 ,403)1
No. Reinforcers 
Earned
20.96 ± 1.19 24.62 ± 1.13 24.00 ± 1.36 2.34 1.04
% Correct Responses 4S.26± 1.74 52.29± 2.55 49.07 ± 2.66 0.78 0.81
Errors o f  Omission 16.19+ 1 .78 12.43 ± 1.15 12.43 ± 1.15* 3.54 0.45
No. ITI Responses 1.81 ± 0 .1 7 1.71 ± 0 .1 6 2.07 ± 0 ,1 2 1.62 0.50
Corr. Resp. Lat. (sec) 1.43 ± 0 .0 7 1.25 ± 0 .0 9 1.41 ± 0 .13 0.98 0.59
Incorr. Resp. Lat. 
(sec)
2.85 ± 0 .1 6 2.66 ±0 .11 2.70 ± 0 .1 4 0.51 0.93
Bias (Index Y) 0.26 ± 0.02 0.24 ± 0.02 0.22 ± 0.03 0.67 1.27
All p’s > 0.050, except for errors of omission (p = 0.041); No.: number; Corr. Resp. Lat.: correct 
response latency; Incorr. Resp. Lat.: incorrect response latency, * p < 0.050 compared to wildtype
222
Noise disturbance
Presenting white noise prior to a session, led to an increase in the number of errors of 
omission (Fi,3i = 8.07, p = 0.008) and the responses made during the ITI (Fi,3i = 
14.31, p < 0.001) (Figures 11.4C, D). No further effects of white noise were seen: 
number of reinforcers earned (Fi,3i = 0.96), percentage correct responding ( Fi,3i = 
0.80, p > 0.05) (Figures 11.4A, B), correct response latency (Fi,3i = 0.16), incorrect 
latency Fi,3i = 0.96) and biased responding (F131 = 2.02) (all p’s > 0.05).
The errors of omission tended to be lower in mutants during this experimental phase, 
but this effect, failed to reach significance (genotype effect p2,3i = 3.06, p = 0.062). 
Genotype and noise presentation did not interaction (Fi,3i = 0.18, p > 0.05). No 
further differences of genotype where found in this experimental phase: percentage 
correct responding (genotype effect F2,3i =0.17, genotype x noise effect Fi,3 i = 2.37), 
reinforcers earned (genotype effect F2,3i = 0.83, genotype x noise effect Fi,3i = 2.74), 
correct response latency (genotype effect F2,3i = 0 .2 2 , genotype x noise effect F2,3i = 
0 .1 2 ), incorrect response latency (genotype effect F2,3i = 0.61, genotype x noise 
effect F2,3i = 0.55), ITI respondings (genotype effect F2,3i = 0.47, genotype x noise 
effect F2,3i = 0.55) and biased responding (genotype effect F2,3i = 0.33, genotype x 
noise effect F2,3i = 0.74) (all p’s > 0.050).
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Figure 11.4 Effects of white noise stimulus presented during the 500 ms preceding the stimulus onset 
on 5-CSRTT performance in mice (partially) lacking CRHR2. (A) Number of reinforcers earned, (B) 
percentage correct responding, (C) number of errors of omission, (D) ITI responses per trial, (B) 
correct response latency, (F) incorrect response latency, and (G) biased responding (index Y). Data 
are presented as means, with error bars denoting SEMs.
Effects of decreasing the ITI duration
Reducing the ITI duration resulted a reduction in number of reinforcers earned ( p2,62 
= 4.71, p = 0.017), together with a concomitant increase in errors of omission (effect 
p2,62 = 13.94, p < 0.001) (Figures 11.5A, C). No effect on percentage correct 
responding was seen (p2,62 = 0.35, p > 0.05) (Figure 11.5B). Furthermore, both 
correct (F2,62 = 12.34) and incorrect (F2.62 = 10.95,) response latencies were increased 
by reducing the ITI duration (both p’s < 0.001, Figures 11.5E, F). Overall, biased 
responding was not affected during this experimental stage (F2,62 = 1.70, p > 0.05) 
(Figure 11.5D).
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Although overall biased responding was not significantly different between 
genotypes (genotype effect p2,3i = 1.87, p > 0.05), a genotype x ITI reduction 
interaction was found (genotype x ITI reduction p4,62 = 3.86, p = 0.006). Post hoc 
testing revealed that mice lacking CRHR2 showed an increased biased responding 
compared to wildtype littermates when the animals were tested with an ITI of 2.5 
seconds. No differences depending on genotype where found in this experimental 
phase: terms of percentage correct responding (genotype effect F2,si = 2.48, genotype 
X  ITI reduction F4,62 = 0.86), reinforcers earned (genotype effect F2,3i = 0.48, 
genotype x ITI reduction F4,62 = 0.45, both), errors of omission (genotype effect F2,3i 
= 1.98, genotype x ITI reduction F4,62 = 0.72), correct response latency(genotype 
effect F2,3i = 2.48, genotype x ITI reduction F4,62 = 0.86) and incorrect response 
latency (genotype effect F2,3i = 2.48, genotype x ITI reduction F4,62 = 0.86) (all p’s > 
0.050).
Effects of increasing the ITI duration
Reducing the ITI duration led to an increase in percentage correct responding (F2,62 = 
4.99, p = 0.013) and in the number of reinforcers earned (p2,62 = 12.88, p < 0.001) 
(Figures 11.6A, B). Furthermore, the errors of omission were decreased (F2.62 = 5.46, 
p = 0.013), as well as incorrect response latency (¥2,62 = 6.47, p = 0.005), whereas 
only a tendency in reduction of correct response latency was seen (F2,62 = 2.98, p = 
0.072) (Figures 11.6C, E, F). Increasing the ITI duration did not affect biased 
responding (ITI increment effect F2.62 = 0.60, p > 0.05) (Figures 11.6D).
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Figure 11.5 Effects of reduction of ITI duration on 5-CSRTT performance in mice (partially) lacking 
CRHR2. (A) Number of reinforcers earned, (B) percentage correct responding, (C) number of errors 
of omission, (D) biased responding (index Y), (E) correct response latency, and (F) incorrect response 
latency. Data are presented as means, with error bars denoting SEMs.
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No effect of genotype was found during this experimental phase: percentage correct 
responding (genotype effect p2,3i = 0.27, genotype x ITI reduction p4,62 = 2.09), 
reinforcers earned (genotype effect p2,3i = 0.17, genotype x ITI reduction p4,62 = 
2.25, both), errors of omission (genotype effect p2,3i = 2.00, genotype x ITI reduction 
p4,62 = 0.49) (all p’s > 0.050), correct response latency (genotype effect p2,3i =0.15, 
genotype x ITI reduction p4,62 = 0.13), incorrect response latency (genotype effect 
p2,3i = 2.34, genotype x ITI reduction p4,62 = 0.21) and biased responding (genotype 
effect p2,3i = 0.20, genotype x ITI reduction p4,62 = 0.14) (all p’s > 0.050).
Effects of further reduction of stimulus duration
Decreasing the stimulus duration reduced accurate responding (p3,93 = 24.30, p < 
0.001) and reinforcers earned (?3,93 = 32.95, p < 0.001), while errors of omission 
remained unaffected (p3,93 = 0.81, p > 0.05) (Figures 11.7A - C). Furthermore, both 
correct (p3,93 = 3.26, p = 0.035) and incorrect (p3,93 = 4.64, p = 0.009) response 
latencies were increased as a consequence of reducing the stimulus duration (Figures
11.7E, F). ITI responses were also reduced (p3,93 = 6.48, p < 0.002), whereas no 
effect on biased responding was seen (p3,93 = 0.72, p > 0.05) (Figure 11.7D).
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Groups did not differ in percentage correct responding (genotype effect Fi,n = 0.37, 
genotype x stimulus duration reduction p6,93 = 1.01, both p’s > 0.050) or number of 
reinforcers earned (genotype effect Fi,n = 0.37, genotype x stimulus duration 
reduction Fô,93 = 1.01, both p’s > 0.050). Furthermore, no interaction was seen 
between genotype and reduction of stimulus duration (genotype x stimulus duration 
reduction Fô,93 = 1.67, p > 0.05). However, heterozygote and knockout animals made 
less errors of omission than wildtype littermates (genotype effect Fi,n = 8.32, p < 
0.001).
Cued detection
Mice were tested under cndition of cued detection for 5 sessions. No group 
differences were found (Table 11.2).
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Table 11.2 Cued detection in CRHR2 knockout mice (means ± SEMs, averaged over five sessions).
Measure wildtype heterozygote knockout
genotype 
effect 
F values 
lEz^il
No. Reinforcers Earned 23.16 ± 1.02 24.00 ± 0.88 23.65 ± 1.30 0.14
% Correct Responses 47.92 ±3.19 45.35 ±1.52 44.97 ± 2.69 0.39
Errors of Omission 10.36 + 2.00 6.83 ±1.41 6.78 ±1.57 1.46
No. ITI Responses 1.53 + 0.21 1.43 ±0.12 1.57 ±0.13 0.26
Corr. Resp. Lat. (sec) 1.23 + 0.14 0.96 ±0.10 1.00 ±0.11 0.67
Incorr. Resp. Lat. (sec) 1.96 ±0.25 1.70 ±0.25 1.54 ±0.26 0.66
Bias (Index Y) 0.29 ± 0.05 0.28 ± 0.05 0.27 ± 0.03 0.08
All p’s > 0.050; No.: number; Corr. Resp. Lat.: correct response latency; Incorr. 
Resp. Lat.: incorrect response latency
Effects of acute scopolamine treatment
Percentage correct responding was not affected during this phase of testing 
(treatment effect p3,8i = 1.43, genotype effect p2,27 = 0.58, treatment x genotype 
effect F6,8i = 0.44, all p’s > 0.050) (Figure 11.8B). However, scopolamine reduced 
the number of reinforcers earned (F3,8i = 29.26, p < 0.001) while no effects of 
genotype were found (genotype effect F2,27 = 2.38, treatment x genotype effect Fe.si 
= 0.32, both p’s > 0.050) (Figure 11.8A). Scopolamine treatment resulted in an 
concomitant increase in errors of omission (F3,8i = 61.81, p < 0.001; treatment x 
genotype effect Fô,8i = 0.27, p > 0.050) (Figure 11.8C). No differences in correct 
response latency were found (treatment effect F3,8i = 0.77, genotype effect F2,27 = 
1.56, treatment x genotype effect Fô,8i = 0.20, all p’s > 0.050), and no genotype or 
treatment effects were found in term of incorrect response latency (treatment effect 
F3,8i = 1.67, genotype effect F2,27 = 0.47, both p’s > 0.050). A significant genotype x 
treatment interaction was found for the latter parameter (Fô,8i = 2.84, p = 0.020) 
(Figures 11.8E, F), but post hoc analysis failed to reveal a difference of individual
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dosages. In addition, ITI responses decreased by scopolamine treatment (Fgjg = 
12.74, p < 0.001) while biased responding increased by treatment (Fs.gi = 61.81, p =
0.003) (Figures 11.8D, G). No effects of genotype were found for either parameters 
(ITI responses: genotype effect F2,26 = 0.94, treatment x genotype effect Fejg = 1.03; 
biased responding: genotype effect F2,26 = 1 05, treatment x genotype effect Fe.vs = 
1.23, all p’s >0.050).
Effects of acute R121919 treatment
Percentage correct responding remained unaffected by treatment (Fi,27 = 0.00, p >
0.05) (Figure 11.9B). However, the number of reinforcers earned decreased as a 
function of dose (Fi,27 = 25.97, p < 0.001), whereas errors of omission concomitantly 
increased (F%,27 = 27.77, p < 0.001) (Figure 11.9A, C). Furthermore, both correct 
(Fi,27 = 7.54, p = 0.011) and incorrect (Fi,27 = 4.70, p = 0.039) response latencies 
were increased after treatment (Figures 11.9E, F). In addition, ITI respondings was 
decreased by treatment (Fi,27 = 5.88, p = 0.023), while biased responding remained 
unaffected (Fi,26 = 1.03, p > 0.05) (Figures 11.9D, G). No effect of genotype were 
found in terms of percentage correct responding (genotype effect F2,26 = 0.37, 
genotype x treatment effect F2,27 = 141), reinforcers earned (genotype effect F2,26 = 
2.58, genotype x treatment effect F2,27 = 0.02), errors of omission (genotype effect 
F2,26 = 1.66, genotype x treatment effect F2,27 = 0.46), ITI responses (genotype effect 
F2,26 = 1.11, genotype x treatment effect F2.27 = 0.58), biased responding (genotype 
effect F2,26 = 0.54, genotype x treatment effect F2,26 = 0.12) and correct response 
latency (genotype effect F2,26 = 2.69, genotype x treatment effect F2,27 = 2.10) (all p’s 
> 0.050). Group differences just failed significance for incorrect response latency 
(F2,26 = 3.34, p = 0.051), and a significant interaction between genotype and
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treatment was found (genotype x treatment effect p2,27 = 4.55, p = 0.020). Post hoc 
testing revealed that knockout mice showed an increase in incorrect response latency 
compared to wildtype (p < 0.010) and heterozygote (p < 0.050) mice.
Discussion
All groups performed equally well during the autoshaping procedure. Animals 
performed above change level during simple visual discrimination learning, 
indicating they all learned the association between the stimulus and reward. 
Although all groups improved in performance over sessions in terms of accurate 
responding, knockout animals showed impaired performance. However, during the 
phase reduction of stimulus duration, homozygote knockout animals performed as 
accurate as the other groups. This suggests that mice lacking the CRHR2 can learn to 
visual discriminate as well as wildtype littermate, but leam at a lower rate.
The data presented in this and in previous chapters show that increasing the 
attentional load by reducing the stimulus duration result in a decrease in number of 
reinforcers earned, in percentage correct responding, response latencies and ITI 
responding, independent of genotype. Strikingly, the errors of omission also 
decreased following reduction of the stimulus duration. Furthermore, both correct 
and incorrect latencies decreased and dissociated: under long stimulus duration, 
correct and incorrect response latencies did not differ, whereas corrects responses 
were made faster than incorrect responses with shortening of stimulus duration, when 
performance started to be attentionally demanding.
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Figure 11.8 Effects of scopolamine on 5-CSRTT in mice (partially) lacking CRHR2. Scopolamine 
was administered at dosages of 0.0, 0.02, 0.1, 0.5 and 1.0 mg/kg i.p., 20 min prior to testing. 
Treatment was given in ascending order. (A) number of reinforcers earned, (B) percentage correct 
responding, (C) number of errors of omission, (D) incorrect response latency, (E) ITI responses per 
trial (F) Biased responding (index Y). Data are presented as means, with error bars denoting SEMs.
234
A40 ■ 
I  30-
I 2 0 ' 
10 •
C
40 
I  30
I 20 
10
E
Reinforcers Earned
mm
40,00
R121919 (mg/kg)
Errors of Omission
m
40,00
R121919 (mg/kg)
Correct Response Latency
40,00
R121919 (mg/kg)
G Biased Responding
B
Percentage Correct Responding
80
U
£ 60
5? 40 
20
40,00
R121919 (mg/kg)
D ITI Responses
40,00
R121919 (mg/kg)
Incorrect Response Latency
4.5
I
1.5 
0,5
40,00
□  wt 
□hz 
I  ko
R121919 (mg/kg)
0 40,00
R121919 (mg/kg)
Figure 11.9 Effects of R121919 (40 mg/kg) on 5-CSRTT in mice (partially) lacking CRHR2. (A) 
number of reinforcers earned, (B) percentage correct responding, (C) number of errors of omission, 
(D) incorrect response latency, (E) ITI responses per trial (F) Biased responding (index Y). Data are 
presented as means, with error bars denoting SEMs.
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Extended testing with 0.5 sec stimulus duration revealed that knockout animals made 
less errors of omission, while no other parameter differed during this experimental 
stage between groups, suggesting that lack of CRHR2 has no effect on target 
scanning, but exerts non-specific effects on responsivity. Furthermore, groups failed 
to differ when predictability of the stimulus was enhanced by cued detection.
After baseline performance was stable, test conditions were changed in order to 
increase task difficulty. Thus, these data as well as fi*om previous studies 
demonstrate that presentation of a pre-sound before stimulus presentation had no 
effect on performance, suggesting that mice do not benefit from this manipulation 
(cued detection, Bushnell, 1995).
A range of alterations of basic parameters was applied in order to increase the 
attentional load. These alteration changed performance of mice in distinct ways: 
white noise primarily increased errors of omission. Although a previous experiment 
revealed an increase in accuracy (Chapter 9), such effect was absent in the present 
study. Reducing the ITI duration resulted in a reduction in reinforcers earned, an 
increase of errors of omission and an increase in correct response latencies. A 
reduction in accurate responding was observed in the study presented in Chapter 10 
but not in the present study. Furthermore, no significant effects of ITI reduction on 
performance were observed in the study presented in Chapter 9. These differences 
between these studies might be due to the small groups size in this study, and 
indicates the subtlety of the altered performance. Increasing the ITI duration did not 
alter performance in two studies, but increased accurate responding, reinforcers 
earned, and both latencies in another. This suggests that the attentional load increases 
following reduction of the ITI, but not due to unpredictability of the stimulus.
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Reducing the stimulus duration below 0.5 sec resulted in reduced accurate re­
sponding, but left errors of omission unaffected. Reinforcers earned were con­
comitantly decreased. Furthermore, correct and incorrect latencies were decreased.
Taken together, an increase in attentional load can be achieved by reducing the ITI 
duration or by reducing the stimulus duration, which is reflected by the effects on 
percentage correct responding and correct response latencies, measures which both 
have been suggested to be predictive for attention in this task (Blondel et al., 2000; 
Carli et al., 1983). An increase in ITI duration only appeared to decrease attentional 
load, whereas presentation of white noise prior to stimulus duration resulted in non­
specific effects on responsivity.
In the present study, alterations of basic parameters did not induce group differences, 
except that knockout mice showed an increased bias during an ITI duration of 2.5 sec 
only. Furthermore, knockout animals showed a reduced rate of errors of omission 
when the stimulus duration was reduced. Under baseline conditions it reached 
significance only when compared over several sessions, indicating the weakness of 
the effect. Attentional performance remained also stable in mutants when the 
attentional load was increased, or when the predictability of the stimulus was is 
reduced or in presence of a disrupting stimulus.
Blockage of muscarinic receptors by scopolamine treatment resulted in a reduction of 
reinforcers earned and an increment of errors of omission. Strikingly, and in contrast 
to the effect of scopolamine seen in other studies (Chapter 8, 9 and 10), no effect on
237
accurate responding was found. Furthermore, it is noteworthy that the disruptive 
effects of scopolamine occurred at lower dosages compared to other studies (Chapter 
8, 9 and 10). This could be due to difference in genetic background of the animals 
used in the different experiments. Alternatively, it is possible that the animals used 
different response strategies in the different experiments. Scopolamine treatment 
resulted in an increase in bias. This indicates that animal focus more on one side of 
the box. Such performance results in an easier strategy, but can be without effect on 
accurate responding (neglecting one side will increase the errors of omission, leaving 
accuracy unaffected). These scopolamine-induced changes occurred independent of 
genotype, suggesting that loss of CRHR2 does not alter the disrupting effect of 
scopolamine.
Treatment with R121919 resulted in an increase in errors of omission, a decrease in 
reinforcers earned, leaving percentage correct responding unaffected. Similar effects 
were reported in Chapter 8 and 10, albeit, less intense. Furthermore, R121919 
treatment also increased response latencies, whilst ITI responses were reduced. Thus, 
comparable to scopolamine treatment, R121919 treatment induced stronger 
disrupting effects with the applied dosage, which could be due to differences in 
genetic background.
Blocking CRHRl in CRHR2 knockout animals should result in total blockade of 
CRH activity. Despite this, no effect were found on attention, which suggests that 
inactivation of the CRH system does not impair attentional processes, as measured in 
the 5-CSRTT, which is in line with the results obtained with CRH knockout mice 
(Chapter 9). However, overproduction of CRH can impair attention. Although these
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disruptive effects could not be blocked acutely with R121919, long term 
administration may improve attention or blockade of CRHR2 may be beneficial, at 
least in improving attentional processes, in diseases in which attention is impaired 
and a hyperactive CRH system is involved such as depression.
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Chapter 12
Discussion
The focus of the present work was to investigate the role of the CRH system in 
emotional function and attention. In the first part of the work, anxiety-related 
behaviour was investigated. Since there is evidence from the literature that different 
anxiety tasks may measure different aspects of anxiety, a battery of anxiety tests was 
employed. Indeed, this was found in several experiments presented in this thesis, 
emphasising the importance to use multiple test for assessment of anxiety-related 
behaviour. This is, at least in part, due to the fact that: “all models used to date have 
limitations and no single paradigm adequately models all aspects of anxiety” (Weiss 
et al., 2000).
This test battery employed was also used to investigate the effects of life-long 
exposure to excessive CRH on anxiety-related behaviour. CRH overexpressing mice 
displayed increased anxiety-related behaviour in the light dark box, and a similar 
tendency was found in the open field and in time spent grooming after arousal, which 
was comparable to the anxiogenic effects of acute central CRH administration (Dunn 
and Berridge, 1990). In striking contrast, conflict behaviour and conditioned fear.
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tested 24 h after conditioning, were not affected by CRH overproduction. Even a 
reduced emotional response was found in conditioned fear when tested 1 hour after 
conditioning. The lack of increase in conditioned fear might be due to an impairment 
in learning and/or memory (see discussion Chapter 5). However, this would not 
explain the lack of overproduction of CRH on conflict behaviour. Alternatively, it is 
possible that CRH affects only a subset of the different types of anxiety measured in 
these paradigms. Thus, live-long overproduction of CRH may increase some, but not 
all aspects of anxiety.
The role of CRH on different aspects of Anxiety
A comparable distinction in the role of CRH in fear and anxiety has been proposed 
by Michael Davis and co-workers, based on studies of the startle reflex in rats. The 
startle reflex in rodents can be elicited by a loud sound. Presentation of a cue prior to 
the sound which was previously associated with an aversive stimulus (e.g. an 
footshock), potentiates the startle reflex is (Brown et al., 1951). Such phenomenon is 
known as fear-potentiated startle. The startle response can also be potentiated by 
i.c.v. administration of CRH, and this effect lasts for several hours. This is 
independent of HPA-axis activity, as adrenalectomy and lesioning the PVN has no 
effect on CRH-induced potentiation (Lee et al. 1994; Liang et al., 1992). Both forms 
of potentiation can be reduced by several classes of clinical active anxiolytics 
(Swerdlow et al., 1986; Lee et al., 1994). However, CRH potentiated startle is, in 
contrast to fear-potentiated startle, a form of long-lasting, unconditioned anxiety 
Fear potentiated startle, on the other hand, is believed to be an index of fear.
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A distinct functional anatomy underlies these forms of potentiation. Lesioning the 
basolateral or central nucleus of the amygdala blocks fear potentiated startle 
(Campeau and Davis, 1995; Hitchcock and Davis, 1986), while lesions of the BNST 
leave fear potentiated startle unaffected (Hitchcock and Davis, 1991). In striking 
contrast, lesioning the central nucleus of the amygdala fails to block CRH- 
potentiated startle, whereas lesioning the BNST blocks the effects of CRH 
completely (Lee and Davis, 1997). Furthermore, the enhancement of startle by i.c.v. 
administration of CRH can be mimicked by microinfusion of CRH directly into the 
BNST (Lee and Davis, 1997). In addition, i.c.v. CRH-enhanced startle can be 
reduced by local administration of a CRH antagonist into the BNST.
Based on the above described evidence, it has been suggested that the BNST may be 
a system that responds to signals more akin to anxiety than fear, whereas the central 
nucleus of the amygdala is clearly involved in fear and perhaps less so in anxiety 
(Lang et al., 2000). Both receive highly processed sensory information from the 
basolateral nucleus of the amygdala and hence are in a position to respond to 
emotionally significant stimuli. Furthermore, it was postulated that phasic activation 
of the amygdala by certain stressors could lead to long-term activation of the BNST 
via CRH (Lang et al., 2000). This in turn suggest that overproduction of CRH may 
enhance anxiety, but not fear, which would explain the increased anxiety-related 
behaviour seen in innate test of anxiety, but not in conditioned fear. This is in line 
with evidence showing that BNST lesions fail to affect conditioned fear (LeDoux et 
al. 1988).
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Conflict behaviour cannot be classified according to this anxiety / fear distinction 
and may possibly be an index of yet another aspect of anxiety-related behaviour. Of 
note, the unaltered conflict behaviour displayed by CRH overexpressing mice 
contrasts the anxiogenic effects seen after acute centrally administered CRH in 
conflict tasks (Britton et al., 1985, 2000). In addition, acute administration of CRHR 
1 antagonist increased responding in the Vogel conflict test (Millan et al., 2001). 
This suggests acute challenge of the CRH system can affect conflict behaviour, 
whereas chronic hyperactivation does not alter conflict behaviour which may reflect 
compensatory mechanisms, in contrast to the increased anxiety-related behaviour in 
innate test of anxiety, for example in the light dark exploration task.
Secondairy effects of overproduction of CRH
These differences between acute and chronic exposure to CRH could be due to 
interactions with other neurotransmitter systems. Indeed, data presented in the 
previous chapters provide evidence that CRH overexpressing mice have altered 
sensitivity to pharmacological challenges with compounds of several 
pharmacological classes such as GABA-ergic, serotonergic and cholinergic drugs, 
which may be absent after acute challenge.
For example, in Chapter 5, it was demonstrated that CRH overexpressing mice are 
less susceptible to the sedative effects of diazepam. GABA-ergic neurotransmission 
is potentiated by diazepam via binding to the GABAa receptors, which results in, 
among other phenomena, sedation and reduced anxiety-related behaviour. Therefore, 
it could be speculated that alterations in the GABA-ergic system might be involved 
in the altered anxiety profile of CRH overexpressors. However, the sedative effects
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and anxiolytic effects are mediated by distinct GABAa receptor subtypes in distinct 
neuronal circuits (Rudolph and Crestani et al., 1999; McKeman and Rosahl et al., 
2000). Therefore, additional experiments assessing GABA-ergic function in CRH 
overproducing mice in terms of anxiety-related behaviour are necessary to draw firm 
conclusions.
Perhaps a more likely neurotransmitter system being involved in the altered anxiety- 
related behaviour of CRH overproducing mice is the serotonergic system. The data 
presented in Chapter 6 indicate that HPA-axis activation via 5-HTia receptors is 
desensitised in CRH overexpressors, whereas hypothermia via 5-HTia receptors 
stimulation is unaltered. This suggests that postsynaptic 5-HTia receptors, probably 
at the level of PVN, are downregulated, whereas 5-HT autoreceptors remain 
unaltered (see Chapter 5 for discussion). The importance for alterations in 
serotonergic neurotransmission secondary to changes in CRH activity for 
behavioural performance is corroborated by findings that citalopram decreased 
anxiety-related behaviour in CRH overexpressing animals, while an opposite effect 
was found in wildtype mice. Surprisingly, the lack of HPA-axis activation after 5- 
HTia challenge still emerged in CRH overexpressors. Of note, one of the features 
often observed after chronic treatment with antidepressants or ECT is a 
desensitisation of the 5-HTia autoreceptor. This phenomenon seems to have occurred 
in both wildtype as well as in transgenic mice
Based on these data, it could be hypothesised that the increase in serotonergic 
ftinction, which is believed to occur after desensitisation of the 5-HTia autoreceptor, 
might be anxiogenic in wildtype animals due to disturbing serotonergic
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neurotransmission. In transgenic animals, on the other hand, the beneficial effect of 
treatment may be due to restoring a disturbed serotonergic system, although it should 
of course be noted that it cannot be excluded that effects of treatment on anxiety- 
related behaviour might be due to changes secondary to those of the serotonergic 
system (for more details see discussion Chapter 7).
Effects of long-term treatment with SSRI’s differed not only in terms of anxiety- 
related behaviour between wildtype and CRH overexpressing animals, but effects on 
body weight also depended on genotype. Clinical studies have indicated that effects 
of SSRIs treatment on body weight also depend on the neurobiology of the 
depressive illness (Harvey and Bouwer, 2000). The data presented here suggest that 
CRH may play a role in such disease-depend effects.
Apart from alterations in the GABA-ergic and serotonergic system in CRH 
overexpressing mice, results presented in Chapter 8 provide evidence that the 
cholinergic system is also affected by overproduction of CRH: mice overproducing 
CRH were less susceptible to the effects of both blockade and indirect stimulation of 
cholinergic receptors in the 5-CSRTT. In this task, it has been demonstrated that 
cholinergic dysfunction can produce deficits in visual attention (Muir et al., 1992), 
and that these processes can also be disrupted by lesioning the basal cholinergic 
forebrain (Muir et al., 1994) or the prefrontal cortex (Muir et al., 1996). Moreover, it 
has recently been demonstrated that extracellular acetylcholine concentration is 
increased in the prefrontal cortex during performance in the 5-CSRTT (Passetti et al.,
2000). Therefore, it is hypothesised that the reduced responsiveness of CRH 
overproducing mice to the disruptive effects of both blockade and indirect
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stimulation of cholinergic receptors may be due to downregulation of cholinergic 
receptors in consequence of CRH-induced increases in cholinergic activity (Day et 
al., 1998a, b). However, it cannot be excluded that it the reduced susceptibility of the 
CRH overexpressors to these cholinergic drug is due to alteration in 
pharmacodynamics and/or pharmacokinetics in these mutants.
Such alterations in cholinergic processes may also affect anxiety-related behaviour at 
the cortical level (Bemtson et al., 1998a). For example, benzodiazepine inverse 
agonists are anxiogenic and enhance basal forebrain-cortical cholinergic activity, 
whereas agonists have opposite effects (Sarter and Bruno, 1994; Moore et al., 1993). 
Moreover, the anxiogenic effect of inverse agonist treatment could be blocked by 
i.c.v. administration of the cholinergic antagonist carbachol and was also no longer 
present after selective immunotoxic lesions of basal forebrain cholinergic neurons 
(Bemtson et al., 1996). More recently, it was reported that these effects may be 
mediated at medial prefrontal level (Hart et al., 1999).
Bemtson and colleagues (1998b) hypothesised that “the basal forebrain cholinergic 
projection is primarily involved in aspects of anxiety that arise from or depend on 
cortical processing of fear and anxiety-associated stimuli and associations”. This in 
tum suggests that alterations in the basal forebrain cholinergic system would affect 
anxiety-related behaviour depending on cortical processing.
One other symptom reported to occur in patients suffering from depression is 
reduced attentional processes. In order to investigate whether overproduction of CRH
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also results in altered attentional processes, CRH transgenic mice were tested in 5- 
CSRTT.
Measuring attention in mice
The 5-CSRTT has analogies with a range of human attentional paradigms (Mirsky 
and Rosvod, 1960; Sahakian et al., 1993; Wilkinson, 1963), and provides measures 
of sustained and divided attention in temporal and spatial domains (Bushnell, 1998; 
Muir et al., 1996; Robbins et al., 1993). The paradigm was adapted by Carli and 
colleagues (1983) for testing rats. In this work it has been demonstrated that 
attentional processes could be assessed in mice in an adapted 5-CSRTT set-up 
(Chapter 9-11), which has also been shown in other laboratories (Humby et al., 
1999).
Muscarinic blockade with scopolamine dose-dependently impaired accuracy and 
responsivity, as indicated by a decrease in percentage correct responses, in the 
number of reinforcers earned, and an increase in errors of omission, comparable to 
what has been reported in related paradigms in rats (Jones and Higgins, 1995; Mirza 
and Stolerman, 2000; Ruotsalainen et al., 2000) and mice (Humby et al., 1999). 
However, in the study presented in Chapter 11, scopolamine disrupted performance 
only in terms of reinforcers earned and errors of omission, leaving accurate 
responding unaffected. Furthermore, the disruption of performance occurred at lower 
dosages as in the other studies, and might be due to differences in genetic 
background. This would be in line with a study reported by Humby and co-workers 
(1999), showing that the disruptive effects of scopolamine on attentional function in 
mice differ between strains.
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The effects of diazepam were small, leaving accuracy unaffected and, if at all, caused 
release of responding, as evidenced by an increase in the number of reinforcers 
earned and an effect on errors of omission, which just failed significance. In similar 
lines, the benzodiazepine chlordiazepoxide did not affect the ability to discriminate 
in a simple conditional discrimination task in rats (Dudchenko et al., 1994), and 
although benzodiazepines impair successive visual discrimination, it has been 
suggested that this may be related to altered responsivity during trials where 
withholding of responding would have been appropriate (Cole and Michaleski, 1986; 
McNaughton, 1985). It is obvious, however, that benzodiazepines affect a range of 
attentional functions as well (e.g., McGaughy et al., 1994). Unfortunately, there is a 
relative paucity of published work on the effects of systemic GABA-ergic drugs, in 
particular of benzodiazepines, on 5-CSRTT performance, and only Muir and 
colleagues (1992) reported impaired performance in rats following administration of 
the G A B A a agonist muscimol directly into the basal forebrain.
Overproduction of CRH disturbs sustained and divided attentional processes
CRH overexpressing mice showed impaired autoshaping of a nose-poke response to 
a light stimulus, as indicated by retarded, but not absent, association between the 
stimulus and reward, and reduced responsivity. Although subsequent simultaneous 
discrimination training indicated that transgenic animals had learned some 
association as they performed above chance level from the first session onwards, 
they clearly performed below wildtype level. However, both groups of animals 
improved performance over session, indicating the ability to leam the discrimination 
in transgenic animals, although they continued to respond with lower accuracy. At
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least part of this may be due to different baselines carried over from autosbaping. In 
addition, biased responding was increased during acquisition and subsequent 
experimental stages, indicating that transgenic animals reverted to a more simple 
response strategy, that is to respond as to whether a signal bad appeared in a sort of 
go/no-go like manner, rather than where it bad appeared (Marston, 1996; Steckler, 
2001).
Extended training with long stimulus durations revealed that transgenic animals were 
able to reach similar accuracy levels as wildtype animals, although responsivity 
continued to be reduced, as indicated by a reduction in the number of reinforcers 
earned, increased errors of omission, decreased responsivity during the ITT, and 
increased response latencies. Once transgenic mice bad reached an accuracy level 
that was comparable to wildtype performance, they were also able to maintain 
accuracy to similar degree as wildtypes over a wide range of different stimulus 
durations. This indicates that learning the discrimination was retarded but 
remembrance of the response rule appeared to be intact once the discrimination was 
acquired. Along similar lines, Radulovic and colleagues (1999) suggested that CRH 
may primarily affect consolidation processes. However, acute local injection of CRH 
in the brain impairs or facilitates learning in the fear conditioning study depending on 
brain area, while CRH overexpressors were impaired in learning the appetitive 
discrimination task in the present set of experiments. Moreover, direct comparison of 
the two studies is hampered as one uses acute localised infusions, while the other 
tests animals with a life-long elevation of CRH activity and hence a wide range of 
potential compensatory processes. Alternatively, this might indicate that CRH 
facilitates association of an emotional response (fear) with an aversive stimulus, but
249
might impair learning in an appetitive situation. However, the results from the 
conditioned fear experiment argue against this possibility. In addition, i.c.v. infusions 
of CRH(6-33), which displaces CRH from its binding protein, have been shown to 
improve acquisition of an appetitively motivated visual discrimination in aged rats 
(Heinrichs et al., 1997), which argues against CRH induced impairment in appetitive 
learning. Yet another possibility would be that the site of action may be of relevance, 
as CRH binding protein is predominantly expressed at cortical and hippocampal level 
(Potter et al., 1992). Thus CRH may facilitate learning at these levels but impair 
learning when infused into other brain areas (Behan et al., 1995). Furthermore, at 
least part of the effect of CRH on performance in tasks of learning and memory are 
due to factors other than effects on learning per se. Indeed, the improvement seen 
following CRH(6-33) in the study by Heinrichs and colleagues (1997) was seen 
during early but not late acquisition sessions, arguing against a direct effect on 
learning. Likewise, we observed a parallel shift in acquisition, i.e., the rate of 
learning was intact in transgenic animals and, for example, altered responsivity could 
have affected accuracy in transgenic mice.
Another factor that could interfere with learning would be a change in arousal or 
attentional processes. Overarousal due to excess CRH could explain the results 
obtained during acquisition.
When animals were tested for an extended period of 17 sessions with shortest 
stimulus duration (0.5 s), a mild but significant impairment in percentage correct 
responding re-emerged in transgenic animals. This was accompanied by longer 
correct response latencies, while incorrect latencies did not differ between groups.
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This accuracy deficit was independent on whether or not a pre-sound was present, 
suggesting that CRH overexpressing mice did not benefit from this manipulation 
guiding stimulus detection (cued detection; Bushnell, 1995).
CRH overexpressing mice have been reported to express high levels of ACTH and 
corticosterone (Stenzel-Poore et al., 1992) and to display hypoactivity when exposed 
to a novel environment (Chapter 5, Stenzel-Poore et al., 1994), which is comparable 
to the effects of acute i.c.v. CRH administration, which is even more accentuated 
following social defeat stress (Stenzel-Poore et al., 1994). Furthermore, these 
animals show enhanced anxiety-related behaviour in several anxiety paradigms. 
Therefore, it is noteworthy that transgenic animals seemingly showed a behavioural 
response that was similar to the one seen in wildtype mice in the five choice 
paradigm. One explanation for this discrepancy could be that animals were highly 
familiarised with the present task, while exaggerated behavioural responses 
following CRH administration or in animals overexpressing CRH are primarily seen 
following exposure to novel situations (Stenzel-Poore et al., 1994). In addition, CRH 
overexpressors display hypolocomotor activity when tested in range of tasks, which 
is not longer present after habituation to the test apparatus (Chapter 5). Along similar 
lines, diazepam failed to affect performance in transgenic animals. Another 
benzodiazepine with comparable anxiolytic, amnestic and sedative properties, 
chlordiazepoxide, has been reported to attenuate the performance deficit in CRH 
overexpressing mice tested in a water maze place navigation task (Heinrichs et al., 
1996), But here again, animals are exposed to a highly novel situation. In the familiar 
operant task, transgenic mice only differed from wildtype mice in a stronger 
behavioural disinhibition induced by diazepam. This renders explanations that
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performance deficits seen in transgenic mice on this task are due to altered anxiety 
unlikely. Therefore, it is suggested that chronic excessive CRH exposure results in a 
mild attentional deficit.
Sustained and divided attention remains intact without CRH
Since it is possible that CRH is not only disruptive, but that a central level of CRH 
activity is necessary for adequate level of arousal and attention, CRH knockout were 
tested in 5-CSRTT. However, in Chapter 9, it was demonstrated that lack of CRH 
does not alter the learning of the association of the light with the reinforcement, 
simultaneous discrimination, or visual spatial attention under basal conditions, under 
conditions with an increased attentional load, or after stress exposure. This suggests 
that either CRH has only disruptive properties in attentional processes, but is not 
required for proper visuospatial attentional functioning, or that the arousing 
properties of CRH, which may be necessary for attentional functioning, might be 
taken over by other ligands of the CRH family such as UCN, UCNII or UCNIII.
The role of CRHRl and CRHR2 in sustained and divided attention
The effects of lack of CRHRl and CRHR2, and acute blockade of CRHRl were 
investigated in subsequent experiments. Animals lacking CRHRl learned the task 
equally well and as fast as wildtype animals. CRHR2 knockouts also learned to the 
task as well as wildtype mice, but at a lower rate. However, CRHR2 knockout mice 
did not display altered performance in parameters that are thought to reflect attention. 
Instead, CRHR2 knockout mice made significantly less errors of omission when 
measured over several sessions or under conditions of increased attentional load. 
This is not likely to be due to altered attentional processes, but may be due to
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increased motivation. Spina and co-workers (1996) showed that i.c.v. administration 
of UCN decreased food intake in food deprived animals as well as in free-feeding 
rats. In fact, CRHR2 is expressed in the ventromedial hypothalamus (Chalmers et al., 
1995), which makes this CRH receptor subtype a likely candidate for mediating the 
food intake suppressive effects of UCN. Mice lacking CRHR2 have been reported to 
have normal basal feeding and weight gain, whereas food intake is decreased 
following food deprivation (Bale et al., 2000; Kishimoto et al., 2000). However, 
UCN inhibited food intake for a longer period in wildtype animals than in CRHR2 
knockouts, indicating that CRHR2 is involved in the suppressive effects of UCN on 
food intake (Conti et al., 1994). This suggests that the reduced number of errors of 
omission could be due to altered motivational drive.
CRHRl knockout, in contrast, show reduced accurate responding. However, this 
difference in accuracy, albeit significant, was marginal (56.72 % vs. 50.07 %). The 
fact that groups only started to dissociate after a few sessions also argues against a 
pure attentional deficit and opens the possibility that other factors contributed to 
these results. Indeed, learning deficits have been reported in mice lacking CRHl 
(Contarino et al., 1999). However, such a learning deficit would have to be regarded 
as subtle as animals perfectly well acquired the initial discrimination in the present 
set of experiments, and the deficit only became apparent under conditions of high 
task difficulty.
This accuracy deficit in CRHRl ko mice was also seen under conditions of short ITI 
durations, i.e., when stimuli were presented at faster rate than expected, but it was 
independent on the length of the ITI, which would also argue against a pure
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attentional deficit. An increase of ITI duration seemed to have even beneficial effects 
in that groups did no longer differ during these latter sessions with the exception of 
an increase in incorrect response latencies in mutant mice.
Acute blockade of CRHRl does not affect sustained and divided attention
Along similar lines, administration of the CRHRl antagonist R121919 reduced 
responsivity, as indicated by increased omissions and decreased reinforcers earned. 
However, R121919 does not alter performance in terms of parameters reflecting 
attenion. Moreover, R121919 also failed to improve performance in CRH 
overproducing animals, suggesting that the deficit seen in the overexpressors was not 
mediated through overactivation of this receptor subtype. In contrast, subchronic 
administration of R121919 has been reported to attenuate the increased anxiety- 
related behaviour seen in CRH overexpressing mice (Min et al., 2000), again 
indicating a dissociation between the effects of CRH excess on anxiety- and stress- 
related behaviour, which may be mediated via the CRHRl or, and the effects of CRH 
overactivity on attention and/or arousal. One possibility could be that the effects of 
CRH on this type of behaviour are mediated via the CRHR2, although lack of 
CRHR2, in absence over excessive CRH, does result in alterations in visuospatial 
attention. Alternatively, repeated administration of R121919 may be necessary to 
restore alterations secondary to live-long CRHRl overstimulation.
Effects of cholinergic dnrgs are altered in mice with mutations in the CRH 
system
Interestingly, manipulation of the cholinergic system affected both CRH 
overexpressors and wildtype animals to different degree. Although the effects of
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scopolamine on accuracy were comparable between groups, the effects of 
scopolamine on the number of reinforcers earned were more pronounced in wildtype 
mice. Likewise, physostigmine had stronger effects in wildtype than in transgenic 
animals at high doses (0.5 mg/kg), suggesting again decreased sensitivity of CRH 
overexpressors to cholinergic manipulation, i.e., to the response depressing effects of 
the drug. The errors of omission and the number of reinforcers measures confirmed 
this suggestion. Strikingly, scopolamine was also more potent in disrupting 
performance in wildtype animals compared to CRH knockout mice. This suggests 
that cholinergic functioning is altered following CRH hypo- as well as hyperactivity. 
However, differences in pharmacodynamics and/or pharmacokinetics in mutant 
animals cannot be ruled out.
One possibility could be that CRHRl blockade led to further decrease in cholinergic 
activity, thereby leading to interaction with scopolamine. However, this effect is 
unlikely to be mediated via the nucleus basalis magnocellularis-cortical axis as 
hardly any co-localisation between CRHRl- and choline-acetyltransferase 
immunoreactivity has been observed at this level (Sauvage and Steckler, 2001). 
Lesions of the nucleus basalis magnocellularis lead to reduced accuracy in the 5- 
CSRTT (Muir et al., 1992; Muir et al., 1994; Robbins et al., 1989), and the lack of 
CRHRl at this level could explain the unaltered attentional function in 5-CSRTT in 
CRHRl and CRH knockout animals. Indeed R121919 failed to affect accuracy, alone 
or in combination with scopolamine. Although CRHRl receptors are highly co­
localised at cholinergic neurons in the medial septum and the diagonal band of Broca 
(Sauvage and Steckler al., 2001), these areas are unlikely to be involved in the 
modulation of attentional function in the 5-CSRTT. Lesions of the vertical limb of
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the diagonal band, from which cholinergic projections to the cingulate cortex 
originate, do not alter 5-CSRTT performance in rats (Muir et al., 1996; Muir et al., 
1992), and lesions of the hippocampus, i.e., of the target area for cholinergic 
projections arising from the medial septum, have been reported to also have no 
effects on a seven-choice serial reaction time task (Burk et al., 1999). Of course, it 
remains a possibility that the interaction between CRHRl blockade and muscarinic 
blockade takes place at brainstem level, involving the penduculopotine tegmental 
nucleus or laterodorsal tegmental nucleus projections to the thalamus, or at cortical 
or other subcortical levels known to be involved in the mediation of performance on 
that task, such as the medial prefrontal cortex, as lesions of this cortical area, i.e., of a 
brain area rich in CRH-containing neurons and CRHRl (Chalmers et al., 1995; 
Wilcoxen et al., 2000; Swanson et al., 1983), have been reported to also impair 
accuracy and response latencies (Muir et al., 1996).
Alternatively, it is possible that CRHRl blockade interfered with dopaminergic 
neurotransmission as dopaminergic neurons in both the substantia nigra pars 
compacta and the ventral tegmental area strongly express CRHRl (Sauvage et al.,
2001). Moreover, dopaminergic neurotransmission is stimulated by CRH (Lavicky 
and Dunn, 1993), and lesions of the mesolimbic dopaminergic system in rats slow 
responding without affecting accuracy in the 5-CSRTT (Cole and Robbins, 1989),
i.e., induce effects comparable to those seen following R121919 administration.
To summarise, visuospatial attention is not affected by lack of CRH or CRHR2. 
Functional deletion of CRHRl, however, results into impaired performance in the 5- 
CSRTT, although this deficit developed over sessions, which argues against a pure
256
attentional deficit. Excessive CRH activity disturbs attentional functioning, which 
cannot be reversed by acute blockade with a CRHRl antagonist. However, CRH 
overproduction also results alteration in various neurotransmitter systems, and 
therefore chronic inhibition of CRH transmission via CRHRl might be necessary to 
restore visuospatial attention. Alternatively, it is possibly that disruption of 
attentional processes occurs via CRH2. This question can be tackled by investigating 
effects of novel compounds blocking CRHR2.
Conclusions
From the results reported in this thesis, the following points can be concluded: 
chronic CRH excess increases some, but not all, aspects of anxiety. More 
specifically, innate anxiety seems to be disrupted, while conflict and fear may be 
spared. These effects were reversed by long-term treatment with citalopram. 
Interestingly, citalopram has beneficial effects in both patients suffering from anxiety 
disorders as well as depressive patients. Moreover, 5-HTia receptor challenge failed 
to activate the HP A axis in CRH overexpressing mice, while the hypothermic 
response following 5-HTia stimulation remained intact, which bears further 
resemblance to the situation seen in depressed patients. These findings suggest that 
CRH overexpressing mice may be a useful model of depression. More importantly 
even, these findings add to the growing literature implicating CRH into the 
pathophysiology of depression and anxiety disorders.
These conclusions received further support from findings on the attentional function 
of these animals. Overproduction of CRH induced an impairment in visuospatial 
attention and altered responsiveness to cholinergic drugs was seen in these mice.
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These findings might have important implications for the development of novel 
strategies to treat depression and suggests that treatments aiming at normalizing the 
activity of the CRH system might be beneficial for a range of symptoms seen in this 
devastating disorder, including anxiety and cognitive dysfunction.
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